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RÉSUMÉ 
L’athérosclérose est une maladie inflammatoire chronique étroitement liée au 
dysfonctionnement des cellules endothéliales (CE). Ce dernier entraîne un 
recrutement excessif des leucocytes en raison d’une expression accrue de 
molécules d’adhésion vasculaire (ex VCAM-1) à la surface des CE et d’une 
désorganisation de leurs jonctions adhérentes constituées par les cadhérines 
vasculaires (VE-cadhérine). L’athérosclérose est aussi associée à un dépôt de 
la fibronectine (FN) et du collagène de type I (Coll I) dans la membrane basale 
(BM) et une diminution progressive de l’élasticité de la paroi artérielle. 
D'autres facteurs comme la protéine morphogénétique osseuse (BMP)-9 
jouent un rôle clef dans le comportement des CE. Néanmoins, la capacité des 
CE à répondre à la BMP-9 dans un contexte d’athérosclérose reste peu 
connue. Par conséquent, nous avons conçu un modèle in vitro en utilisant 2 
films de polydiméthylsiloxane (PDMS) mimant l’élasticité de la paroi de 
l’artère saine (1 MPa) ou athérosclérotique (2.8 MPa) afin, dans un premier 
temps, d’étudier l’influence de l’élasticité sur le comportement des CE 
aortiques abdominales humaines (HAAECs) en réponse à la FN. Nous avons 
montré que la méthode utilisée pour moduler l’élasticité du PDMS n’affectait 
pas ses propriétés de surface (angle de contact et rugosité). L’adsorption de la 
FN était aussi similaire sur les 2 films. Cependant, l’étalement des CE et 
l’adhésion focale étaient plus rapides sur les films PDMS 1 MPa par rapport 
aux films 2.8 MPa. Les cellules organisaient ainsi plus d’adhésion fibrillaire 
à 6h mais migraient de manière similaire à 24h. La capacité des CE à 
réorganiser une matrice de FN semble donc diminuer avec celle de l’élasticité 
d’un substrat mimant l’athérosclérose tardive, ce qui pourrait affecter la 
capacité des CE à répondre à leur environnement. Dans un second temps, nous 
avons donc analysé l’effet de la BMP-9 sur les HAAECs en fonction de 
l’élasticité du substrat, des protéines FN +/- Coll I et d’un environnement pro-
inflammatoire (TNF-α). La combinaison BMP-9/TNF-α augmentait 
l’expression de VCAM-1 en fonction du type de protéines utilisées. De plus, 
l’activation des gènes codant pour des interleukines (IL)-1β et IL-6 dépendait 
du type de protéines et de l’élasticité du PDMS. Les jonctions adhérentes VE-
cadhérine dépendantes étaient aussi partiellement rompues lors de la 
stimulation BMP-9/TNF-α. Ainsi, les changements de composition de la BM 
et de l’élasticité du substrat retrouvés dans un contexte d’athérosclérose 
pourraient accroître la réponse des CE aux stimuli inflammatoires en présence 
de la BMP-9. 
MOTS CLÉS: PDMS, Module de Young, Fibronectine, Collagène, VCAM-
1, VE-cadhérine, Inflammation  
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ABSTRACT 
Atherosclerosis is a chronic inflammatory disease initiated by endothelial cell 
dysfunction (EC). Such EC dysfunction favor leukocyte recruitment via the 
expression of vascular adhesion molecules (eg VCAM-1) on the EC 
membrane as well as a disruption of their adherent junctions made of vascular 
cadherins (VE-cadherin). Atherosclerosis is also associated with a deposition 
of fibronectin (FN) and collagen type I (Coll I) in the basement membrane 
(BM) and the progressive increase in arterial wall stiffness. Other factors such 
as bone morphogenetic protein (BMP)-9 play a key role in EC behavior. 
Nevertheless, the ability of ECs to respond to BMP-9 in the context of 
atherosclerosis remains unclear. Therefore, we developed an in vitro model 
using 2 films of polydimethylsiloxane (PDMS) mimicking the stiffness of the 
healthy artery wall (1 MPa) or of atherosclerotic arteries (2.8 MPa) in order 
to study the influence of stiffness on human abdominal aortic EC (HAAECs) 
behavior in response to FN. We have first shown that the method used to 
obtain the elasticity of PDMS did not affect its surface properties in terms of 
contact angle and roughness. The adsorption of FN was also similar on both 
films. However, EC spreading, and focal adhesion were faster on 1 MPa 
PDMS films compared to 2.8 MPa films. Indeed, the cells organized more 
fibrillar adhesion at 6h but migrated similarly after 24 h. The ability of ECs to 
rearrange an FN matrix thus appears to decrease with increasing stiffness of a 
substrate mimicking late atherosclerosis, which could affect the EC's ability 
to respond to their environment. Then, we have therefore analyzed the effect 
of BMP-9 on HAAECs as a function of substrate elasticity, FN +/- Coll I 
protein coating and a pro-inflammatory environment (TNF-α). The BMP-9 / 
TNF-α combined treatment increased the expression of VCAM-1 in function 
of the type of protein coating used. In addition, the activation of the genes 
encoding for interleukins (IL)-1β and IL-6 depended on the type of coated 
proteins and on the elasticity of the PDMS. The adherens junctions as shown 
by VE-cadherin staining were also partially disrupted during BMP-9 / TNF-α 
stimulation. Thus, changes in BM composition and substrate stiffness found 
under atherosclerotic conditions may increase the response of ECs to 
inflammatory stimuli in the presence of BMP-9. 
KEYWORDS: PDMS, Young’s modulus, Fibronectin, Collagen, VCAM-1, 
VE-cadherin, Inflammation  
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1 CHAPTER 1 INTRODUCTION  
1.1 Problematic and Project Outline 
Cardiovascular diseases (CVDs) are the main cause of death in the world (WHO, World 
Health Organization 2017). In Canada CVDs and stroke, which can be the outcome of 
CVDs, are the leading causes of death after cancer (Government of Canada 2017). In 
addition, myocardial infarction alone exerts around $3 billion annual cost on Canadian 
economy (Heart and Stroke Foundation of Canada 2016). Hence, biomedical researchers 
are vigorously engaged in the field to develop new measures and applicable solutions in 
order to reduce CVDs’ damage as well as to provide the scientific community with more 
insight on CVDs development (Bayoumi et al. 2018; Estrada-Luna et al. 2018). 
Atherosclerosis, an inflammatory disease, is a major causal factor of CVDs that can also 
lead to stroke (Betts et al. 2013). There are many risk factors associated with 
atherosclerosis occurrence such as smoking, aging, and sedentary lifestyle (Rafieian-
Kopaei et al. 2014; Wang et al. 2018). Atherosclerosis disease locally develops in certain 
areas of the vascular tree such as branching sites (Kumar et al. 2014), and its development 
and progression are tightly linked to endothelial cells (ECs) dysfunction (Ross et al. 1977; 
Stocker and Keaney 2004; Hansson 2005; Rajendran et al. 2013; Gimbrone and García-
Cardeña 2016). ECs line interior wall of blood vessels, forming a monolayer known as 
endothelium which is in direct contact with blood flow (Kumar et al. 2014). 
ECs evolve from a quiescent to an activated phenotype affecting vascular homeostasis 
through several factors such as excessive recruitment and extravasation of leukocytes, 
especially macrophages, that, in subendothelial region, become fat-laden foam cells after 
oxidized low-density lipoprotein (ox LDL) engulfment (Ross et al. 1977; Stocker and 
Keaney 2004; Hansson 2005; Rajendran et al. 2013; Gimbrone and García-Cardeña 2016). 
Furthermore, changes in the composition and structure of the basement membrane (BM) 
(e.x., enhancement in fibronectin (FN), FN/collagen type I (Coll I), Coll I, in 
atherosclerosis) influence EC phenotype (Voss and Rauterberg 1986; Kalluri 2003; Zent 
and Pozzi 2010; Yurchenco 2011; Schnittler et al. 2014; Yurdagul et al. 2014). Such 
changes promote an increase in pro-inflammatory chemokines synthesis such as tumor 
necrosis factor (TNF)-α (Hansson 2005) involved in higher endothelial permeability 
2 
 
(Angelini et al. 2006; Lampugnani 2010; Abu Taha and Schnittler 2014) and subsequent 
leukocyte recruitment (Mitrofan et al. 2017). EC dysfunction is also associated with 
stiffening of arterial wall in atherosclerosis changing from 1.0 MPa to ~3 MPa in human 
coronary arteries (Ozolanta et al. 1998; Karimi et al. 2013).  
Other circulatory factors especially growth factors, GF, such as vascular endothelial growth 
factor, VEGF, and transforming growth factor beta (TGF-β) family can also affect ECs 
activation states (Bidart 2012; Daniel and van Buul 2013; Luo et al. 2017). A prominent 
regulator of EC behavior is the bone morphogenetic protein (BMP)-9, a member of the 
TGF-β family (Bidart 2012), which is a potent soluble cytokine circulating in blood plasma, 
with a high concentration ranging from 2 to 12 ng/mL (David et al. 2008). In fact, BMP-9 
concentration in blood plasma is much above its EC50 (50 pg/mL) (Baeyens et al. 2016).  
BMP-9 is particularly known for its effects on ECs proliferation, migration, and 
inflammatory response (David et al. 2008; Mitrofan et al. 2017). For example, it has been 
shown that BMP-9 blocked EC (human umbilical vein endothelial cell, HUVEC) sprouting 
in vitro (Larrivée et al. 2012). Interestingly, FN, an abundant ECM protein in 
atherosclerosis, can enhance BMP-9 signaling as result of integrin (α5β1) activation in 
human microvascular endothelial cell (HMEC) ( Tian et al. 2012).  
Nevertheless, despite some studies on the interplay between BMP-9 and pro-
atherosclerosis factors (i.e. risk factors such as hyperglycemia and pro-inflammatory 
cytokines) (Chait and Bornfeldt 2009; Luo et al. 2017; Mitrofan et al. 2017; Akla et al. 
2018), the influence of BMP-9 in atherosclerosis is still poorly investigated.  
Hence, to better understand the role of BMP-9 in atherosclerosis, we developed an in vitro 
model partially replicating atherosclerosis condition using human abdominal aortic 
endothelial cells (HAAECs) attached to polydimethylsiloxane (PDMS) films. We prepared 
PDMS films that had a stiffness mimicking human arterial wall bulk stiffness in both 
physiological (i.e. E = 1.0 MPa) and healthy (i.e. E = 2.8 MPa) conditions (Ozolanta et al. 
1998; Karimi et al. 2013).  
The PDMS films were produced by adjusting curing temperature while keeping the same 
chemistry for both soft and stiff conditions. Furthermore, we included ECM protein 
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coatings, i.e. FN, Coll I, and FN/Coll I to better replicate BM changes under atherosclerosis 
condition. Importantly, we applied BMP-9 to study its effect in atherosclerosis by adding 
also pro-inflammatory cytokine TNF-α. To conclude, by means of this ECM protein-coated 
PDMS-based in vitro model, we were able to perform experiments to shed light on the 
crosstalk between atherosclerosis-related markers under HAAECs behavior.  
1.2 Project Definition and Objectives 
1.2.1 Research Hypothesis  
The research hypothesis of this PhD project is that changes in stiffness and basement 
membrane protein composition mimicking atherosclerosis development can influence EC 
adhesion kinetics and gene/protein expression in response to BMP-9.   
1.2.2 Research Objectives  
The principal aim of this PhD thesis was, therefore, to replicate stiffness of arteries in early 
and late atherosclerosis and change ECM protein composition to investigate ECs adhesion, 
migration, and answer to BMP-9 regarding ECs’ role in inflammation and endothelial 
permeability.  
• Subobjective 1 (corresponding to Chapter 3): Studying the influence of FN on 
HAAEC adhesion as function of substrate stiffness mimicking healthy artery/early 
and late atherosclerosis.  
For this purpose, PDMS films with defined stiffness, representing healthy and 
atherosclerotic arteries with Young’s modulus of 1.0 and 2.8, respectively, were first 
produced and characterized (engineering Young’s modulus, roughness, and water contact 
angle). Then the ability of PDMS stiffness to influence FN physisorption and the 
conformation of the coated FN molecule was assessed. The influence of substrate stiffening 
on HAAEC adhesion within 6h (i.e. 30min, 1h, 2h, 4h, and 6h) was also determined by 
analyzing roundness factor and cell spreading over time. The kinetics of focal adhesion 
(FA) formation (1h and 4h) as well as the organization of fibrillar adhesion and 
organization of FN fibrils (6h) were both studied. Finally, the effect of PDMS stiffness on 
HAAECs migration was observed at 24h. 
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• Subobjective 2 (corresponding to Chapter 4): Studying the influence of FN and Coll 
I as function of PDMS stiffness on ECs’ response to BMP-9 in a pro-inflammatory 
environment. 
For this purpose, HAAECs attached to PDMS films (1.0 and 2.8 MPa) coated by FN, Coll 
I, or FN/Coll I were treated under BMP-9 and translocation of phosphorylated Smad1/5 
(P-Smad1/5) into the nucleus was analyzed at 4h. As a control, the kinetics of BMP-9-
induced Smad1/5/8 activation were also studied in HAAECs adherent to cell culture treated 
polystyrene coated by FN, Coll I, FN/Coll I, or porcine gelatin. The ability of HAAECs to 
respond to BMP-9 alone or BMP-9 in a pro-inflammatory environment by adding TNF-α 
was also studied at 24h in terms of cell morphology and expression of genes encoding for 
proteins involved in inflammatory response (vascular cell adhesion molecule VCAM-1, 
interleukin IL-1 and IL-6) and EC function such as permeability (vascular endothelial VE-
Cadherin and vascular endothelial growth factor, VEGF, involved in disruption of 
endothelial integrity and angiogenesis). Finally, the protein expression of adhesion 
molecule involved in leukocytes recruitment (i.e. VCAM-1) and the integrity of cell-cell 
contact via VE-cadherin localization involved in leukocyte extravasation were studied 
(48h).  
  
1.3 Original Contributions 
• Subobjective 1: at this step of the project we aimed to study HAAECs adhesion on FN-
coated PDMS films regarding substrate stiffness replicating early and advanced 
atherosclerosis:  
o By using 2 distinct curing temperatures, PDMS films with bulk stiffness mimicking 
healthy (1.0 MPa) and atherosclerotic arteries (2.8 MPa) were obtained without any 
change in both global water contact angles and surface roughness 
o We verified that HAAECs attached to the PDMS films mimicking healthy arteries 
at 2h in serum free medium have a lower roundness factor and a higher cell surface 
area (spreading)  
o We verified that FAs are formed faster in HAAECs on softer PDMS films after 1h 
despite a quite similar FN cell binding domain accessibility. 
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o We verified that HAAECs have an increased ability to organize FN fibrillar 
adhesion on softer PDMS films up to ~ 5-fold  
o We verified that HAAECs can migrate in a similar way on both PDMS films 
 
• Subobjective 2: in this phase of the project, we improved our PDMS model by 
including more ECM protein coating combinations, i.e. Coll I and FN/Coll I, to study 
the influence of soluble growth factor BMP-9±TNF-α. We observed:  
o In terms of Smad pathways within 4h: 
o Faster Smad1/5/8 phosphorylation in HAAECs attached to FN and FN/Coll 
I-coated polystyrene in response to BMP-9 compared to Coll I and gelatin 
o Translocation of P-Smad1/5/8 into the nucleus of HAAEC attached to FN, 
Coll I and FN/Coll I-coated PDMS films with stiffness of 1.0 and 2.8 MPa 
(4h), where translocation appeared more important in FN and Coll I 
coatings on the soft film and in Coll I coating on the stiff film  
o In terms of cell adhesion at 24h: 
o Higher cell attachment on FN and FN/Coll I coatings on both stiffness (24h)  
o More organization of actin stress fibers on FN and FN/Coll I coatings rather 
than Coll I alone, on both stiffness (24h) 
o In terms of gene and/or protein expression: 
o BMP-9 alone had no effect at 24h on VCAM-1, IL-1β and IL-6 gene 
expression in HAAECs attached to PDMS films (1.0 and 2.8 MPa). 
o TNF-α alone increased IL-1β mRNA levels in HAAECs attached to Coll I-
coated stiffer films (2.8 MPa) compared with BMP-9 plus TNF-α 
o BMP-9 plus TNF-α significantly increased at 24h  
o VCAM-1 gene expression in HAAECs attached to PDMS films (1.0 
and 2.8 MPa) as function of the protein coating, FN being the most 
effective  
o IL-6 gene expression in HAAECs in a protein coating and stiffness 
dependent manner:  
▪ FN/Coll 1-coated PDMS films (2.8 MPa) enhanced IL-6 
mRNA amounts in comparison to 1.0 MPa PDMS films. 
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▪ HAAECs attached to Coll I-coated stiffer films (2.8 MPa) 
had higher IL-6 mRNA amounts in comparison to TNF-α 
alone 
o VCAM-1 protein expression but reduced VE-cadherin protein 
localization at cell-cell contact (48h).  
 
1.4 Plan of the Document 
The thesis includes six main chapters. Chapter 1 (Introduction) describes a short 
problematic, research hypothesis and the objectives. Further, it briefly highlights the 
original contributions of this PhD project.  
First part of Chapter 2 (Literature Review) is dedicated to the accepted review paper 
discussing the most recent information on atherosclerosis disease, arterial histology, EC 
function/dysfunction, BMP structure/signaling, and BMP-9 effect on ECs behavior 
regarding proliferation, migration, sprouting, tube formation, angiogenesis and 
inflammation. The review also addresses interplay between BMP-9 and other 
atherosclerotic related players such as other cell types (e.x., vascular smooth muscle cells, 
VSMCs) and soluble cytokines and growth factors (e.x., TNF-α and VEGF).   
Title of the review: Effect of BMP-9 on endothelial cells and its role in atherosclerosis 
o  Authors: H. Hassanisaber, L. Rouleau, N. Faucheux 
o Journal: Frontiers in Bioscience 
The second part of the literature review describes and discusses how methods used to 
prepare PDMS films can influence some of their properties, especially stiffness. This part 
also introduces studies on PDMS under static or dynamic conditions as an in vitro model 
to analyze EC behavior.  
Chapter 3 is a research paper (published in Materials Science and Engineering: C) 
presenting the characterization of PDMS films in terms of stiffness, wettability and 
roughness and the effect of PDMS bulk stiffness on FN physisorption and availability of 
FN cell-binding domain. Further, regarding cell-substrate interactions, this paper reports 
7 
 
data on how PDMS stiffness affects HAAECs morphology, adhesion kinetics, and ability 
to form FA and fibrillar adhesion, as well as cell migration.  
o Title of the research paper: The Effect of Substrate Bulk Stiffness on Focal 
and Fibrillar Adhesion Formation in Human Abdominal Aortic Endothelial 
Cells 
o Authors: H. Hassanisaber, L. Jafari, M. A. Campeau, O. Drevelle, M-A. 
Lauzon, E. Langelier, N. Faucheux, L. Rouleau 
o Journal: Materials Science and Engineering: C 
 
Chapter 4 mainly includes data addressing BMP-9-induced Smad signaling in HAAECs 
seeded on ECM protein coated PDMS films with two distinct stiffness (i.e. FN, Coll I, and 
FN/Coll I on films with E = 1.0 MPa or  2.8 MPa). The kinetics of Smad1/5 
phosphorylation within 4h in HAAECs attached to petri dishes coated by FN, Coll I, 
FN/Coll I, or porcine gelatin  are also presented as a control to identify the better time to 
study P-Smad 1/5 nuclear translocation. The translocation of P-Smad1/5 into the nucleus 
in HAAECs attached to ECM protein coated-PDMS films was verified (4h). Further, 
HAAECs attachment morphology and mRNA level of genes including VCAM-1, IL-1, and 
IL-6 (24h) as well as VCAM-1 protein expression and localization of VE-cadherin protein 
in EC-EC contact (48h) were discussed regarding BMP-9 ± TNF-α treatment.   
Chapter 5 (Global Conclusion and Perspectives) briefly summarizes the highlights of the 
findings in this PhD project particularly addressing substrate stiffness, ECM coating, and 
BMP-9 effects. Further, suggestions are proposed to design/perform further experiments 
for improving scientific community’s insight into BMP-9/ECs interactions in the context 
of atherosclerosis disease development.  
Chapter 6 includes APPENDIXA introducing table of all prepared PDMS molds and 
Chapter 7 is the list of the references.  
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2 CHAPTER 2 LITERATURE REVIEW: Effect of BMP-9 on 
Endothelial Cells and its Role in Atherosclerosis  
 
Avant-propos 
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Titre français: Effet de la BMP-9 sur les cellules endothéliales et son rôle dans 
l'athérosclérose 
Title: Effect of BMP-9 on endothelial cells and its role in atherosclerosis 
 
Contribution to the document:  
This review introduces the general histology of arteries where atherosclerosis disease 
occurs. It also comprehensively discusses EC function and how their injury/dysfunction 
would lead to development of atherosclerosis. Further, it provides information about bone 
morphogenetic protein (BMP) soluble growth factor structure as well as their signaling 
pathways, BMP-9 in particular. It describes how BMP-9 influences ECs behavior in terms 
of proliferation, sprouting, cord formation, angiogenesis, and inflammatory response. 
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Importantly, it discusses how such BMP-9 effects can influence EC’s role during 
atherosclerosis directly or through other atherosclerotic related players such as soluble 
cytokines (e.x., TNF-α).   
 
2.1 RÉSUMÉ 
Les maladies cardiovasculaires telles que l'athérosclérose sont les principales causes de 
décès dans le monde et représentent environ 30% des décès au Canada. Le vieillissement, 
le tabagisme, une vie sédentaire et le diabète figurent parmi la liste croissante des facteurs 
de risque de l'athérosclérose. La genèse et la progression de cette maladie inflammatoire 
impliquent un dysfonctionnement des cellules endothéliales (CE), ce qui nuit à l'intégrité 
de l'endothélium et augmente la perméabilité de l'endothélium aux lipoprotéines de faible 
densité oxydées et à la transmigration des monocytes du sang vers l'intima où ils sont 
transformés en cellules spumeuses après l’incorporation des lipides. Des modifications de 
la composition de la membrane basale entraînant une augmentation du dépôt de la 
fibronectine se produisent également et affectent le processus de mécanotransduction via 
les interactions EC-matrice extracellulaire (ECM). La libération de lipides due à l'apoptose 
des cellules spumeuses, ainsi que la migration des cellules musculaires lisses vasculaires 
de la média vers l'intima et leur prolifération, augmentent la rigidité des artères aux stades 
ultérieurs de l'athérosclérose. La contrainte de cisaillement sur les parois qui en résulte peut 
considérablement augmenter pendant la formation de la plaque d'athérome et la sténose des 
vaisseaux sanguins. 
Le dysfonctionnement des CE implique également d'autres facteurs, y compris les 
cytokines solubles et les facteurs de croissance (GF) tels que le VEGF et les BMP. La 
BMP-9 est un facteur circulant dans le sang qui a une incidence sur le comportement des 
CE. Cependant, à ce jour, peu d'études ont évalué son rôle dans l'athérosclérose. 
Cette revue de la littérature a donc pour objectif, après une courte description de 
l'histologie, de l'homéostasie des artères ainsi que des fonctions / dysfonctionnements des 
CE, de discuter comment les BMP, en particulier la BMP-9, et leur transduction du signal 
affectent le comportement des CE. Finalement, cette revue présente l'effet de la BMP-9 sur 
divers facteurs impliqués dans l'activation des CE, de l'inflammation à la perméabilité de 
l'endothélium, qui jouent un rôle crucial dans le développement de l'athérosclérose. 
10 
 
MOTS-CLÉS: protéine morphogénétique osseuse, angiogenèse, inflammation, 
fibronectine 
 
2.2 ABSTRACT 
Atherosclerosis is an inflammatory disease involving dysfunction of endothelial cells (EC) 
and enhanced permeability of the endothelium to oxidized low-density lipoprotein and the 
transmigration of monocytes from the blood to the intima where they are transformed into 
foam cells after lipid engulfment. Changes in the composition of the basement membrane 
leading to increased fibronectin deposition also occur and modify EC-extracellular matrix 
(ECM) mechanotransduction. The release of lipids due to foam cell apoptosis, as well as 
the migration of vascular smooth muscle cells from the media to the intima and their 
proliferation, increase the stiffness of arteries at later stages of atherosclerosis. EC 
dysfunction also involves other factors, including soluble cytokines and growth factors 
(GF) such as bone morphogenetic proteins (BMP). BMP-9 is a potent circulatory GF which 
has been shown to affect EC behavior. However, to date, few studies have investigated its 
role in atherosclerosis. The present review describes the histology and homeostasis of 
arteries by explaining EC function/dysfunction and discusses BMP-9 effect on EC 
behavior, considering factors engaged in the development of atherosclerosis. 
KEYWORDS: bone morphogenetic protein, angiogenesis, inflammation, fibronectin 
 
2.3 INTRODUCTION  
The maintenance of the proper functioning of the body is a complicated process known as 
homeostasis. Cardiovascular homeostasis is necessary for controlling the balance of vital 
parameters in blood vessels, including pressure, volume, temperature, and pH (Chien 
2007). It ensures the transport of hormones, oxygen, nutrients, and metabolic products in 
the blood circulatory system (Betts et al. 2013). The functionality of ECs, which line the 
interior wall of blood vessels and form the endothelium, is thus crucial for cardiovascular 
homeostasis. For example, the integrity of the endothelium is required to conserve the 
selective migration of leukocytes such as monocytes into the intima during inflammatory 
responses and to reduce the risk of thrombosis (Michiels et al. 2003; Moss et al. 2016). 
11 
 
EC injury and dysfunction can result in atherosclerosis, an inflammatory disease that paves 
the way for cardiovascular disease (CVDs) (Ross et al. 1977; Stocker et al. 2004; Hansson 
2005; Betts et al. 2013; Kumar et al. 2014). CVDs are the leading cause of mortality 
worldwide, with cancer being the second (WHO, World Health Organization 2017). Heart 
disease is the second leading cause of death in Canada, and heart failure costs the Canadian 
economy $3 billion a year (Statistics Canada 2017, Heart and Stroke Foundation of Canada 
2016). Many GFs, cytokines, and chemokines influence EC function. Of these, BMPs have 
an impact on EC survival and proliferation (Dyer et al. 2014). BMP-9 is of particular 
interest as the active form is present in blood plasma at high concentrations (Brown et al. 
2005; Bidart et al. 2012). It can regulate the effects of several factors known to be involved 
in EC dysfunction during atherosclerosis. These factors range from soluble molecules to 
ECM components and cells, including oxidized low-density lipoprotein (ox-LDL), soluble 
cytokines such as TNF-alpha and VEGF, basement membrane (BM)/ECM proteins such 
as fibronectin (FN), wall shear stress (WSS), and vascular smooth muscle cells (VSMCs) 
(Griffioen et al. 2000; Scharpfenecker et al. 2007; Chatzizisis et al. 2007; David et al. 2009; 
Suzuki et al. 2010; Tian et al. 2012; Xu et al. 2012; Yurdagul et al. 2014; Schnittler et al. 
2014; Zhu et al. 2015; Baeyens et al. 2016; Mitrofan et al. 2017). A review of currently 
available literature on the roles played by BMP-9 in EC function/dysfunction is thus of 
great interest and will also provide the scientific community with insights into the potential 
roles of BMP-9 in the genesis and development of atherosclerosis. 
The present review thus provides a brief INTRODUCTION to arterial histology and the 
location of atherosclerotic plaque as well as vascular cell functions. EC-ECM and EC-EC 
interactions are explained by describing the molecules involved in these interactions, 
including integrins, adhesion receptors, and vascular endothelial VE-cadherin as they play 
a crucial role during EC inflammatory responses and the progression of atherosclerosis. 
The structures, the canonical Smad and MAPK signaling pathways induced by BMP family 
members, and their crosstalk with the Wnt and Notch pathways are addressed. Lastly, a 
comprehensive summary of the effect of BMP-9 on EC function (quiescence, 
sprouting/vessel formation, and inflammation) and on atherosclerotic factors is provided. 
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2.3.1 Histology of Arteries  
2.3.1.1 Tunica  
Arteries, which carry blood away from the heart, are comprised of three main layers or 
tunica. The innermost layer is the tunica intima (or interna). The next layer is the tunica 
media, while the outermost layer is the tunica adventitia (Figure 1) (Betts et al. 2013). The 
tunica intima is covered with a monolayer of ECs (the endothelium), which is in direct 
contact with the blood flow. The intima is also comprised of a BM, which is a layer of 
connective tissue in the sub-endothelial region that is part of the ECM connected to ECs 
(Lampugnani et al. 1991; Betts et al. 2013). The connective tissue provides the intima with 
structural flexibility (Betts et al. 2013). The tunica media is mainly responsible for 
adjusting the size of the lumen by contracting/releasing VSMCs, which are highly 
specialized spindle-shaped cells whose main function is contraction beneath the intima to 
preserve blood pressure (Betts et al. 2013). ECs partially modulate this process by secreting 
NO, a free radical with short half-life that induces the constriction of VSMCs. NO 
production can be increased by various stimuli such as histamine and WSS through the 
upregulation of eNOS, the enzyme responsible for NO production (Xiao et al. 1997; 
Michiels 2003). The tunica adventitia provides structural support for arteries and is rich in 
fibrillar type I and III Collagen (Coll) and elastin (Wheeler et al. 2014; Xu et al. 2014). 
Coll in the adventitia provides a supporting framework whereas elastin is responsible for 
the uniform distribution of stress that enables arteries to better resist mechanical forces 
(Ushiki 2002). The adventitia fixes arteries in their location by providing linkages with the 
surrounding connective tissue (Betts et al. 2013). Arteries can be categorized into two 
major forms based on the thickness and composition of these three layers: elastic and 
muscular (Betts et al. 2013). Large diameter arteries (> 10 mm) are considered elastic 
because they contain higher levels of elastin in the tunica. They are located closer to the 
heart and are thus subject to higher pressures. The mechanical properties of elastic arteries 
allow them to resist changes in blood pressure caused by systole and diastole (~120/80 
mmHg) (Betts et al. 2013). The walls of muscular arteries are generally the thicker of the 
two forms. In regions more distant from the heart, there is not much need for arteries to 
expand as the blood pressure drops. These arteries thus have fewer elastic fibers in their 
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intima and higher numbers of VSMCs in their media and are smaller in diameter than 
elastic arteries (typically around 0.1 mm to 10 mm) (Betts et al. 2013; Pollard et al. 2016).  
Atherosclerotic plaques preferentially develop in the arterial tree in curves, branching 
points, and bifurcations, which are associated with recirculating eddies and changes in 
WSS direction and magnitude (Yurdagul et al. 2016). These alterations in WSS can affect 
EC function and can trigger the development of atherosclerosis (Traub et al. 1998; Tzima 
et al. 2005; Chatzizisis et al. 2007; Yurdagul et al. 2016; Yang et al. 2018). Although 
atherosclerosis occurs mainly in large and midsize arteries, it can also occur in peripheral 
arteries (Betts et al. 2013). 
 
2.3.2 EC-BM Interactions and EC-EC Contacts 
ECs can recognize and interact with BM proteins through specific transmembrane 
receptors called integrins. Human ECs express integrins, including α5β1, αvβ3, α1β1, 
α2β1, α3β1, α6β1, and αvβ5 (Dejana et al. 1993; Caiado and Dias 2012). Integrin/ECM 
interactions influence EC behavior such as cell survival, proliferation, and migration 
(Hynes et al. 1978; Legate et al. 2006; Alexander et al. 2011; Feng et al. 2017; Giordano 
et al. 2018; Chen et al. 2018). 
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2.3.2.1 Integrins  
Integrins are composed of non-covalently linked heterodimeric alpha and beta subunits 
(Hynes 2004). Their interactions with specific ECM proteins induce the recruitment of 
cytoplasmic structural proteins (talin, vinculin, and kindlin) and the activation of FAK and 
Src signaling proteins by an outside-in mechanism (Figure 2) (Mitra et al. 2005). However, 
the activation state of integrins is regulated by inside-out signaling. For example, talin 
binding to the cytoplasmic tail of resting integrins activates the integrins by forcing the 
extracellular segments of the alpha and beta subunits away from cell membrane where they 
can bind to their ECM ligands (Hynes 2004; Mitra et al. 2005; Thinn et al. 2018).  
Integrin activation can be followed by clustering and the formation of nascent adhesions. 
These adhesions can develop into FXs that can mature to form FAs (Eyckmans et al. 2011). 
FAs contain both structural cytoplasmic proteins (e.g., vinculin) and cytoplasmic signaling 
proteins (e.g., FAK) (40). FAs also connect the actin cytoskeleton to the ECM (Gilmore et 
al. 1996; Hynes 2004; Mitra et al. 2005; Schwartz et al. 2010). When signaling proteins 
come into the vicinity of FAs, they induce various signaling transduction pathways, 
including Rho GTPase (Etienne-Manneville et al. 2002). These pathways can ultimately 
affect the arrangement of the actin cytoskeleton (Alexander et al. 2011). Certain soluble 
factors such as VEGF and TNF-alpha can induce the rearrangement of the actin 
cytoskeleton to form stress fibers. This is associated with EC activation (Gamble et al. 
1985; Griffioen et al. 2000; Schnittler et al. 2014). 
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2.3.2.2 Composition of the BM in Normal and Pathological Conditions 
The ECM is responsible for various tasks, including maintaining the structural integrity of 
vessels and modulating cell functions through signaling pathways (Gelse et al. 2003; 
Beauvais et al. 2016). The BM is a specialized ECM with an amorphous, dense, sheet-like 
structure (Kalluri et al. 2003; Yurchenco et al. 2011). In physiological conditions, the BM 
of the endothelium contains Coll IV, laminin, nidogens, and perlecan (Yurchenco et al. 
2011). However, in atherosclerotic lesions, the BM is enriched in FN and Coll I (Voss et 
al. 1986). 
 
2.3.2.2.1 Fibronectin 
FN is a glycoprotein composed of two quite similar subunits linked at their C-terminal 
extremities by disulfide bridges. This dimeric protein (440-500 kDa) contains 
approximately 2300 amino acids that are mainly divided into three repeating modules, i.e., 
homology sequence types I (12), II (2), and III (15-17) (Proctor et al. 1987; Zollinger et al. 
2017). FN can bind to other proteins such as Coll and fibrin as well as to 
glycosaminoglycans such as heparin (Williams et al. 1982; Hynes 1990; Sevilla et al. 
2013). The FNIII-10 module is an important motif as it contains the RGD-loop that binds 
to many integrins in ECs, including alpha5 beta1 and alphav beta3 (Magnusson et al. 1998; 
Krammer et al. 2002). The FNIII-9 module contains a synergy site (proline-histidine-
serine-arginine-asparagine sequence, PHSRN) that, upon interacting with the FNIII-10 
module, can significantly enhance the affinity of alpha5 beta1 integrin for FN (Krammer 
et al. 2002; Grant et al. 1990; Stabenfeldt et al. 2010). The alpha5 beta1 integrin can also 
translocate from the periphery (FA) to the center of cells to form fibrillar adhesions, which 
allow the cell to transform soluble FN into insoluble fibrils by inducing FN molecule 
stretching (Figure 3) (Zamir et al. 2000; Marquis et al. 2009). This also unmasks cryptic 
binding sites that are mostly available at the N-terminal domain, especially FNIII modules 
such as III1-2 (Aguirre et al. 1994; Zamir et al. 2000; Cseh et al. 2010). Raitman et al. used 
CHO-677 cells to identify the key role played by heparin/heparan sulfate binding sites in 
FN fibrillogenesis (Raitman et al. 2018). 
By binding to alpha5beta1 integrin, FN can also regulate the role of ox-LDL in changing 
ECs into a pro-inflammatory phenotype by enhancing the activation of a pro-inflammatory 
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transcription factor (NF-kappaB) and the expression of VCAM-1 (Yurdagul et al. 2014). 
It also induces the Rho signaling pathway, reducing the integrity of the EC barrier by 
disrupting AJs (Schnittler et al. 2014). 
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2.3.2.2.2 Collagen  
Members of the collagen family are the most ubiquitous ECM proteins (Gelse et al. 2003). 
So far, 27 Coll proteins have been identified. Coll proteins usually contain a triple helix of 
polypeptide chains (Gelse et al. 2003; Brodsky et al. 2005). For example, two identical 
alpha1(I)-chains and one alpha2(I)-chain make up the triple helix of Coll I, the most 
abundant Coll protein in the body (Lullo et al. 2002; Gelse et al. 2003). Coll I maintains 
the structural integrity of the ECM. It also contains an RGD sequence that can be 
recognized by alpha1 beta1 and alpha2 beta1 integrins on ECs and that can influence actin 
stress fiber formation (Lullo et al. 2002; Iivanainen et al. 2003; Whelan et al. 2003). Rother 
et al. used PAECs seeded on a 3D hydrogel scaffold made of Coll I to show that this 
interaction can promote EC proliferation (Rother et al. 2017). Coll I also interacts with 
other ECM proteins (FN, Coll V) and glycosaminoglycans (Proctor et al. 1987; Lullo et al. 
2002; Gelse et al. 2003; Sevilla et al. 2013; Johnson et al. 2004). 
 
2.3.3 EC-EC Adhesion and Vascular Permeability 
The passage of circulating cells such as leukocytes and soluble molecules such as LDL 
from the blood to the intima depends on the integrity of the endothelium. Injuries to or 
dysfunctions of the EC barrier affect vascular homeostasis by disrupting the selectivity and 
effectiveness of the barrier (Hansson 2005; Muller et al. 2013). The main cell-cell contacts 
in ECs include AJs, TJs, and GJs (Figure 4).  
The present review focuses primarily on AJs because of the key role they play in vascular 
permeability (Michiels 2003; Dejana 2004; Daniel 2013; Lampugnani et al. 2018; Neto et 
al. 2018). However, more information on TJs and GJs can be found in the articles by 
Radeva and Waschke (2018) and Komarova et al. (2017) (Komarova et al. 2017; Radeva 
et al. 2018). 
The integrity of AJs is closely associated with VE-cadherin, a transmembrane adhesion 
protein (Dejana 2004; Daniel 2013). Cadherins are classified as type I and type II. Type II 
cadherins lack the histidine-alanine-valine (HAV) motif, which prevents cadherin-
mediated cell aggregation (Willems et al. 1995; Yulis et al. 2018). VE-cadherin is a type 
II cadherin and contains an extracellular cadherin domain (EC-domain) and a cytoplasmic 
tail (C-terminus). The EC-domain of VE-cadherin mediates calcium ions dependent 
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hemophilic binding between ECs, whereas its C-terminus can bind to catenins and stabilize 
AJs (Lampugnani et al. 2018, Vestweber 2008; Giannotta et al. 2013). Cortical actin 
filaments aligned with the cell surface are associated with AJs through VE-
cadherin/catenin complexes (beta, alpha, and gamma-catenin). Quiescent ECs in the 
endothelium contain continuous VE-cadherin/catenin complexes at the cell periphery 
(Dejana 2004; Chatzizisis et al. 2007). Intense tyrosine phosphorylation of VE-cadherin 
has been reported in non-attached and migrating ECs with disrupted AJs (Lampugnani et 
al. 1997; Lee et al. 2002; Vestweber 2008; Lampugnani 2010; Abu Taha et al. 2014). In 
contrast, VE-cadherin/beta-catenin complex formation increases when the cytoplasmic tail 
of VE-cadherin is phosphorylated on a serine (Dejana 2004).  
Soluble cytokines such as TNF-alpha and GFs such as VEGF can enhance endothelial 
permeability by phosphorylating VE-cadherin. This results in a weaker EC barrier by 
inhibiting AJs and increasing leukocyte recruitment/extravasation through the endothelium 
as a result of an immune response (Lampugnani et al. 1991; Esser et al. 1998; Michiels 
2003; Angelini et al. 2006; Funk et al. 2012). However, the maintenance of cortical actin 
filaments can inhibit these EC barrier (AJ) disruptions (Prasain et al. 2009). In addition to 
soluble GFs and cytokines, mechanical cues such as WSS in bovine aortic ECs can affect 
the stability of AJs by increasing the tyrosine phosphorylation of VE-cadherin (Rami et al. 
2013; Conway et al. 2017). 
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2.4 EC FUNCTIONS 
2.4.1 Blood Fluidity 
ECs maintain the non-adhesive nature of the lumen in order to maintain blood fluidity in 
vessels. ECs have antithrombotic (preventing thrombosis or local blood clotting), 
anticoagulant (preventing the activation of the coagulation cascade), and fibrinolytic 
(hydrolyzing fibrin) activities (Michiels 2003; Rijken et al. 2009). For example, ECs 
synthesize thrombomodulin (TM), which prevents blood coagulation by binding to 
thrombin, which is responsible for turning soluble fibrinogen into an insoluble fibrin 
network (Betts et al. 2013). ECs also produce PGI2 and NO, which limit platelet activation 
and aggregation and thus clotting (Michiels 2003; Rijken et al. 2009). They also synthesize 
plasminogen activating factor, which is responsible for the conversion of plasminogen into 
plasmin, the protein involved in fibrin cleavage (Rijken et al. 2009).  
However, in damaged vessels, ECs can secrete other factors that can cause blood clotting 
(Conway et al. 1988). For example, vWF is synthesized by ECs following vascular injury 
to provide needed clot formation. This occurs as result of vWF-mediated platelet-collagen 
and platelet-platelet adhesion leading to platelet aggregation at the injury site (Turitto et al. 
1984; Federici et al. 1989; Hattori et al. 1989; Peyvandi et al. 2011).  
In addition to the roles played by ECs in the regulation of hemostasis, ECs also play a role 
in vascular tone. This occurs mainly via NO-mediated EC-induced contraction of VSMCs, 
which alters the luminal cross-section and, in turn, blood pressure (Rubanyi 1993; Michiels 
2003; Ling et al. 2015). 
 
2.4.2  Inflammatory Response 
Inflammation (acute and chronic) weakens the EC barrier and causes an increase in the 
migration of circulating leukocytes through the endothelium as part of the immune 
response (Michiels 2003). Leukocyte tethering to the EC monolayer is essential for the 
proper functioning of the innate and adaptive immune responses (Dejana 2004). Local 
inflammatory cues in particular can initiate the recruitment of neutrophils and monocytes 
(which are leukocytes of the innate immune system) from the blood stream that can, in 
turn, initiate the adaptive immune response and prevent the progression of infections 
(Daniel et al. 2013). The inflammatory response relies on interactions between ECs and 
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leukocytes that are promoted by the expression of E-selectin, ICAM-1, VCAM-1, and 
MCP-1 by ECs (Wittchen 2009). An increase in the expression of these proteins notably 
occurs in response to soluble TNF-alpha via NF-kappaB activation (Hardy et al. 2004; 
Hansson 2005; Angelini et al. 2006; Chatzizisis et al. 2007; Funk et al. 2012).  
Transcellular (through a cell) and paracellular (between cells) transport mediate the 
passage of isolated circulatory leukocytes once they adhere to ECs (Dejana 2004; Wittchen 
2009). Paracellular passage, also known as leukocyte diapedesis, occurs when leukocytes 
squeeze through EC-EC junctions whereas transcellular passage occurs via the cytoplasm 
of ECs (vesicular system) (Dejana 2004). EC-EC junctions normally reassemble quickly 
after paracellular transport to maintain the integrity of the EC barrier (Dejana 2004). 
Leukocytes use the transcellular pathway to pass through approximately 40% of cultured 
human umbilical vein ECs (HUVEC: a common EC line for in vitro models) (Daniel et al. 
2013). PECAM-1 (or CD31) is also intimately involved in leukocyte extravasation and is 
expressed on EC, monocyte, and neutrophil membranes (Michiels 2003). PECAM-1 is 
initially concentrated at EC-EC junctions to protect endothelial integrity. However, it can 
facilitate leukocyte extravasation through homophilic (i.e., CD31 on the leukocyte surface) 
or heterophilic (alphav beta3 integrin on the neutrophil surface) binding (Michiels 2003; 
Conway et al. 2015).   
 
2.4.3 Angiogenesis 
Angiogenesis is a process that results in the production of new vessels and normally occurs 
following metabolic modifications in the body such as changes in oxygen supply (Adair et 
al. 2010; Shoeibi et al. 2018). In contrast, vasculogenesis is a process related to embryonic 
development by which new vessels are formed as result of the differentiation of 
mesodermal cells into endothelial progenitor cells (Adair et al. 2010). ECs play an essential 
role in forming new vessels during angiogenesis, which is initiated by the activation and 
migration of ECs (Lamalice et al. 2007). EC activation can occur as result of various events, 
including changes in the gradient of soluble cytokines secreted by monocytes/neutrophils 
(e.g., TNF-alpha) and soluble GFs secreted by macrophages, parenchymal cells, 
cardiomyocytes, skeletal muscle fibers, and hepatocytes (e.g., VEGF) (Binion et al. 2009; 
Adair et al. 2010; Shoeibi et al. 2018). When ECs are activated, the integrity of the 
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endothelium weakens under the influence of NO produced by ECs, which paves the way 
for the other steps required for the formation of new vessels such as the dilation of pre-
existing vessels, the removal of the BM by MMPs, and the migration of ECs to form 
tip/stalk cells (Griffioen et al. 2000; Gerhardt et al. 2003; Larrivée et al. 2009; Herbert et 
al. 2011; Shoeibi et al. 2018). During angiogenic sprouting, ECs separate into two distinct 
phenotypes: (a) tip cells, which are migrating polarized cells that acquire long filopodia 
that, in turn, direct new sprouts, and (b) stalk cells, which are proliferating cells that follow 
tip cells to form the lumen of new sprouts (Geudens et al. 2011). VEGF activates VEGF-
Receptor 2 (VEGFR2) in ECs and triggers a selection process in which ECs form distinct 
tip or stalk cells. The Notch signaling pathway inhibits VEGFR2 activation, which is 
common in stalk cells (Geudens et al. 2011).  
For the new tubes to mature and stabilize, ECs secrete PDGF, which causes the 
differentiation of adjacent mural cells into VSMCs in large vessels and pericytes in small 
vessels. The maturation process includes the deposition of proteins such as laminin that are 
required for EC quiescence (Geudens et al. 2011; Thomsen et al. 2017).  
Angiogenesis plays an important role in the development of atherosclerosis as new vessels 
in atherosclerotic lesions contribute to plaque growth. However, the fragility of new 
vasculature can undermine plaque stability, resulting in thromboembolism (Camare et al. 
2017). 
  
2.4.4 EC Dysfunction in Atherosclerosis 
Atherosclerosis is a chronic inflammatory disease that has a causal association with EC 
activation (Ross et al. 1977; Stocker et al. 2004; Hansson 2005). Many risk factors are 
associated with the activation of ECs and atherosclerosis, including hyperlipidemia, 
smoking, chronic infections, diabetes, aging, and genetic predisposition (Kumar et al. 
2014; Schnittler et al. 2014). EC activation weakens the EC-EC junction, which enhances 
the passage of circulating LDL into sub-endothelial regions. This is followed by a higher 
expression of adhesion molecules (VCAM-1, ICAM-1, MCP-1, P-selectin), an increase in 
the extravasation of leukocytes such as monocytes (Hansson 2005; Schnittler et al. 2014), 
and an increase in pattern-recognition receptors (scavenger and toll-like receptors) on 
macrophages in sub-endothelial regions (Hansson 2005). When scavenger receptors engulf 
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LDL oxidization products and accumulate cholesterol buildups, this leads up to the 
formation of foam cells, which are predominantly present in fatty streaks in the core of 
atherosclerotic plaque. LDL oxidization and heat shock protein 60 (HSP 60) increase the 
activation of toll-like receptors and the production of proteases by macrophages (Kumar et 
al. 2014). MMPs and cysteine proteases enhance the risk of plaque rupture by disrupting 
Coll fibers (Hansson 2005; Kumar et al. 2014). The expression of MMPs also depends on 
endothelial-to-mesenchymal transition (EndMT), which involves the TGF-beta family and 
hypoxic conditions (Chen et al. 2017; Evrard et al. 2016; Wesseling et al. 2018). Evrard et 
al. used a model of atherosclerotic mice to show that EndMT-derived ﬁbroblasts make up 
to 9% of intimal plaque (Evrard et al. 2016). An accumulation of MMP-secreting EndMT-
derived ﬁbroblasts may be a possible cause of atheroma plaque destabilization (Evrard et 
al. 2016). 
 
MMPs such as MMP-9 can also favor the proliferation and migration of VSMCs by 
promoting anchorages between the cell surface and the matrix (Johnson et al. 2004). 
VSMCs in the intima play two roles, depending on the stage of atherosclerosis. They 
induce plaque formation by excessive proliferation in the early stage of atherosclerosis, 
and they contribute to plaque stabilization by reinforcing the fibrous cap in advanced 
lesions (Bennett et al. 2016; Allahverdian et al. 2018). However, the engulfment of ox-
LDL by VSMCs can alter their ability to synthesize and organize ECM proteins such as 
fibrillar FN and subsequent FN-induced Coll I fibrillogenesis (Glukhova et al. 1989; 
Sevilla et al. 2013). To summarize, as atherosclerosis progresses, both ECs and VSMCs 
undergo phenotypic changes. 
The calcification of VSMCs is also a key aspect of the development of atherosclerosis as 
it contributes to arterial stiffening and increases the chance of luminal thrombosis (e.g., 
coronary artery), potentially causing a stroke (Shirwany et al. 2010; Sakakura et al. 2013; 
Durham et al. 2018).  
An increase in stiffness makes arteries less expandable when they need to dilate during 
systole to accommodate the surge of a large volume of blood from the left ventricle (stroke 
volume). This lack of compliance does not allow arteries to expand, resulting in higher 
resistance and thus higher blood pressure (Betts et al. 2013). 
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Atherosclerosis is classified into six stages or lesions depending on the gravity of the 
disease as defined by the American Heart Association (Figure 5) (Stary et al. 1995). The 
stages are as follows: 1. initial or type 1 lesions, which involve the transition of isolated 
macrophages into foam cells (fat-laden macrophages); 2. type 2 lesions, which are typified 
by the formation of fatty streaks under the endothelium due to the deposition of 
intracellular lipid rather than extracellular lipid build-up; 3. type 3 or intermediate lesions, 
which occur when small extracellular lipid pools appear; 4. type 4 or atheroma lesions, 
which have an extracellular lipid core; 5. type 5 or fibroatheroma lesions, which have lipid 
cores and fibrotic (excess fibrous connective tissue) layers; and, lastly, 6. type 6 or 
completed lesions, which cause surface defects, hematoma-hemorrhage, and thrombus 
(Stary et al. 1995). Type 1, 2, and 3 lesions are considered clinically silent, while type 4, 
5, and 6 lesions can be clinically silent or can become clinically overt. Type 1 and 2 lesions 
mostly develop during the first decade of life while type 3 and 4 lesions progress during 
the third decade. Type 5 and 6 lesions occur during the fourth decade of life (Kumar et al. 
2014). 
 
Atherosclerosis may lead to many cardiovascular conditions. Plaque formation on the 
arterial wall causes ischemia by disrupting the blood flow and the supply of nutrients and 
oxygen (hypoxia) (Lusis 2000; Betts et al. 2013; Tang et al. 2017). Hypoxia can be 
followed by the decay of associated tissues, which can have clinically grave consequences 
if it impairs the activity of the heart or brain (Betts et al. 2013). Plaque rupture accompanied 
by bleeding in the arterial wall may also occur and result in clot formation and thrombus 
(Betts et al. 2013). Clots in coronary arteries can occlude the blood stream and lead to 
stroke or myocardial infarction while clots in cerebral arteries can cause cerebrovascular 
accidents (CVA) (Betts et al. 2013). Normally, thrombus formation is more dangerous than 
stenosis (narrowing) given the consequences of strokes (Hansson 2005). 
The blockage of smaller arteries is another potential outcome of atherosclerosis. If plaques 
are damaged, debris and fragments can travel in the blood and obstruct smaller arteries 
along the way (Lusis 2000; Kumar et al. 2014; Tang et al. 2017). Blockages in arteries 
carrying fresh blood to the legs can cause leg pain (claudication), changes in skin color, 
and sores and may lead to gangrene (Singh et al. 2013; Kumar et al. 2014).  
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Atherosclerosis lesions can also trigger aneurysms (abnormal swellings and localized 
dilations of arteries). Aneurysms can occur in the aorta, causing discomfort and pain, as 
well as in the brain (Adamson et al. 1994; Stary et al. 1995; Lusis 2000; Betts et al. 2013; 
Singh et al. 2013; Tang et al. 2017). 
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2.5 BONE MORPHOGENETIC PROTEINS  
The functions of the EC layer in blood vessels are affected by WSS patterns and values 
and, like all adherent cells, the behavior of ECs also depends on the composition and 
stiffness of the BM (Chatzizisis et al. 2007; Schnittler et al. 2014; Baeyens et al. 2016; 
Sack et al. 2016). Cytokines in the EC microenvironment are also crucial players (Griffioen 
et al. 2000). BMPs are potent regulators of EC function (David et al. 2008; Bidart et al. 
2012; Dyer et al. 2014). BMPs, BMP-9 in particular, not only affect EC behavior directly 
but also regulate the impact of other players on endothelium physiology, including FN, 
TNF-alpha, and VEGF (Scharpfenecker et al. 2007; David et al. 2009; Tian et al. 2012; 
Mitrofan et al. 2017). It is thus important to determine how BMP-9 influences EC behavior 
during atherosclerosis, both directly and indirectly. 
To date, 20 distinct BMPs have been identified, 14 of which are produced in the human 
body by various cell types such as osteoblasts, MSCs, and ECs (Nakase et al. 2006; Dyer 
et al. 2014; Katagiri et al. 2016). BMP-1, a C proteinase precursor of collagen composed 
of 730 amino acid residues, is a metalloproteinase, whereas other BMPs belong to the TGF-
beta superfamily, which includes TGF-beta and activins (Massagué 1998; Bobik 2006; 
Yang et al. 2014). 
 
2.5.1 BMP Subgroups 
 Members of the BMP family can be divided into four main subgroups based on their amino 
acid sequence homology (Rengachary et al. 2002). The main BMP subgroups are: (1) the 
BMP-2/-4 subgroup (up to 83% amino acid sequence homology); (2) the BMP-5, -6, -7, -
8, -8b subgroup; (3) the BMP-9 (growth/differentiation factor 2, GDF-2) and BMP-10 
subgroup; and the BMP-12, -13, -14 subgroup (Kawabata et al. 1998; Nakase et al. 2006; 
Marquis et al. 2009). 
TGF-beta family members share some common structural features such as a cysteine knot 
(six residues), a wrist epitope (four-turn alpha helix in the dimerization region), and a 
knuckle epitope (four antiparallel beta sheets emanating from a cysteine knot) (Brazil et al. 
2015; Rahman et al. 2015). The majority of BMPs are synthetized as ~500-amino-acid pre-
pro-peptides with a signal peptide, a pro-domain, and a mature domain containing seven 
cysteines (Brown et al. 2005). The signal peptide (N-terminal) enables BMP secretion, 
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while the pro-domain facilitates effective folding (Bragdon et al. 2011). The Arg-X-X-Arg 
sequence in the C-terminal domain of BMPs allows them to form homodimers or 
heterodimers (e.g., BMP-2/5, BMP-2/6, and BMP-9/10) through disulfide bridges and to 
become active signaling molecules (Israel et al. 1996; Constam et al. 1999; Littleet al. 
2009; Tillet et al. 2018). Human mature BMP-9, which consists of 110 amino acids, 
normally does not lose the N-terminal pro-domain (Bi et al. 2014). In contrast, mature 
BMP-2 (114 amino acids) does not contain the pro-domain (Yang et al. 2014). Molecular 
dynamics and thermodynamic simulations have revealed that the structural differences 
between BMP-2 and BMP-9 are responsible for binding to distinct receptors (Coskuner et 
al. 2017). Interestingly, both BMP-9 dimers, with or without the pro-domain, are active 
and can initiate BMP signaling pathways (Brown et al. 2005; Bidart 2012).  
BMPs were first discovered by Urist in 1965 when he observed de novo bone formation in 
rabbit models resulting from the differentiation of osteoprogenitor cells stimulated by 
decalcified components of the bone matrix (Urist 1965). However, several studies suggest 
that some BMP subgroups are more efficient at stimulating de novo bone formation than 
others (Cheng et al. 2003; Kang et al. 2004). For example, Kang et al. injected murine 
myoblast C2C12 cells infected with recombinant adenoviral vectors encoding BMP 
(AdBMP) in mouse quadriceps and found that BMP-6 and BMP-9 promote more bone 
formation than BMP-2 and BMP-7 (Kang et al. 2004). However, the role of BMPs is not 
limited to bone formation as they also participate in other processes such as embryogenesis 
and vascular homeostasis (Lawson et al. 1999; David et al. 2008). In terms of 
vasculogenesis during embryonic development, it has been reported that human BMP-4 
contributes to the growth of the posterior intermediate cell mass (ICM, blood island, 
including endothelial precursor cells) in zebrafish embryos while BMP-9 can affect 
embryonic vascular development by reducing the expression of the gene encoding 
Tmem100 in hPAECs (He et al. 2005; Camare et al. 2017). Tmem100 is a vital player in 
mice embryo vascular development since Tmem100-null mice and endothelial-specific 
Tmem100 knockout mouse embryos do not survive due to the lack of EC differentiation 
(Somekawa et al. 2012). 
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2.5.2  BMP Signaling Pathways 
BMPs act on cells by binding to type I and type II Ser/Thr kinase receptors, which leads to 
the activation of both the canonical Smad and the non-canonical TGF-beta-activated 
tyrosine kinase, TAK1, and MAPK signaling pathways. 
 
2.5.2.1 Canonical Smad Pathway 
The canonical BMP pathway (Figure 6) is referred to as Smad because of the similarity of 
the amino acid sequences of these proteins to the Caenorhabditis elegans SMA protein 
(small worm) and the MAD (Mothers Against Decapentaplegic) protein, which is a 
member of the basic helix-loop-helix leucine zipper family that influences the 
transcriptional activities of BMPs (Savage et al. 1996; Grinberg et al. 2004; McKay et al. 
2012). BMPs trigger the association of type I and type II Ser/Thr receptors into hetero-
tetrameric complexes (Ripamonti et al. 2006). Type I Ser/Thr kinase receptors interact with 
the wrist epitopes of BMPs, whereas Ser/Thr kinase type II receptors interact with the 
knuckle epitopes (Brazil et al. 2015). The binding of BMPs to type I and II receptors can 
also occur separately, i.e., where type I and type II receptors are not associated. However, 
BMPs have a higher affinity for hetero-tetrameric complexes (Varga et al. 2005).  
Upon BMP binding, the Gly-Ser repeats of type I receptors are phosphorylated by Ser/Thr 
kinase type II receptors and, in turn, phosphorylate the intracellular receptor-regulated 
Smad 1/5/8 (R-Smad) (Zhang et al. 2005). Phosphorylated R-Smad can then interact with 
the common-partner Smad (Co-Smad, Smad-4) molecule to create a hetero-dimeric 
complex that translocates into the nucleus (Massagué et al. 2005). The transcriptional 
activity of Smad complexes can regulate the expression of numerous genes, including those 
encoding molecules involved in EC functions such as eNOS, MCP-1, VCAM-1, ICAM-1, 
E-selectin (CD62E), NF-kappaB, VEGF, endothelin-1, Id-1, Id-2, and BMPER (Upton et 
al. 2009; Helbing et al. 2010; Anderson et al. 2010; Star et al. 2010; Suzuki et al. 2010; 
Gangopahyay et al. 2011; Tian et al. 2012; Park et al. 2012; Yao et al. 2012; Zhu et al. 
2012; Kim et al. 2013; Mitrofan et al. 2017; Chen et al. 2017). 
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2.5.2.2  Ser/Thr Kinase Receptors of BMPs and Type III Co-Receptors 
Type I and II Ser/Thr kinase receptors are composed of a short extracellular domain with 
a cysteine residue, a single transmembrane domain, and a Ser/Thr kinase in the intracellular 
domain. To date, seven type I (activin receptor-like kinases 1 to 7, ALK-1-7) and five type 
II (type 2 BMP receptor, BMPRII, type 2 activin receptor, ActRIIA, type IIB activin 
receptor, ActRIIB, TGF-betaRII, and anti-Mullerian hormone receptor type II, AMHRII) 
receptors have been identified (Schmierer et al. 2007; Wang et al. 2014). ALK-1 and ALK-
5 (TGF-beta receptor, TbetaRI) are both expressed in ECs, including HAEC, HUVECs and 
HMEC-1 cells (Fernandez-L et al. 2007; Tian et al. 2010; Tian et al. 2012; Larrivée et al. 
2012; Wang et al. 2014; Seystahl et al. 2015). However, ALK-1 is expressed preferentially 
in ECs while ALK-5 is ubiquitously expressed (Tian et al. 2010). Both BMP-9 and BMP-
10 bind to ALK-1 in HMVEC-d, BOEC, and HAEC cells (David et al. 2007; Mitrofan et 
al. 2017). Johnson et al. analyzed the genetic profiles of five families and found that 
patients suffering from a genetic vascular dysplasia called Osler-Rendu-Weber syndrome 
or hereditary hemorrhagic telangiectasia present several mutations in the ALK-1 gene 
(Johnson et al. 1996).  
Type III co-receptors are also influential in the BMP pathway (Miyazono et al. 2010). This 
subgroup of BMP receptors is composed of GPI-anchored RGM proteins such as the 
Dragon protein, which is expressed by COS-1 fibroblast cells (Rebbapragada et al. 2003; 
Samad et al. 2005; Babitt et al. 2005) and the transmembrane protein ENG, which is 
expressed in ECs (McAllister et al. 1994; Barbara et al. 1999; Lebrin et al. 2004; Babitt et 
al. 2005). BMP-9 strongly binds to ENG in ECs such as HMECs. Moreover, the 
ENG/integrin alpha5 beta1 complex can increase the surface density of ALK-1 by favoring 
endocytic recycling in MEECs (Tian et al. 2012). 
 
2.5.2.3  Smad 
Smad proteins have two conserved MAD-homology domains, one in the N-terminal (MH1, 
except for the N-terminals of Smad6 and 7) and one in the C-terminal (MH2). MH1 and 
MH2 are linked together by a linker domain (Moustakas et al. 2001; Moustakas et al. 2009). 
The Type I Ser/Thr kinase receptor phosphorylates intracellular R-Smad on two Ser 
residues (Ser-Val-Ser motif, Ser-Met-Ser for Smad2) in the C terminus (Zhang et al. 2005; 
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Massagué et al. 2005). This pSer-X-pSer motif directs the association of R-Smad and the 
basic pocket in the Smad4 MH2 domain (Massagué et al. 2005). The beta-hairpins in the 
MH1 domains of R-Smad and Smad4 are involved in binding to the DNA molecule 
(Massagué et al. 2005). The MH2 domain of R-Smad also interacts with co-factors such as 
FoxH, FoxO, Mixer, OAZ, and Smad4, which can attach to DNA molecules and can thus 
also mediate the transcriptional activity of Smads (Massagué et al. 2005). Both R-Smad 
and I-Smad also have a PY motif (polyproline-tyrosine rich motif) in the linker domain 
that paves the way for ubiquitination by Smurf ubiquitin ligases after its recognition by the 
Smurf WW domain. Ubiquinated Smads are then broken down by proteasome complexes 
(Stroschein et al. 2001; Massagué et al. 2005). 
 
2.5.2.3.1 Regulation of Smad Pathway Activation 
Many events can disrupt BMP signaling. BMPRI and BMPRII can both be internalized by 
endocytosis and become unavailable for BMP binding. Endocytosis can also increase 
BMPRI availability by recycling it back to the cell membrane (Dyer et al. 2014; Brazil et 
al. 2015). Some pseudo-receptors such as BAMBI (BMP and activin membrane-bound 
inhibitor) are receptors without the intercellular Ser/Thr kinase phosphorylation domain 
required for Smad signaling (Bai et al. 2017; Wang et al. 2018). 
BMP signaling can be inhibited by extracellular and intracellular factors. Extracellular 
BMP antagonists such as noggin, chordin, and Grem1 can inhibit the BMP signaling 
pathway by binding to BMP dimers and preventing their recognition by BMP receptors. 
Noggin can inhibit BMP-2, BMP-4, and BMP-7 but has no effect on the ability of BMP-9 
to act on cells directing by example the differentiation of mesenchymal stem cells into 
osteoblasts (McMahon et al. 1998; Seemann et al. 2009; Wang et al. 2014). In the same 
way, BMP-3 can inhibit the bone formation induced by BMP-2, BMP-6, and BMP-7 in 
mice but has no effect on BMP-9 (Kang et al. 2004).  
BMPs can also downregulate their own canonical pathways by triggering the expression of 
intracellular Smad6/7. The binding of I-Smad to the intracellular domains of Ser/Thr kinase 
type I receptors prevents the phosphorylation of R-Smad, which blocks BMP signal 
transduction (Kugimiya et al. 2006). Various intracellular phosphatases such as PP1, 
dullard protein, pyruvate dehydrogenase phosphatase (PDP), phosphatase 
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methyltransferase 1 (PPM1), and small C-terminal domain phosphatase 1/2 (SCP 1/2) can 
also dephosphorylate and thus inactivate R-Smad (Bruce et al. 2012). For example, it has 
been shown that PP1 inhibits ALK-1/TGF-beta-induced Smad1/5 activation after 6 h in 
MEECs (Valdimarsdottir et al. 2006). 
 
2.5.2.4 MAPK Pathways 
MAPK pathways are engaged in many aspects of cell functions, including survival, 
proliferation, and differentiation (Kolch et al. 2005). These pathways involve three main 
cascades consisting of p38 (4 isoforms alpha, beta, gamma, and delta), extracellular signal-
regulated kinase (ERK, 8 isoforms ERK1 to ERK8), and c-Jun NH2-terminal kinase (JNK, 
3 isoforms, JNK1-JNK3) (Figure 6) (Kim et al. 2010). The activation of the MAPK 
pathway following BMP stimulation is related to the type I Ser/Thr kinase receptor 
interacting with the X chromosome-linked inhibitor of apoptosis (XIAP), TGF-beta-
activated kinase 1/MAP3K7 binding protein 1 (TAB1), and TGF-beta-activated kinase 1 
(TAK1) (Herrera et al. 2014).  
MAPKs such as ERK1/2, CDKs (cyclin-dependent kinase), and other kinases can 
phosphorylate the linker region of R-Smad, inhibiting their translocation to the nucleus 
(Rosen 2009; Alarcon et al. 2009). For example, ERK1/2 activation by BMP-9 in MSCs 
can in turn inhibit the phosphorylation of Smad1/5/8 on the C-terminal MH2 domain 
(Massagué et al. 2005; Herrera et al. 2014). 
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2.5.3 Other Signaling Pathways Involved in BMP Signal Transduction  
2.5.3.1 Wnt Pathway 
Wingless-type (Wnt) pathways are involved in the control of EC differentiation from 
hematopoietic precursors during embryonic development and, especially, during the 
vascularization of the central nervous system (Reis et al. 2013). Wnt pathways also 
contribute to cell migration and polarity and cellular responses to shear stress (Abuammah 
et al. 2018). They are classified into at least three major signal transduction cascades: one 
is beta-catenin-dependent (canonical) while two, the Wnt/calcium and Wnt/planar cell 
polarity (PCP) pathways, are beta-catenin-independent (non-canonical) (Komiya et al. 
2008).  
The non-canonical Wnt/calcium pathway can be activated by the binding of Wnt ligands 
(a family of 19 secreted glycoproteins to date) such as Wnt-5a or Wnt-4 to Frizzled (Fz) 
receptors, which activates the disheveled protein, leading to the stimulation of 
phospholipase C and an increase in the concentration of intracellular calcium ions. These 
calcium ions in turn activate calmodulin-dependent protein kinase II and protein kinase C. 
The activation of the Wnt/PCP pathway depends on the activation of small G proteins such 
as Rac and Rho GTPases by Wnt-Frizzled receptor recognition (Liebner et al. 2010).  
The canonical Wnt pathway is activated in ECs by the binding of some Wnt ligands such 
as Wnt1, Wnt-3/3a, and Wnt-7a/7b to a complex composed of Fz receptors and LDL 
receptor-related protein 5 (LRP5) or LRP6 co-receptor (Liebner et al. 2010). This Wnt-
receptor interaction leads to the inactivation of glycogen synthase kinase-3beta 
(GSK3beta) by favoring, for example, its entrapment in multivesicular bodies (Fuentealba 
et al. 2007; Metcalfe et al. 2011). Canonical Wnt activation induces the accumulation of 
cytoplasmic beta-catenin that can then translocate into the nucleus to regulate the 
expression of targeting genes by displacing the transcription repressor Groucho and 
interacting with DNA-bound T cell factor/lymphoid enhancer-binding factor (TCF/LEF). 
When the Wnt ligand is missing, GSK3beta remains active and forms a complex with Axin, 
APC, and CK1alpha. CK1alpha and GSK3beta can phosphorylate beta-catenin at its N-
terminus, inducing its ubiquitination by E3 ubiquitin ligase beta TrCP and its degradation 
in the proteasome (Rubinfeld et al. 1993; Zhan et al. 2017).  
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GSK3beta can strongly influence the BMP canonical pathway by phosphorylating the 
linker domain of Smad1/5 (Figure 7), leading to Smad1/5 ubiquitination and subsequent 
proteasomal degradation (Fuentealba et al. 2007; Rosen 2009; Eivers et al. 2009). The 
canonical Wnt pathway can also control angiogenesis during embryonic development by 
stopping the progression of the cell cycle via crosstalk with the Notch pathway (Phng et al. 
2009). 
 
2.5.3.2 Notch Pathway 
The Notch pathway plays a key role in angiogenesis by favoring stalk ECs involved in the 
sprouting step (Phng et al. 2009). It was also recently found to be involved in the 
endothelial-to-mesenchymal transition, a phenomenon observed during embryonic 
cardiogenesis and atherosclerosis progression (Chen et al. 2015; Reichman et al. 2016; 
Wesseling et al. 2018). Signaling via the Notch pathway is initiated in cells by the 
activation of transmembrane Notch receptors (Notch 1-4) by specific membrane-bound 
Delta-like (Dll-1, Dll-3, Dll-4) and Jagged (Jagged-1, Jagged-2) ligands. Dll and Jagged 
ligands can also initiate signaling via the Notch pathway in neighboring cells by 
transactivating their transmembrane receptors, leading to the release of the NICD due to 
receptor cleavage by gamma-secretase complexes (De Strooper et al. 1999). NICD is then 
translocated to the nucleus where it promotes the expression of targeting genes of the hairy 
enhancer of split (Hes)/Hairy-related (Hey) family or the gene encoding decoy receptor 
VEGFR1 in ECs. In contrast, the Notch pathway can also induce a downregulation of 
VEGFR2 and VEGFR3 gene expression in stalk ECs, blocking VEGF signaling (Lobov et 
al. 2007; Suchting et al. 2007; Hellstrom et al. 2007; Tammela et al. 2008).  
Interestingly, the number of Dll ligands/Notch receptors expressed by ECs changes during 
inflammation. For example, the expression of Dll4 by ECs is involved in communication 
between ECs and macrophages (Pabois et al. 2016). Dll4 and Notch1 act in synergy with 
BMP-9 to control vascular homeostasis, especially EC quiescence (Figure 6) (Moya et al. 
2012). Laminar shear stress can also influence the expression of Dll4 and its Notch 
transmembrane receptor, increasing the nuclear translocation of NICD in ECs (Abuammah 
et al. 2018). In addition, a non-canonical Notch pathway was recently discovered in ECs 
40 
 
that uses the transmembrane domain of Notch to regulate AJ and EC permeability 
(Polacheck et al. 2017). 
 
2.6 ROLE OF BMPS IN VASCULAR HOMEOSTASIS 
BMPs such BMP-2, BMP-4, BMP-9, and BMP-10 can affect the survival, proliferation, 
and function of ECs (Teichert-Kuliszewska et al. 2006; Suzuki et al. 2010; Alastalo et al. 
2011; Poirier et al. 2012; Dyer et al. 2014). In the present review, we focus on the effect of 
BMP-9 on EC function since there is ample evidence of its effects on vascular homeostasis 
(Table 1) (David 2008; David et al. 2009; Tian et al. 2012; Young et al. 2012; Ricard et al. 
2012; Wooderchak-Donahue et al. 2013; Tian et al. 2017). 
 
2.6.1 Effect of BMP-9 on EC Proliferation 
BMP-9 is mainly synthetized in the liver by hepatocytes and intrahepatic biliary epithelial 
cells, approximately 60% of which circulate in an active form in blood plasma (Bidart 
2012). Its EC50 for Smad1/5/8 activation, as measured by the expression of ID1 promoter-
derived (BRE), is as low as 50 pg/mL (2 pM). Healthy flow shear stress (12 dynes/cm2) 
can reduce the EC50 to 3.5 pg/mL (David et al. 2007; Baeyens et al. 2016). In addition, 
BMP-9 can induce the phosphorylation of both Smad1 and Smad2 in HPAEC, HAEC, and 
HMEC-1 cells (Upton 2009). Despite the fact that BMP-9 and BMP-10 share sequence 
homology, BMP-10 circulates in blood plasma in an inactivated form (Sengle et al. 2011; 
Herrera et al. 2014).  
In addition, many studies have suggested that BMP-9 does not act in the same way on cells 
as BMPs from other subgroups (Brown et al. 2005; Bidart 2012; Coskuner et al. 2017; 
Khorsand et al. 2017). For example, BMP-9, but not BMP-2 and BMP-4, is able to 
significantly induce ET-1 in HPAECs (Star et al. 2010; Park et al. 2012). ET-1 is a potent 
peptide involved in the process of blood vessel narrowing and vascular remodeling (Shao 
et al. 2011; Park et al. 2012).  
Yoshimatsu et al. reported that 65% of the decrease in HDLEC proliferation after 48 h can 
be attributed to a BMP-9 treatment (1 ng/mL), suggesting that BMP-9 has an inhibitory 
effect on the formation of new lymphatic vessels (Yoshimatsu et al. 2013). On the other 
hand, blocking BMP-9 (10 ng/mL) with the recombinant human ALK-1 extracellular 
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domain/Fc (ALK-1ecd) increases the proliferation of HMVEC-d cells (David et al. 2007). 
The influence of BMP-9 on EC proliferation appears to depend on the type II receptors 
involved. BMP-9 inhibits DNA synthesis in HPAECs by binding to ALK1 and BMPRII 
receptors, while blocking the type II receptor ActR-II by siRNA transfection does not alter 
the ability of BMP-9 to inhibit growth (Upton et al. 2009). 
 
2.6.2 Effect of BMP-9 on Vessel Formation and Sprouting  
The capacity of ECs to form new vessels following a treatment with VEGF can be altered 
by BMP-9 (Scharpfenecker et al. 2007; David et al. 2009; Larrivée et al. 2012). For 
example, 7-day parallel stimulations with BMP-9 (100 ng/mL) and VEGF (50 ng/mL) in 
ex vivo mouse fetus models show that BMP-9 inhibits vascularization (Scharpfenecker et 
al. 2007).  
The anti-angiogenesis effect of BMP-9 on ECs has been reported in several studies 
(Scharpfenecker et al. 2007; David 2008; Tian et al. 2012; Ouarne et al. 2018). Larrivée et 
al. reported a 9-fold decrease in the number of tip cells in mice retina 16 h after a BMP-9 
(10 ng/mL) treatment by intraocular injection (Larrivée et al. 2012). They also showed that 
VEGFR1 mRNA levels were 4-fold higher in HUVECs treated for 24 h with BMP-9 (10 
ng/mL) and that there was a 0.5-fold decrease in VEGF-induced HUVEC tube formation, 
indicating that BMP-9 has an inhibitory effect on VEGF-mediated sprouting (Larrivée et 
al. 2012). 
Tian et al. reported that the effect of BMP-9 on sprouting may also involve FN via an 
integrin alpha5 beta1/ENG/ALK1 complex (Tian et al. 2012). They used murine 
embryonic endothelial cells (MEEC+/+ ENG wild-type and -/- ENG knockout cells) 
cultured on FN (40 µg/mL) to show that Smad1/5 activation mediated by BMP-9 (2 ng/mL) 
is ENG-dependent (Tian et al. 2012). The results of this study suggest that the blockade of 
BMP-9/ENG signaling contributes to abnormal disrupted intersegmental vessel (ISV) 
sprouting. In the same way, when type I receptor ALK-1 expression is disrupted by small 
interfering RNA, the Smad1/5-mediated BMP-9 anti-angiogenic effect is blocked 
(Gangopahyay et al. 2011). 
In contrast, Tachida et al. reported that BMP-9 (10 ng/mL) mediates the upregulation of 
pro-angiogenesis signaling (i.e., a 5-fold increase in HEY1 mRNA levels) in co-cultures 
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of HASMCs and HAECs (Tachida et al. 2017). However, the authors did not perform any 
experiments to determine whether there is an increase in angiogenesis. 
 
2.6.3  Effect of BMP-9 on Inflammation  
BMP-9 influences the role of ECs in inflammation (Figure 8) (Mitrofan et al. 2017; Chen 
et al. 2017). Chen et al. reported that there is a downregulation of MCP-1 mRNA, which 
is involved in ECs monocyte recruitment, in HPAECs (~5 fold) and HMECs (~2 fold) in 
in vitro cultures following a BMP-9 treatment (5 ng/mL, 4 h) (Chen et al. 2017). Unlike 
the anti-inflammatory role of BMP-9 mentioned above, Mitrofan et al. reported that a pre-
treatment with BMP-9 (5 ng/mL) 16 h prior to adding TNF-alpha (0.05 ng/mL for 4 h) 
upregulates the mRNA and protein levels of adhesion molecules (E-selectin, ICAM-1, 
VCAM-1) (Mitrofan et al. 2017). The upregulation of the adhesion proteins was followed 
by an increase in monocyte recruitment (~1.6 fold) in HAECs. An increase in monocyte 
recruitment (~1.4 fold) has also been reported in BOECs (Mitrofan et al. 2017). The 
discrepancy in the effect of BMP-9 on monocyte recruitment reported by Mitrofan et al. 
and Chen et al. may be related to the TNF-alpha used in the later study (Mitrofan et al. 
2017; Chen et al. 2017). Appleby et al. also observed an increase (~2-fold) in neutrophil 
recruitment in BOECs and HPAECs following a pre-treatment with BMP-9 (5 ng/mL, 16 
h), although only when an endotoxin (LPS, 100 ng/mL, 4 h) was added to the cell culture 
(Appleby et al. 2016). 
 
2.6.4 Effect of BMP-9 on Factors Involved in Atherosclerosis 
The effect of many players involved in the development of atherosclerosis, ranging from 
risk factors to soluble cytokines, may also be influenced by BMP-9 (Figure 8). Akla et al. 
recently reported that an increase in D-glucose concentration (from 5 to 11 mM) can block 
the Smad 1/5 activation induced by BMP-9 (1 ng/mL) bound to type 1 receptor (ALK-1) 
(Akla et al. 2018). D-glucose at 11 mM also significantly reduced the expression of ALK-
1 at the cell membrane. Interestingly, hyperglycemia had no effect on BMP-9/ALK-1 
signaling for BMP-9 concentration >1 ng/mL. Using C57BL/6J mice with or without 
induced diabetes mellitus (blood glucose >17 mM), Akla et al. also found that the 
concentration of BMP-9 in blood was similar in control and diabetic mice. In contrast, a 
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decrease in circulating BMP-9 levels has been observed in the plasma of newly diagnosed 
Type 2 diabetes mellitus patients and may be linked to insulin resistance (Luo et al. 2017). 
BMP-9 can also prevent hyperglycemia-induced vascular permeability as shown by Akla 
et al. both in vitro (HUVECs with D-glucose at 25 mM) and in vivo (mouse model with 
induced diabetes mellitus) (Akla et al. 2018). Thus, BMP-9 signaling plays a crucial role 
in the regulation of glucose homeostasis and diabetes diseases and vice-versa, diabetes 
being a major risk factor for the development of atherosclerosis.  
Furthermore, BMP-9 signaling appears to be associated with other major atherosclerosis 
risk factors and with atherosclerotic complications. For instance, in advanced lesions, 
fibrous cap formation in atherosclerotic plaques requires the formation of new vessels 
while BMP-9 can be an anti-angiogenic factor (Larrivée et al. 2012; Camare et al. 2017). 
The inhibition of cap formation makes plaque less stable in complicated lesions (Bennett 
et al. 2016; Allahverdian et al. 2018). Furthermore, the matrix calcification induced by 
VSMCs (also called calcification of VSMCs), a phenomenon involved in advanced 
atherosclerotic lesions, is intensified by in vitro BMP-9 treatments, further indicating that 
BMP-9 signaling is involved in the progression of atherosclerosis (Baeyens et al. 2016; 
Durham et al. 2018). 
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2.7 CONCLUSION  
Many studies have shown that BMP-9 markedly affects EC behavior, either directly or by 
regulating the effects of other factors such as VEGF. BMP-9 may thus have the capacity 
to influence the progression of atherosclerosis. During the genesis of atherosclerosis, BMP-
9 combined with TNF-alpha may increase the expression of adhesion molecules that 
facilitate leukocyte extravasation and, in turn, foam cell formation. BMP-9 may also 
regulate plaque development and growth by blocking angiogenesis. However, this anti-
angiogenetic property can enhance the risk of plaque rupture in more advanced plaques, 
where BMP-9 may also promote VSMC calcification. These observations suggest that 
BMP-9 may play a complex role in the progression of atherosclerosis in the early and 
advanced stages. The involvement of BMP-9 in atherosclerosis needs to be investigated 
further using systems that study the effect of a combination of atherosclerosis-related 
factors. For instance, BMP-9 treatments in a dynamic system (WSS) of an EC/VSMC co-
culture with a mixed FN/Coll coating could pave the way for designing more effective in 
vitro models. 
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Table 1: BMP-9/EC Interactions: Cell Proliferation, Angiogenesis, and Inflammation. 
EC Function Treatment Syste
m 
Type 
Cell/Specie Method 
Highlights 
Effect of Treatment Other 
Observations 
References 
Proliferation BMP-9 
(10 ng/mL, 
48 h) 
in vitro HMVEC-d 5% FBS BMP-9 ┤ Proliferation 
compared to control 
 (David et al. 
2007) 
 BMP-9 
(1 ng/ml,  
48 h) 
+ VEGF (30 
ng/mL, 48 
h) 
in vitro MESEC Serum-free BMP-9 + VEGF → 
Proliferation compared to 
VEGF alone 
 
BMP-9 + VEGF → 
Pro-angiogenic 
↑mRNA coding 
VEGFR2, Tie2, 
VEGF, compared to 
VEGF alone in 
mouse embryonic 
stem cells 
(Suzuki et al. 
2010) 
 BMP-9 
(1 ng/ml,  
48 h) 
+ VEGF (30 
ng/mL, 48 
h) 
in vitro MESEC Serum-free BMP-9 + ALK-1-Fc + 
VEGF ┤ Proliferation 
compared to BMP-9 + 
VEGF 
 (Suzuki et al. 
2010) 
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+ ALK-1-Fc 
(30 ng/mL, 
48 h) 
 BMP-9 
(10 ng/mL, 
72 h) 
+ bFGF  
(30 ng/mL, 
72 h) 
in vitro BAEC Serum-free BMP-9 + bFGF ┤  
Proliferation compared to 
bFGF alone 
 (Scharpfenec
ker et al. 
2007) 
Migration 
 
BMP-9 
(10 ng/mL, 
24 h) +/- 
bFGF  
(30 ng/mL, 
24 h) 
in vitro BAEC  BMP-9 ┤ Migration 
compared to bFGF  
 (Scharpfenec
ker et al. 
2007) 
BMP-9 
(10 ng/mL, 
48 h) 
in vitro HMVEC-d 0.5% FBS BMP-9 ┤ Migration 
compared to control 
 (David et al. 
2007) 
BMP-9-
transduced 
cells vs. 
in vitro BMP-9-
SVEC,  
0.5% BSA, 
Coll coating 
BMP-9-SVEC →  
Migration, compared to 
BMP-9 (5 ng/mL, 
24 h) ┤ activation of 
gene encoding E-
(Young et al. 
2012) 
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pWzl 
retrovirus 
treaded cells 
Wzl-SVEC pWzl-SVEC with little 
BMP-9 mRNA expression 
selectin in HMVEC-
d, compared to 
control 
BMP-9 
(2 ng/mL, 
168 h), +/- 
control Fc 
protein (20 
µg/ml, 168 
h) 
ex vivo Mice & 
MS1 EC 
Serum-free, 
Matrigel 
BMP-9 ┤ Migration, 
compared to control Fc 
protein 
 (Cunha et al. 
2010) 
Sprouting BMP-9 
(10 ng/mL, 
144 h) +  
VEGF  
(25 ng/mL, 
144 h) 
in vitro HUVEC 2% FBS, 
3D fibrin 
gel 
BMP-9 + VEGF ┤ Sprouting 
compared to VEGF alone 
 
 (Larrivée et 
al. 2012) 
 anti-BMP-9 
(RAP-041) 
in vitro HUVEC Complete 
medium+ 
0.1% 
methylcellu
lose, Coll I  
anti-BMP-9 had no effect on 
sprouting, compared to 
control 
 (Cunha et al. 
2010) 
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 anti-BMP-9 
(RAP-041) 
+ VEGF-A 
(50 ng/mL) 
in vitro HUVEC Complete 
medium + 
0.1% 
methylcellu
lose, Coll I  
anti-BMP-9 + VEGF-A 
┤Sprouting, compared to 
VEGF-A alone 
 (Cunha et al. 
2010) 
 anti-BMP-9 
(18h) + 
VEGF (50 
ng/ml, 18h) 
in vitro HUVEC EGM2 + 
2% FCS + 
0.1% 
methylcellu
lose, Coll I 
anti-BMP-9 + VEGF 
┤Sprouting, compared to 
VEGF alone 
anti-hALK-1 (40 
µg/mL, 18 h) + 
VEGF ┤HUVEC 
sprout lengths, 
compared to VEGF 
alone 
(Meeteren et 
al. 2012) 
 BMP-9 
(0.5 mg/mL, 
16 h) 
in vivo Postnatal 
mice  
 BMP-9 ┤ Hyper-sprouting 
compared to control 
 (Larrivée et 
al. 2012) 
Cord 
formation 
anti-BMP-9 
(RAP-041,  
10 µg/mL,  
16 h) 
in vitro HUVEC 4% FBS, 
Matrigel 
plug 
anti-BMP-9 ┤ Cord 
formation, compared to 
control 
 (Cunha et al. 
2010) 
Angiogenesis 
 
BMP-9 
(100 ng/mL, 
168 h)  
ex vivo Metatarsals 
of mouse 
foetuses 
 BMP-9 ┤Angiogenesis 
compared to control 
 (Scharpfenec
ker et al. 
2007) 
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BMP-9 
(100 ng/mL, 
168 h) + 
VEGF 
(50 ng/mL, 
168 h) 
ex vivo Metatarsals 
of mouse 
foetuses 
 BMP-9 + VEGF 
┤Angiogenesis  compared to 
VEGF alone 
 (Scharpfenec
ker et al. 
2007) 
BMP-9 
(4 ng/mL,  
48 h) 
ex vivo Mouse 
embryos 
 BMP-9 → Angiogenesis 
compared to control 
 (Suzuki et al. 
2010) 
Endo-MO 
(blocking 
ENG 
translation,  
5 ng/nL,  
48 h) 
in vivo  Zebrafish 
embryos 
 Endo-MO ┤ Angiogenesis 
compared to control 
 (Tian et al. 
2012) 
BMP-9 
(55 ng, 24 h) 
in vivo Chick 
embryos 
 BMP-9 ┤ Angiogenesis 
compared to control 
 (David 2008) 
BMP-9 
(20 ng, 168 
h) 
in vivo Balb-C 
mice 
 BMP-9 ┤ Angiogenesis 
compared to FGF-2 
 (David 2008) 
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 +/- FGF-2 
(200 ng, 168 
h) 
BMP-9 
(10 ng/mL, 
168 h) 
+ FGF-2  
(1 µg/mL, 
168 h) 
in vivo BALB/c 
mice 
Matrigel BMP-9 + FGF-2 → 
Angiogenesis compared to 
FGF-2 alone 
 
 (Suzuki et al. 
2010) 
BMP-9 
(BMP-9 
encoding 
lentivirus,  
35 days) 
in vivo BALB/c 
nude mice 
Subcutaneo
usly 
inoculation 
of BxPC3 
human 
pancreatic 
adenocarcin
oma cells, 
infected 
with 
lentiviruses 
encoding 
BMP-9 or 
GFP 
(control) 
BMP-9 → Angiogenesis, 
compared to control 
 (Suzuki et al. 
2010) 
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BMP-9 
(adenoviral 
over-
expression) 
in vivo Postnatal 
mice  
 
BMP-9 
adenovirus 
injection vs. 
control 
siRNA 
adenovirus 
injection 
BMP-9 ┤ Angiogenesis 
compared to control 
 (Larrivée et 
al. 2012) 
BMP-9 
(2 ng/mL, 
168 h)  
+/- TGF-
beta (2 
ng/mL,  
48 h) 
in vivo Mice Subcutaneo
usly 
injected 
Matrigel 
plugs 
BMP-9 + TGF-beta had no 
effect on angiogenesis 
compared to control 
 (Cunha et al. 
2010) 
BMP-9 
(2 ng/mL, 
168 h)  
+ TGF-beta 
(2 ng/mL,  
48 h) +/- 
VEGF-A 
in vivo Mice Subcutaneo
usly 
injected 
Matrigel 
plugs 
BMP-9 + TGF-beta 
┤Angiogenesis compared to 
BMP-9 + TGF-beta + 
VEGF-A + bFGF-2 + 
control Fc 
 (Cunha et al. 
2010) 
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(300 ng/mL, 
168 h) 
+/- bFGF-2 
(700 ng/mL, 
168 h) 
+/- control 
Fc protein 
(20 µg/ml, 
168 h) 
Inflammation BMP-9 
(5 ng/mL,  
16 h) + 
TNF-alpha 
(0.05 
ng/mL, 4 h) 
in vitro HAEC 
BOEC 
 BMP-9 + TNF-alpha → 
Inflammation compared to 
TNF-alpha alone and control 
 (Mitrofan et 
al. 2017) 
BMP-9 
(5 ng/mL,  
4 h) 
in vitro  
 
PAEC 
HMEC 
 
Serum-free  
 
BMP-9 ┤ Inflammation 
compared to control 
BMP-9 ┤IL-6 and 
MCP-1 gene 
expression  
(Chen et al. 
2017) 
BMP-9 
(5 ng/mL,  
in vitro BOEC 
HPAEC 
 BMP-9 + LPS → 
Inflammation compared to 
LPS alone and control  
 (Appleby et 
al. 2016) 
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16 h) + LPS 
(100 ng/mL, 
4 h) 
BMP-9 
(50 µg/kg,  
240 h) 
in vivo Rat pups Hyperoxia  
 
BMP-9 ┤ Inflammation 
compared to control 
 (Chen et al. 
2017) 
 
Abbreviations: activin receptor (ActR), bovine aortic endothelial cell (BAEC), basic fibroblast growth factor (bFGF), bone 
morphogenetic protein (BMP), bone morphogenetic protein receptor (BMPR), blood outgrowth endothelial cell (BOEC), bone 
morphogenetic protein‐responsive element Luciferase (BRE-Luc), bovine serum albumin (BSA), collagen (Coll), endothelial cell (EC), 
endothelial cell growth medium (EGM2), endoglin (ENG), endothelial selectin (E-selectin), fetal bovine serum (FBS), fragment 
crystallizable (Fc), fetal calf serum (FCS), green fluorescent protein (GFP), human aortic endothelial cell (HAEC), human activin 
receptor-like kinase (hALK), dermal human microvascular endothelial cells (HMEC-d, HMVEC-d), human pulmonary artery 
endothelial cell (hPAEC), human umbilical vein endothelial cell (HUVEC), DNA-binding protein inhibitor (ID), interleukin (IL), 
lipopolysaccharide (LPS), intercellular monocyte chemoattractant protein-1 (MCP-1/CCL2), mouse embryonic-stem-cell-derived 
endothelial cell (MESEC), messenger RNA (mRNA), mouse microvascular endothelial cell (SVEC), MILE SVEN 1 (MS1), 
phosphorylated Smad (pSmad), stromal-derived factor 1 (SDF1, CXCL12), small interfering (siRNA), tumor necrosis factor (TNF), 
vascular endothelial growth factor (VEGF), vascular endothelial growth factor receptor (VEGFR), Signs: [→ increase/activation] [↑ 
increase/more] [┤block/decrease] 
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2.9 In vitro Model Mimicking Tissue Stiffness 
So far, a wide variety of in vitro cell culture models based on polymers have been 
developed to study the effect of substrate stiffness on ECs (LaValley et al. 2017; Eguiluz 
et al. 2017) (Table.2). For example, Eguiluz et al. (Eguiluz et al. 2017) have used 
polyacrylamide gels of 1.1 and 40 kPa Young’s moduli, on which FN was covalently 
bound, to study how substrate stiffness in the range of lung artery elasticity influences the 
force transduction signaling via VE-cadherin in human pulmonary artery endothelial cells 
(HPAEC) and thus endothelial monolayer integrity. They found cell stiffening, in response 
to mechanical stimulation induced by magnetic twisting cytometry, was higher on soft 
polyacrylamide gel compared to stiff gels. This force transduction signaling, via VE-
cadherin, enhanced the number and size of FAs only on stiffer substrates (Eguiluz et al. 
2017).  
Such study is very interesting and may help develop new experimental approaches to better 
understand force transduction signaling involved in several vascular diseases such as 
atherosclerosis. In the same way, Stroka et al. (2012) produced FN-coated (0.1 mg/mL) 
polyacrylamide gels with Young’s modulus of 0.87 kPa, 5 kPa, and 280 kPa to investigate 
how subendothelial matrix stiffening affects HUVEC response to ox-LDL, involved in 
foam cell formation during atherosclerosis (Maiolino et al. 2013). They found that the 
integrity of the EC monolayer was weakest on stiffer gels after treatment during 24h by 
ox-LDL (25 μg/mL) (Stroka et al. 2012).  
Among polymers used to develop in vitro cell culture models, polydimethylsiloxane 
(PDMS), a silicon elastomer with the chemical formula: [(CH3)2SiO]n, is one of the most 
used (Table.2) (Owen 2001; Mata et al. 2005; Farcas et al. 2009; Rouleau et al. 2010; Rossi 
et al. 2010; Goli-Malekabadi et al. 2017; Zhao et al. 2018).  
 
2.9.1 Polydimethylsiloxane (PDMS)  
PDMS offers notable flexibility in tuning of bulk stiffness (Palchesko et al. 2012; Lamberti 
et al. 2014). A common approach to measure PDMS stiffness is to determine nominal or 
engineering Young’s modulus value (E, Pa) via tensile test (Johnston et al. 2014). 
Engineering stress, in contrast to true stress, is the force divided by initial cross-sectional 
area neglecting necking changes of cross-section (Roylance 1996):  
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ε = ΔL / L0 
σ = E ε 
σ: engineering stress (Pa), ε: strain, L0: initial length (mm), L: length (mm), ΔL = L - L0: 
elongation (mm)  
 
Moreover, PDMS is a biocompatible transparent material (Mata et al. 2005; Liu et al. 2011; 
Palchesko et al. 2012; Subramaniam and Sethuraman 2014) that limits inflammatory 
response.  
  
2.9.1.1  Preparation of PDMS Elastomer and its Influence on Physicochemical and 
Mechanical Properties of the Substrate 
PDMS substrates, commercially available from Dow Corning Corporation as Sylgard®184 
(specific gravity of 1.03 [Dow Corning Corporation, ON, Canada]) can be prepared by 
using kits containing the prepolymer (base) and the curing agent (mainly a crosslinker 
molecule such as dimethyl methyl hydrogen siloxane). The base used to prepare 
Sylgard®184 is made of more than 60% of prepolymer (vinyl terminated dimethylsiloxane 
oligomers) with traces of ethylbenzene, elastomer fillers (silica), some silane and a Pt 
catalyst (Wolf et al. 2018).  
To produce PDMS, the base and curing agent are mixed in a specific base:curing agent 
mass ratio, 10:1 being recommended by the manufacturer (Suh et al. 2001) to get the 
highest crosslinking efficiency and limit the number of unreacted molecules (Lamberti et 
al. 2014). The base:curing agent mixture is then degassed in a vacuum chamber and finally 
heat cured into oven (Figure 9 A-C).  
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PDMS stiffness can be modified by adjusting the base:curing agent mass ratio (Mata et al. 
2005; Seo et al. 2013; Goli-Malekabadi et al. 2017). For example, Seo et al. (2013) have 
obtained PDMS films with stiffness varying from around ~0.1 to 1.7 MPa after 2h at a heat 
curing temperature of 60 °C by increasing the base:curing agent mass ratio from 10:0.2 to 
10:4.  
Another strategy to obtain PDMS substrates with various stiffnesses is to blend together 
two miscible Sylgard® elastomers at different mass ratios (Palchesko et al. 2012). Using 
this method, Palchesko et al. found that a PDMS substrate made of Sylgard® 184 or 
Sylgard® 527 yielded Young’s modulus of 1.72 MPa and 5 kPa, respectively, while a 
Sylgard®184:527 mass ratio of 1:1 produced a Young’s modulus of 830 kPa. This change 
in stiffness is due to differences in Sylgard® elastomer filler content. In fact, Sylgard® 184 
contains fumed silica (glassy nanoparticles) that significantly increase its stiffness, whereas 
Sylgard® 527 does not contain such fillers (Palchesko et al. 2012). Furthermore, increasing 
Sylgard® 184:527 mass ratio from 1:10 to 5:1 to stiffen the PDMS substrate had no 
significant effect on the elastomer surface roughness with values remaining below 1 nm 
(measured by atomic force microscopy, AFM). The PDMS stiffness can also be altered by 
adding other molecules such as UV photosensitizers to the elastomer (Jothimuthu et al. 
2009; Raczkowska and PrauznerBechcicki 2016). Raczkowska et al. (2016) have added 
UV-sensitive material i.e. benzophenone to the Sylgard® 184 (base:curing agent mass ratio 
of 10:1) and observed that the Young’s modulus of the PDMS films decreased with 
increased duration of UV exposure. In fact, the value of Young’s modulus dropped from 
1.67 MPa initially to 0.75 MPa and 0.24 MPa after 2h and 5h, respectively, of UV 
irradiation. Raczkowska et al. (2016) also found that addition of the photosensitizer neither 
alters the chemical surface properties of the PDMS nor its topography.  
Nevertheless, changes in the mass ratio of base:curing agent or elastomers with or without 
nanocomposite fillers as well as the addition of molecules to get various stiffness affect the 
number of unreacted groups or chemical composition of the substrate (Lamberti et al. 
2014). Interestingly, tuning PDMS stiffness can also be performed by increasing curing 
temperature (Johnston et al. 2014; Campeau et al. 2017). For example, using a Sylgard®184 
base:ratio of 10:1, Campeau et al. (2017) obtained PDMS films with Young modulus 
varying from 1 to 4 MPa by increasing the curing temperature from 50 °C to 150 °C for 
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4h. The duration of the heat curing step plays a significant role in elastomer stiffness. Fuard 
et al. (2008) have cured Sylgard®184 at 100 °C for 3 days and measured the Young’s 
modulus for different base:curing ratios. For all tested percentages (3, 5 and 10%), they 
observed a time-dependent increase in PDMS stiffness, from 800 kPa after 15 min to 3.5 
MPa after 17 hours (10 % curing agent).  
Due to its methyl groups, PDMS is a hydrophobic material with a contact angle θ > 90° 
(Bracco and Holst 2013; Campeau et al. 2017). Seo et al. suggested a slight effect of the 
base:curing agent mass ratio on PDMS hydrophobicity where higher base:cross-linker 
ratios resulted in a lower water contact angle ranging from 120° to 100° (Seo et al. 2013). 
In contrast, Brown et al. did not notice any impact of the base:curing agent mass ratio (10:1 
to 50:1) on wettability (Brown et al. 2005). As hydrophobicity can affect the physisorption 
of proteins and their conformation, it is important to quantify the properties of PDMS 
(Toworfe 2004; Seo et al. 2013). Chumbimuni-Torres et al. (2011) have shown that 
hydrophobic PDMS influences the amount of adsorbed proteins and their initial adsorption 
rate using thin PDMS films prepared using n-dimethylsiloxanes deposited onto silicon 
wafers and analyzed by spectroscopic ellipsometry. In fact, they investigated the adsorption 
kinetics of Coll I, fibrinogen and bovine serum albumin (BSA) at a concentration of 
0.01mg/mL. The PDMS films adsorbed after 3 h a high quantity of Coll and fibrinogen 
with saturation amounts around 2.6 mg/m2 and 2.2 mg/m2, respectively, while the BSA 
was adsorbed at less than 1 mg/m2. The adsorption of fibrinogen onto PDMS films occurred 
faster as it reached 50% of its saturation amount at 30 min compared to 50 min for Coll 
type I and 40 min for BSA. Both fibrinogen saturation amounts and its initial adsorption 
rate increased in a dose-dependent manner. Fibrinogen adsorption was greater at pH near 
its isoelectric point (pH=6.6), as electrostatic interactions between the macromolecules 
would be the lowest (Chumbimuni-Torres et al. 2011). Therefore, the adsorption of the 
proteins onto PDMS substrates depends on the balance between hydrophobic and 
electrostatic interactions.  
To control protein adsorption and limit the risk of denaturation, the PDMS surface can be 
treated to become more hydrophilic (Wolf et al. 2018). This can be achieved by using 
strong acids (Farcas et al. 2009; Campeau et al. 2017) or argon and oxygen plasma (Mata 
et al. 2005; Fuard et al. 2008). Oxygen plasma treatment for 5 min reduced PDMS 
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(base:curing agent mass ratio 10:1, cured at 95 °C for 30 min) water contact angle from 
113° to 60° while hydrochloric acid treatment for 10 min on similar PDMS caused a 3° 
reduction in contact angle (Mata et al. 2005). In the same way, sulfuric acid treatment (~30 
min) of PDMS surface reduced the contact angle from ~110° to ~95° (Campeau et al. 
2017). Despite its efficiency to decrease wettability, one major drawback of the oxygen 
plasma treatment remains the hydrophobic recovery of PDMS after its storage in air for 
few hours due to polar/apolar group reorganization between the surface and bulk (Tan et 
al. 2010). Yamada et al. have shown that the contact angle (15°) of air plasma treated 
PDMS films (Sylgard®184 base:curing agent mass ratio 10:1) was only stable within 2 h. 
The contact angle increased after 5 days to reach 60° while untreated PDMS films have a 
contact angle of 86° (Yamada et al. 2014). To avoid hydrophobic recovery of treated 
PDMS, Yamada et al. have therefore performed their protein adsorption (vitronectin and 
gamma globulin) 1h after the air plasma treatment (Yamada et al. 2014). Tan et al. proposed 
to store the plasma treated PDMS into deionized water to prevent hydrophobic recovery of 
the substrates (Tan et al. 2010). Furthermore, Campeau et al. demonstrated that storing 
acid-treated PDMS films in water prevented hydrophobic recovery for up to 7 days 
(Campeau et al. 2017).  
Another strategy to obtain proteins onto PDMS substrates consist to directly grafted the 
molecules on the PDMS surface using silane such as APTES (3-
aminopropyl)triethoxysilane (Siddique et al. 2017), zwitterionic molecules with EDC/NHS 
chemistry or polymers (Wolf et al. 2018), and glutaraldehyde (Liu et al. 2018).  
 
2.9.1.2 Effect of PDMS Stiffness on Protein Adsorption and Endothelial Cell 
Behaviors 
PDMS stiffness can mimic human tissue stiffness varying from 103 Pa (brain) to 109 Pa 
(bone) (Fekete et al. 2018). For example, the average bulk stiffness of human right brachial 
artery is around 0.8 MPa, human abdominal aorta is around 0.570 MPa (O’Rourke et al. 
2002), human healthy coronary artery is around 1 MPa, and human coronary artery with 
atherosclerosis is around 3 MPa (Ozolanta et al. 1998; Karimi et al. 2013). Therefore, 
PDMS is a material of choice for evaluating the effect of stiffness on protein adsorption 
and subsequent vascular cell behaviors (Goli-Malekabadi et al. 2017). Casillo et al. (Casillo 
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et al. 2017) have coated PDMS (5 kPa and 2 MPa) with physiological BM proteins 
Geltrex® (which includes laminin, vitronectin, and collagen IV, 0.15 mg/mL) to determine 
the ability of HUVECs to reorganize synthetized FN into fibrillogenesis in serum-starved 
conditions. After 24h of incubation, immunolabeling of cellular FN revealed that HUVEC 
attached to 5 kPa and 2 MPa PDMS and had organized similarly their FN fibrils. However, 
the number of HUVECs with vinculin included in the FAs were ~1.3 fold higher on the 
stiffer PDMS films (Casillo et al. 2017). Several studies have confirmed better cell 
spreading and improved FA organization on stiffer PDMS substrates coated by Coll I or 
FN (Prager-Khoutorsky et al. 2011; Yeh et al. 2017; Goli-Malekabadi et al. 2017). 
PDMS have been also used to develop cell culture models to better understand the 
angiogenesis process during tumor development (Lee et al. 2014; Zhao et al. 2018). Zhao 
et al. (2018) have used base:curing agent ratios, varying from 10:1 to 40:1 with temperature 
curing at 60°C for 24h to obtain PDMS films with 135 kPa to 6 kPa of Young’s moduli. 
By using a co-culture of lung cancer cell line A549 (seeded on PDMS film) and HUVECs 
(seeded on transwell chamber with 0.4 and 0.8 μm porous membranes), they showed up to 
a ~1.6 fold increase in VEGF protein level (72h) as well as ~1.6-fold higher migration of 
HUVECs (24h), in the case of the stiffest PDMS film (Zhao et al. 2018).  
 
2.9.2 Static and Dynamic in vitro Models 
In addition to ECM protein changes and substrate stiffness, wall shear stress (WSS) is 
another influential parameter regarding ECs behavior and vascular homeostasis (Traub and 
Berk 1998; Tzima et al. 2005; Chatzizisis et al. 2007; Yang et al. 2018). In fact, WSS plays 
an essential role in the genesis, development and progression of atherosclerosis lesions. 
Both WSS magnitude (below 10 dyne/cm2 and above 70 dyne/cm2 (Malek et al. 1999) and 
pattern (non-unidirectional, oscillatory, and with complex vortices in post-stenosis areas 
(Cecchi et al. 2011) can cause EC dysfunction such as disrupted AJs (Bhullar 1998; Malek 
et al. 1999; Friedland et al. 2009; Chatzizisis et al. 2007).  
PDMS is used in dynamic in vitro bioreactors with a peristaltic pump since it can be molded 
into tubular form similar to blood vessels (Rouleau et al. 2010; Campeau et al. 2017; van 
Engeland et al. 2018). Indeed, Rossi et al. (2010) showed that laminar WSS (12 dyne/cm2) 
applied during 30h on HAAECs attached to FN (40 μg/ml) coated PDMS tubes, using a 
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base:curing agent ratio of 10:1, prevented the increase in VCAM-1 protein level induced 
by TNF-α (10 μg/ml), in comparison to static condition. Indeed, this effect can attenuate 
leukocyte recruitment by ECs (Muro 2007). Using PDMS tubes, Mannino et al. (2015) also 
found that a decrease of WSS from 12 to 5 dyne/cm2 in bifurcation-mimicking sites 
enhanced around 2-fold VCAM-1 protein expression which is observed in abnormal 
arterial wall swelling, aneurysm (Boussel et al. 2008).  
Using a Förster resonance energy transfer (FRET)-based tension sensor, Conway et al. 
(2017) showed that low and oscillatory WSS would induce VE-cadherin phosphorylation 
on cytoplasmic tyrosine Y658 increasing endothelial permeability (Dejana et al. 2008; 
Daniel 2013; Conway et al. 2017). Also, Cheng et al. (2013) reviewed PDMS usage for 
producing culture surfaces with flexible micro-post arrays. Such in vitro models are used 
for performing cell traction tests and investigating force stimulation effects on cell-cell 
junctions, cell-matrix and cytoskeleton. 
PDMS is also widely used in microfluidics (Choi et al. 2013; Zanotelli et al. 2016; Pitingolo 
et al. 2017; Nguyen et al. 2018). For example, van Engeland et al. (2018) produced a porous 
and a non-porous double layer microfluidic channel to achieve an artery-on-a-chip model 
accompanied by WSS ranging from 10 to 15 dyne/cm2. Their goal was to investigate the 
effect of crosstalk in terms of Notch signaling pathway activation between human aortic 
vein endothelial cells (HAVECs) and human aortic smooth muscle cells (HASMCs) in 
porous PDMS channels and non-porous channels without cell-cell communication. They 
coated these PDMS layers (base:curing agent weight ratio of 10:1, cured at 65 °C, 4h) with 
FN (100 μg/ml) (van Engeland et al. 2018). They observed higher HEY1 mRNA levels in 
non-porous channels in ECs (van Engeland et al. 2018). HEY1 gene expression is an 
indication of Notch signaling pathway activity which is engaged in activation of ECs and 
atherosclerosis progression (Thomas et al. 2013; Chen et al. 2015; Wesseling et al. 2018). 
Furthermore, Menon et al. (2017) used a two-layered PDMS (10:1 w/w ratio, cured at 80 
°C, 2h) model to investigate HUVEC monolayer permeability while being co-cultured with 
aortic SMCs in a microfluidic chip (WSS: 1-10 dyne/cm2). Neutrophil transendothelial 
migration assays (TNF-α: 10 ng/mL, 12h) in this study revealed a ~2-fold increase in 
endothelial permeability when ECs were cultured without VSMCs (Menon et al. 2017), as 
VSMCs can contribute to maintenance of vascular integrity (Bergers and Song 2005). 
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Thus, to conclude, PDMS properties make it a desired material for designing and 
developing in vitro models to investigate ECs behavior in the context of atherosclerosis. 
Such distinct properties include effective tuning of bulk stiffness to mimic those of arteries, 
simplicity of production method, being commercially available at low cost, high 
biocompatibility, capacity to be functionalized with ECM proteins, and possibility to be 
molded in tubular forms compatible for more complex dynamic models.  
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Table 2: Summary of Studies Addressing Substrate Stiffness Effect on ECs Behavior.  
Material Preparatio
n 
Young’s 
Modulus 
Cell 
Function 
Cell type Method 
Highlights 
Observation Ref. 
PDMS 
Sylgard® 184 
10:1 to 40:1 
60°C, 24h 
135 kPa 
to 6kPa 
Angiogenesis Lung cancer 
cell line A549 
and HUVECs 
co-culture 
FBS 1%, 72h 
(Western 
Blot,WB) for 
VEGFA protein) 
Stiffness 
→Angiogenesis 
compared to 
softer films; i.e. 
↑VEGF protein 
expression, ECs 
↑migration 
Zhao et al. 
(2018)  
10:1, 50°C 
to 150°C, 
4h 
1-4 MPa Attachment HAAEC Coll I (5-10 
µg/mL), FN 
(10–40 µg/mL), 
and Coll I/FN 
(10 µg/mL, 
each) 
(phase contrast 
microscopy, 
PCM) 
 
No influence of 
stiffness on cell 
number after 48h  
Campeau et al. 
(2017)  
66 
 
50:1 to 10:1 
65 °C 
12 kPa 
and 2.5 
MPa 
Migration BPAECs 
(bovine 
pulmonary 
artery 
endothelial 
cells) 
FN (0.1 mg/mL) 
(PCM) 
Stiffness → cell 
number compared 
to softer sections 
(48h) 
Gray et al. 
(2003)  
10:1 and 
50:1, 
80 °C, 1h 
2 MPa 
and 50 
kPa 
Adhesion HUVECs FN (2 μg/mL) 
(immunofluores
cence 
microscopy, IF) 
 
Stiffness → 
filopodia 
formation (24h) 
compared to 
softer films 
Goli-
Malekabadi 
(2017) 
PDMS 
Sylgard® 184 
Al2O3 
1:10, 50 °C, 
4h; Al2O3 
Ratio to 
PDMS:2.5, 
5, 7.5, and 
10 wt % 
0.3-1.07 
MPa 
Proliferation BAECs FN (50 µg/cm2) 
FBS 20%, 72h 
(Alamar blue 
assay based on 
resazurin) 
Stiffness → cell 
proliferation 
compared to 
softer films 
Ataollahi et al. 
(2015)  
PDMS 
Sylgard® 184 
10:1, 60°C, 
4h 
3 MPa 
PDMS vs 
Adhesion HUVECs FN (25 µg/ml) 
(IF) 
Stiffness → cell 
spreading 
velocity (2h) 
Versaevel et al. 
(2017)  
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Hydroxy-
polyacrylami
de hydrogels 
5 kPa 
hydrogels 
compared to 
softer films 
Hyaluronic 
acid hydrogel 
 78 Pa, 
309 Pa, 
and 596 
Pa 
Sprouting Human 
umbilical cord 
blood 
endothelial 
colony-
forming cells 
(ECFC), 
HT1080 
fibrosarcoma 
cells 
Serum-free, 24h, 
SDF1α (125 
µM) S1P (125 
µM) (IF: lectin) 
Stiffness ┤ ECs 
sprouting 
compared to 
softer films 
Shen et al. 
(2014)  
Acrylamide 
hydrogels 
 25 kPa, 
50 kPa, 
and 75 
kPa 
Elongation, 
Proliferation 
and 
migration 
HAEC  
Human 
saphenous vein 
endothelial 
cells 
(HSaVECs)  
FN, Coll, + 
Serum 
(IF, and live cell 
imaging) 
Stiffness ┤ ECs 
elongation 
Stiffness → 
Proliferation  
Stiffness ┤ 
Migration (only 
HSaVEC)  
Wood et al. 
(2011) 
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compared to 
softer films 
Polyacrylami
de gels 
 0.87 kPa, 
5kPa, and 
280 kPa 
Inflammation 
and Cell-cell 
adhesion 
HUVEC FN (0.1 mg/mL), 
oxLDL (25 
mg/mL, 24h) 
(Phase contrast 
& IF) 
Stiffness → 
ruptures in EC 
layer (2h) 
Stiffness → 
neutrophil 
transmigration 
(1min) 
compared to 
softer films 
Stroka et al. 
(2012)  
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3 CHAPTER 3 The Effect of Substrate Bulk Stiffness on Focal and 
Fibrillar Adhesion Formation in Human Abdominal Aortic 
Endothelial Cells  
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Title: The Effect of Substrate Bulk Stiffness on Focal and Fibrillar Adhesion Formation in 
Human Abdominal Aortic Endothelial Cells 
 
Contribution to the document:  
This study discusses PDMS Young’s modulus, physicochemical surface properties 
(roughness and water contact angle) as well as FN physisorption state on PDMS films. 
Further, it introduces HAAECs adhesion kinetics on FN-coated PDMS films and the 
kinetics of focal and FN fibrillar adhesions formation. Moreover, HAAECs migration is 
discussed.  
 
3.1 RÉSUMÉ 
Le dysfonctionnement des cellules endothéliales (CE) contribue à l'athérosclérose, qui est 
associée à la rigidification des parois artérielles et au dépôt de fibronectine (FN) par les CE 
et les cellules musculaires lisses (SMC). L'effet de l’élasticité sur l'interaction CE / FN et 
la formation des sites d’adhésion fibrillaire a été peu étudié. Nous avons donc développé 
un modèle in vitro, qui reposait sur l’utilisation de films de polydiméthylsiloxane (PDMS) 
revêtus de FN, présentant une hydrophobicité et une rugosité similaires, mais des valeurs 
de module de Young différentes, imitant l’élasticité des artères saines (1,0 MPa) et 
athérosclérotiques (2,8 MPa). Nous avons observé que des cellules endothéliales 
abdominales aortiques humaines (HAAEC) ensemencées sur les films de PDMS à 1,0 MPa 
s'étalaient dans le temps et atteignaient leur aire maximale plus rapidement par rapport à 
des films de PDMS à 2,8 MPa. De plus, les HAAEC semblaient organiser plus rapidement 
leur adhésion focale sur des films de PDMS à 1,0 MPa, malgré une accessibilité similaire 
sur la FN adsorbée du domaine de liaison cellulaire. Fait intéressant, comme le prouvent 
les marquages des sous-unités de l'intégrine α5, de la tensine et des fibres de FN, nous 
avons également observé une augmentation de 5 fois environ du pourcentage de HAAEC 
présentant une adhésion fibrillaire bien développée sur des films PDMS 1,0 MPa par 
rapport à ceux de 2,8 MPa. Cependant la migration des HAAECs étaient similaires sur les 
2 films de PDMS. Ces résultats suggèrent qu'il existe des conditions favorables pour 
l'assemblage de la matrice de FN par les CE dans l'athérosclérose précoce plutôt qu'à un 
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stade avancé. Notre modèle in vitro nous aidera donc à comprendre l’influence de 
l’élasticité de la paroi sur les cellules impliquées dans l’athérosclérose. 
MOTS-CLÉS: Polydiméthylsiloxane, module de Young, kinase adhésion focale, 
athérosclérose, fibronectine 
 
3.2 ABSTRACT  
Endothelial cell (EC) dysfunction contributes to atherosclerosis, which is associated with 
arterial stiffening and fibronectin (FN) deposition, by ECs and smooth muscle cells 
(SMCs). The effect of stiffness on the EC/FN interaction and fibrillar adhesion formation 
has been poorly studied. An in vitro model was prepared that included FN-coated 
polydimethylsiloxane (PDMS) films with similar hydrophobicity and roughness but 
distinct Young’s modulus values, mimicking healthy (1.0 MPa) and atherosclerotic (2.8 
MPa) arteries. Human aortic abdominal endothelial cells (HAAECs) seeded on 1.0 MPa 
PDMS films spread over time and reached their maximum surface area faster than on 2.8 
MPa PDMS films. In addition, HAAECs appeared to organize focal adhesion more rapidly 
on 1.0 MPa PDMS films, despite the similar cell binding domain accessibility to adsorbed 
FN. Interestingly, we also observed up to a ~5-fold increase in the percentage of HAAECs 
that had a well-developed fibrillar adhesion on 1.0 MPa compared to 2.8 MPa PDMS films 
as verified by integrin α5 subunits, tensin, and FN staining. This variation did not affect EC 
migration. These results suggest that there are favourable conditions for FN matrix 
assembly by ECs in early atherosclerosis rather than at advanced stages. Our in vitro model 
will therefore be helpful to understand the influence of bulk stiffness on cells involved in 
atherosclerosis.  
KEYWORDS: Polydimethylsiloxane, Young’s modulus, Focal adhesion kinase, 
Atherosclerosis, Fibronectin  
 
3.3 INTRODUCTION  
According to the World Health Organization (WHO), cardiovascular disease (CVD) is the 
leading cause of mortality in the world (WHO 2017). Nearly one out of four deaths in 
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Canada is due to heart disease or stroke (Government of Canada 2017). Atherosclerosis is 
a chronic inflammatory disease that causes CVDs, including coronary artery disease, 
carotid artery disease, and peripheral arterial disease, which hinder blood flow towards the 
heart, brain, and limbs, respectively (Moss and Ramji 2016).  
Atherosclerosis development is associated with the oxidation of low-density lipoprotein 
(LDL), its uptake into cells and its subendothelial accumulation, triggering an 
inflammatory response (Le Master et al. 2018; Tabas et al. 2015). This increase in the 
expression of pro-inflammatory molecules by endothelial cells (ECs), such as vascular cell 
adhesion protein-1 (VCAM-1) and intercellular adhesion molecule-1 (ICAM-1), leads to 
the recruitment of monocytes in the intima, where they differentiate into macrophages 
(Yurdagul et al. 2014). Later, fatty streaks are formed due to the transformation of 
macrophages into foam cells after the engulfment of oxidized LDL and their subsequent 
apoptosis (Moss and Ramji 2016). Additionally, migration of smooth muscle cells (SMC) 
results in the formation of a fibrous cap through matrix remodelling and stabilizing 
atherosclerotic plaque as well as further hindering the blood stream. Atherosclerotic 
plaques can rupture, resulting in artery blockage and eventually myocardial infarction 
(Moss and Ramji 2016). 
EC dysfunction, therefore, contributes to the development of atherosclerosis and to its 
evolution in the early stages of pathology (Gimbrone and García-Cardeña 2016; Jaoude et 
al. 2018). In fact, under healthy conditions, ECs play important roles, as they provide a 
selective barrier, reduce inflammation through expression of anti-inflammatory molecules, 
inhibit clot formation, and regulate vascular tone (Aird 2012). Thus, EC dysfunction can 
alter vascular homeostasis and result in a pro-inflammatory and pro-thrombotic 
environment (Gimbrone and García-Cardeña 2016). EC dysfunction is closely linked to 
modifications of the basement membrane composition, as it is known to regulate EC 
intracellular signalling and subsequent adhesion, survival, proliferation and migration 
(Ding et al. 2017; Yun et al. 2016; Bourdoulous et al. 1998). Under physiological 
conditions, the vascular basement membrane mostly consists of collagen type IV, laminin, 
nidogens, and perlecan (Yurchenco 2011), while atherosclerosis favours deposition a 
dimeric protein that is recognized by multiple cell integrins, such as α5β1 (Shekhonin et al. 
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1987; Yang et al. 2018; Zollinger and Smith 2017). Different studies have made 
contradicting claims regarding the source of the FN increase in a atherosclerosis lesion 
(Cseh et al. 2010; Moore and Fisher 2012; Langley et al. 2017; Rohwedder et al. 2012). 
For example, using a bovine aortic EC culture, Cseh et al. (2010) found that FN 
fibrillogenesis occurs as a result of cellular FN synthesis. Langley et al. (2017) observed a 
high amount of FN in lipid loaded human SMCs from atherosclerotic carotid artery plaques 
of patients who suffered a stroke via secretome analysis (including FN, galectin-3-binding 
protein, and tenascin C). By contrast, Rohwedder et al. (2012) showed that soluble plasma 
FN was essential for FN deposition in the atherosclerotic plaque located in the aorta and 
its branches in the ApoE -/- mouse model.  
FN can be turned into polymerized insoluble fibrils through a process involving the 
translocation of integrin α5β1 and tensin complexes from focal adhesion points to the centre 
of the cells, leading to fibrillar adhesion formation (Zamir et al. 2000; Faucheux et al. 2006; 
Ivanova et al. 2017). Adhesion of ECs to FN through α5β1 increases their pro-inflammatory 
properties as well as vascular permeability, for example, by promoting expression of 
VCAM-1 and ICAM-1 and enhancing monocyte attachment (Yurdagul et al. 2014). FN is 
also crucial for preventing plaque ruptures and thrombosis by stabilizing the fibrous cap, 
as shown in the aorta of the ApoE -/- mouse model (Rohwedder et al. 2012).  
Concurrent with the increase in FN deposition, other alterations also occur in the EC 
environment during atherosclerosis development, such as arterial wall stiffening (Ozolanta 
et al. 1998; Karimi et al. 2013). Post-mortem measurement studies have classified the bulk 
stiffness (Young’s modulus, E) of human coronary arteries into three major categories: ~ E 
≤ 1.5 MPa for healthy or early atherosclerotic arteries, ~ E = 2.1 MPa for atherosclerosis 
in stage 1 or 2 and ~ E = 3.6 MPa for advanced atherosclerosis at stage 3 (Ozolanta et al. 
1998; Karimi et al. 2013) (based on the WHO definition, i.e., stage 1: fatty streak 
appearance; stage 2: formation of fibrous plaque; stage 3: atheroma or atherosclerotic 
plaque with a soft fatty core; and stage 4: complicated lesions in which complex 
developments, such as thrombosis, occur) (WHO 1958). For comparison, the global 
abdominal aorta stiffness for healthy men and women between the ages of 20 and 30 years 
(in vivo measurements) is approximately 1 MPa (Åstrand et al. 2011).  
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Several in vitro models have been developed to study atherosclerosis and limit the use of 
animal in vivo studies (Campeau et al. 2017; Rouleau et al. 2010; Rouleau et al. 2010b; 
Profumo et al. 2016). In particular, biocompatible polymer polydimethylsiloxane (PDMS) 
has been used because its Young’s modulus can be tuned to mimic the values within the 
range of human tissue (Gray et al. 2003; Ataollahi et al. 2015; Zhao et al. 2018). For 
example, Gray et al. (2003) showed a higher cell density for bovine pulmonary artery 
endothelial cells (BPAECs) (up to ~ 2 fold) in stiff PDMS regions (2.5 MPa) compared to 
soft neighbouring segments (12 kPa) after 48 h. Additionally, Ataollahi et al. (2015) 
observed increased bovine arterial endothelial cell (BAEC) proliferation (up to ~ 3 fold) 
on stiff PDMS/alumina (Al2O3) composites (1.07 MPa) in comparison to soft ones (0.33 
MPa) after 3 days.  
Although many studies have examined EC function under different conditions, the effect 
of bulk stiffness of PDMS films that represent healthy (approximately 1 MPa) and 
atherosclerotic (higher than 2 MPa) arteries on the capacity of ECs to develop FN fibrillar 
adhesions has never been investigated. We designed an in vitro model using FN-coated 
PDMS substrates that had an adjusted stiffness to mimic the Young’s modulus values of 
healthy and atherosclerotic arteries. The mechanical and physicochemical properties of the 
PDMS films produced were characterized. Then, the influence of bulk stiffness on human 
abdominal aortic endothelial cells’ (HAAECs) capacity to spread and organize both focal 
and fibrillar adhesions were studied, as well as the accessibility of FN and its RGD cell 
binding domain/synergy site under different film conditions. Finally, scratch assays were 
performed to compare HAAEC migration on PDMS films with the various Young’s 
modulus values.  
 
3.4 MATERIALS AND METHODS  
 
3.4.1  Polydimethylsiloxane (PDMS) Film Preparation and Characterization  
3.4.1.1 Film Preparation 
PDMS films were prepared by adapting the previously described moulding process 
(Rouleau et al. 2010; Rouleau et al. 2010b; Farcas et al. 2009). A Sylgard® 184 silicone 
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elastomer kit (Dow corning corporation, ON, Canada) was purchased. The curing agent 
(also known as cross-linker) was added to the base at a volumetric ratio of 10/1, as 
measured using syringes. The mixture was stirred using two glass rods for 5 minutes in a 
plastic container (400 mL polypropylene disposable beaker, Thermo Fisher Scientific, 
Massachusetts, USA, FB0129112). Then, the mixture was degassed in a vacuum chamber 
(-70 kPa) for 45 minutes and poured into aluminium moulds to manufacture disk-shape 
films with a diameter × height equal to 45 mm × 3 mm (volume = 4.7 cm3). Then, the 
moulds were cured in a forced convection oven for 4 h at the desired temperature (i.e. 50 
and 100 °C).  
 
3.4.1.2 Characterization 
3.4.1.2.1 PDMS Film Young’s Modulus Measurement  
PDMS rectangles were prepared with a width × length × height = 9 × 60 × 2 mm and cross 
section = 0.18 cm2 (volume = 1.1 cm3) following the same steps as described above. These 
specimens were later tested in a specially designed traction machine equipped with a load 
cell (Tedea Huntleig, Vishay Precision Group, Malvern, USA) and an optical encoder 
(EM1 LIN 50-6, USDigital, Washington, USA) as previously described (Parent et al. 
2011). Traction tests were conducted at the rate of 0.5 mm/sec (0.83%/s) up to 10% 
elongation. Two samples were tested for each curing temperature, and the engineering 
stress/strain curve was obtained by using the initial cross-sectional area and length of the 
samples. The calculation procedure is shown below:  
E = σ/ ε 
ε = ΔL/ L0 
σ = (F × 0.001 × g / A) / 106 
E: engineering Young’s modulus (MPa) 
σ: engineering stress (MPa)  
ε: engineering strain 
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L0: initial length (mm) 
L: length (mm) 
ΔL = L - L0: elongation (mm) 
A: initial cross-sectional area (m2) 
F: force (g) 
g: gravity (m/s2) 
Finally, the mean engineering Young’s modulus (E, MPa) was evaluated from the linear 
interpolation of the engineering stress/strain data obtained. For each test sample, over 950 
data points were considered for the linear interpolation. The grand mean was determined 
as the weighted average relative to the inverse of the squared standard error of each 
independent experiment.  
 
3.4.1.2.2 Water Contact Angle 
The dynamic (advancing and receding) and static (equilibrium) contact angles were 
measured using an OCA 15 Tensiometer (Data Physics, California, USA) and video-based 
measuring system (SCA 20). A droplet (with a volume of approximately 10 µL) of ultrapure 
water (with an electrical resistance of 17.8 m Ωcm) was placed on the PDMS film surfaces 
using a syringe. The water contact angles were estimated on the surface by optical image 
analysis of three droplets in triplicate. 
 
3.4.1.2.3 Atomic Force Microscopy (AFM)   
An AFM device (NanoScope® IIIa, Digital Instruments, Veeco Metrology Group, New 
York, USA) was used to determine the surface roughness of the PDMS films. As the 
samples were hydrophilized prior to cell culture, the films undergoing acid treatment were 
tested for surface roughness. AFM images were acquired using the tapping mode via a 
monolithic silicon cantilever (ARROW-NC-20, Neuchâtel, Switzerland). Images (5 µm by 
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5 µm) were collected from three randomly chosen areas on the PDMS films (6 in total) and 
analysed with Gwyddion software (Version 2.48, open software).  
 
3.4.2  Fibronectin Coating 
The PDMS films were removed from the aluminium moulds and rinsed with a distilled 
water flow for 10 seconds. They were then treated with 70% (v/v) sulfuric acid (Thermo 
Fisher Scientific, A300, diluted in distilled water) for 45 minutes at room temperature and 
rinsed with a distilled water flow for 10 seconds. Films were then submerged in 70% 
ethanol (v/v) (Commercial Alcohols, Québec, Canada, P016-EAAN, diluted in distilled 
water) as a first sterilization step and after were rinsed with sterile MilliQ® purified water. 
The films were then exposed to UV light under a safety biological hood for 30 minutes for 
further sterilization. They were then washed with sterile phosphate buffer saline (1.5 mL 
for each film, d = 28 mm, 1X PBS: 137 mM NaCl, Thermo Fisher Scientific S671, 2.7 mM 
KCl, Thermo Fisher Scientific P3911, 10 mM Na2HPO4, Thermo Fisher Scientific S0876, 
1.91 mM KH2PO4, Thermo Fisher Scientific P5379, in 0.1 L distilled water). After 
sterilization, 10 µg/mL FN from human plasma (Sigma Aldrich, Missouri, USA, F0895, 
diluted in 1X PBS) was deposited on the PDMS films (1.5 mL for each film, i.e., FN surface 
concentration 2.4 µg/cm2). PDMS rings, manufactured and treated using the same 
procedure, were installed on the PDMS films to maintain the FN solution in the cell seeding 
area. Finally, the films were incubated overnight at 37 °C under 5% CO2 (v/v) in a 
humidified incubator.  
 
3.4.3  Enzyme-Linked Immunosorbent Assay (ELISA)  
The FN-coated PDMS films were washed three times with 1X PBS for a few seconds (1.5 
mL for each film) and were blocked with 3% (w/v) skim milk solution (fat free skim milk, 
Carnation, Ontario, Canada 1.5 mL for each film) in a 1X PBS for 30 minutes in a 
humidified incubator at 37 °C. Next, the films were washed once with 1X PBS and the 
primary antibodies against FN were deposited on the surface (750 µL for each film). The 
antibodies, both primary and secondary, were diluted in a blocking solution containing 3% 
w/v skim milk in 1X PBS. The primary antibodies included: (a) polyclonal, produced in a 
rabbit, against FN (Sigma Aldrich, F3648, 1:10,000) and (b) monoclonal IgG, produced in 
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a rabbit, against the FN cell binding domain HFN 7.1 (abcam, Cambridge, UK, ab80923, 
1:1,000). After incubation at room temperature for 30 minutes, the primary antibodies were 
removed from the PDMS films, and three 1X PBS washes were performed. Next, the films 
were incubated with secondary antibodies for 2 h at room temperature (750 µL for each 
film). The secondary antibodies included: (a) whole molecule–peroxidase anti-rabbit IgG, 
produced in a goat (Sigma Aldrich, A6154, 1:10,000) and (b) Fab specific–peroxidase anti-
mouse IgG, produced in a goat (Sigma Aldrich, A9917, 1:60,000). The PDMS films were 
then washed three times with a 1X PBS, and an o-Phenylenediamine dihydrochloride 
(OPD) substrate was added onto each film (750 µL for each film). The OPD substrate 
solution was prepared by dissolving one OPD tablet (Sigma Aldrich, P8287) in 50 mL of a 
0.05 M phosphate citrate buffer (by mixing 24.3 mL of 0.1 M citric acid, Sigma Aldrich, 
251275, with 25.7 mL of 0.2 M dibasic sodium phosphate, Sigma Aldrich, S0876) with a 
pH = 5.0, containing 20 µl of H2O2. The substrate was kept on the films for 30 minutes at 
room temperature in the dark, and the reaction was quenched by adding 3 M of sulfuric 
acid (750 µL for each film). At the end of the reaction, the coloured supernatant was 
transferred from the surfaces of the PDMS films to a 96-well plate, and the optical density 
were spectrophotometrically determined using a BioTek® microplate reader (Synergy HT, 
Vermont, USA) at a wave length of 492 nm.  
 
3.4.4  Cell Experiments 
3.4.4.1 Cell Culture 
In all cell experiments, human abdominal aortic endothelial cells (HAAECs, PromoCell, 
Germany) were used at passage 6. Cells were incubated in an endothelial cell growth 
medium (PromoCell, C-22010), with 2.5% (v/v) of SupplementMix (PromoCell, C-
39215), 10% (v/v) heat-inactivated foetal bovine serum (FBS) (Wisent, Inc., 080150, 
Québec, Canada), and 1% (v/v) penicillin streptomycin (PS) (Wisent, Inc., 450-201-EL), 
and at 37 °C, under 5% (v/v) CO2 in a humidified incubator. Before incubation, the surfaces 
of the culture flasks were covered with 0.1% (w/v) porcine gelatine (Sigma Aldrich, 
G1890) in 1X PBS (20 mL for T-175 culture flasks). The gelatine deposition was performed 
overnight in the incubator. Trypsin-EDTA 0.25% (Gibco, Thermo Fisher Scientific, 25200-
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056) was used to detach the cells through incubation for 5 minutes at 37 °C. Then, soybean 
trypsin inhibitor solution, 1% (w/v) in 1X PBS, (Gibco, 17075-029) was used to neutralize 
the trypsin. Subsequently, the cells were collected and centrifuged at 200 g for 8 minutes 
and resuspended in a fresh culture medium.  
HAAECs were seeded on sterile FN-coated PDMS films at a density of 5,000 cells/cm2 for 
non-confluent layer (or 10,000 cells/cm2 for confluency in cell migration tests) and were 
incubated in a serum-free medium (only containing 1% (v/v) PS). The cells were fixed at 
specific time lapses i.e., 0.5, 1, 2, 4, and 6 h, using 3% (w/v) paraformaldehyde (PFA) 
(Sigma Aldrich, P6148) in 1X PBS for 15 minutes, at room temperature. After fixation, the 
PDMS films were cut into four equal sections to be used for immunostaining, and stored 
at 4 °C in 1X PBS. Cell permeabilization was performed with triton X-100 (Sigma Aldrich, 
T8787) 0.5% (v/v) diluted in 1X PBS. The blocking of non-specific binding sites was 
achieved by incubation at 37 °C for 45 minutes in either 3% (w/v) solution of bovine serum 
albumin (BSA) (Sigma Aldrich, A7030) or 3% (w/v) solution of skim milk, diluted in 1X 
PBS.  
 
3.4.4.2 Cell Spreading and Morphology (Shape) 
After fixation, permeabilization, and blocking, staining was performed at 37 °C for 30 
minutes to investigate the cell shape (circularity and roundness) and spreading area. Actin 
filaments (F-actin) and cell nucleus were stained with Phalloidin-Tetramethylrhodamine B 
isothiocyanate (Sigma Aldrich, P1951, 1:200), and 4-6-diamidino-2-phenylindole (DAPI, 
Sigma Aldrich, 62248, 1 µg/mL), respectively. All stains were diluted in 1X PBS and 0.1% 
(w/v) of either skim milk (or BSA). Prior to imaging, the samples were washed three times 
with 1X PBS and mounted on 29 mm glass-bottom petri-dishes (Cellvis, D29-20-0-N, 
California, USA) on 100 µl of 50% (v/v) Glycerol (Thermo Fisher Scientific, G33) in 1X 
PBS. The images were collected using a Nikon inverted Fluorescent microscope (Eclipse, 
TE2000-S) and an EVOS FL Auto microscope (Thermo Fisher Scientific). The images 
were analysed using a MatLab-based (R2014a, MathWorks, MA, USA) software 
developed by Lauzon et al. (2017). Cell spreading and roundness were determined using 
the Image Processing ToolboxTM of MatLab (MatLab 2014a, Mathworks). Briefly, 
cytoskeleton (F-actin)/nucleus stained cells were segregated by cropping the surrounding 
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area of each cell. For each individual cell, the area and the perimeter corresponding to the 
cell body (cytoskeleton stained) were determined using the MatLab regionprops function 
(pixel² and pixel units respectively). For cell spreading, pixel values were further converted 
to surface units using the scale from the image acquisition software coupled to the 
microscope. The roundness factor was determined as the isoperimetric quotient of the cell 
body (𝑓𝑟𝑜𝑢𝑑𝑛𝑒𝑠𝑠 = 4𝜋𝑆𝑃2  , were S is the cell surface and P the cell perimeter). The farther from 
unity the roundness factor was, the less round the cells were. For each independent 
experiment, the average cell area and roundness were determined as the weighted mean 
relative to cell number analysed for each surface. The grand mean was then calculated as 
the weighted mean relative to the inverse of the squared standard error of each independent 
experiment.  
 
3.4.4.3 Immunolabeling of Proteins Involved in Focal Adhesion 
Immunolabeling of the proteins involved in both focal adhesion and fibrillar adhesion was 
performed after the blocking step by incubating the samples at 37 °C for 45 minutes with 
the primary antibodies described below. After three washes in 1X PBS, the secondary 
antibodies were used in the dark for 30 minutes at 37 °C.  
Vinculin was studied for the cells being fixed after 1 and 4 h of incubation. A monoclonal 
anti-vinculin IgG primary antibody, produced in a mouse (Sigma Aldrich, V9131, 1:250) 
and an anti-mouse IgG secondary antibody, conjugated with Alexa Fluor 488 (Thermo 
Fisher Scientific, A-11017, 1:200) were used along with DAPI and F-actin (with the same 
dilution as described before), after washing the primary antibody off the samples. 
Phospho-FAK (Y-397) organization was investigated after 1 and 4 h by applying the human 
p-FAK (Y397) IgG primary antibody, produced in a rabbit, (R&D Systems, AF4528, 
Minnesota, USA, 1:100), and an anti-rabbit IgG secondary antibody conjugated with Alexa 
Fluor 555 (Thermo Fisher Scientific, A-21430, 1:100).  
 
3.4.4.4 Immunolabeling of Proteins Involved in Fibrillar Adhesion  
The integrin α5 organization was inspected after 6 h. A monoclonal primary antibody, 
produced in a mouse, against integrin α5 subunit (Santa Cruz Biotechnology, sc-376199, 
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Texas, USA, 1:50) was used as well as a F(ab')2-Goat anti-mouse IgG secondary antibody 
cross-adsorbed with Alexa Fluor 488 (Thermo Fisher Scientific, A-11017, 1:150).  
The tensin organization was assessed after 6 h. A polyclonal IgG tensin primary antibody, 
produced in a rabbit, (Novus, NBP1-84129, Ontario, Canada, 1:50) was used as well as a 
F(ab')2 fragment anti-rabbit IgG secondary antibody with Alexa Fluor 488 (Cell Signaling, 
4412, Massachusetts, USA, 1:150). Images were gathered and analysed to quantify the 
percentage of cells with distinct centripetal tensin organization.  
FN fibrils formation was also verified after 6 h via applying total FN immunolabeling with 
a polyclonal primary antibody, produced in a rabbit, against FN (Sigma Aldrich, F3648, 
1:1,000) along with an anti-rabbit IgG secondary antibody with Alexa Fluor 555 (Thermo 
Fisher Scientific, A-21430, 1:600).  
 
3.4.4.5 Cell Scratch Migration Assay 
HAAECs were seeded on the FN-coated PDMS films at a density of 10,000 cells/cm2 to 
reach the confluent EC layer in serum-starved culture medium for 4 h. Then, by using a 
plastic pipette tip, a scratch was made in the cell monolayer to each condition, and the 
serum-free culture medium was replaced by the culture medium containing 2.5% (v/v) of 
SupplementMix and 1% (v/v) heat-inactivated FBS. The cells were fixed in a 3% PFA 
solution at time 0 (i.e., immediately after the introduction of the scratch) and after 24 h of 
incubation. Following the same protocol as explained in the section on cell spreading, 
DAPI was used to label the nucleus while rhodamine-phalloidin was used to stain the F-
actin. The EVOS microscope scan mode was applied to take images of the scratches and 
their surrounding cells. Finally, changes in length of the scratches from time 0 to 24 h was 
calculated using the distance measuring tools of ImageJ software (version 1.50i).   
 
3.4.5 Statistical Analysis: 
Student t-test was used when only one pair of treatments needed to be assessed statistically. 
When more than two pairs of treatments had to be compared, either one-way and two-way 
ANOVA tables were computed using the data analysis module in the Microsoft® Excel 
program. The data from the tables were used to verify the statistical significance via 
performing the Tukey-Kramer test. The significance of changes between the various groups 
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are presented with asterisks in all presented graphs regarding the studentized range q Tables 
(* p < 0.05, ** p < 0.01, *** p < 0.001). In all figures, “N” represents the total number of 
values for each condition, and “n” is equal to the number of independent experiments (or 
batches).  
3.5 RESULTS  
 
3.5.1 PDMS Film Properties  
3.5.1.1 Young’s Modulus 
The relative stiffness of the prepared PDMS films compared to the reported stiffness of 
healthy and atherosclerotic arteries (Ozolanta et al. 1998; Karimi et al. 2013) needed to be 
validated. For this purpose, tensile tests were performed on the PDMS rectangular films 
and the engineering stress/strain curve was plotted. A linear relation between stress and 
strain was found for each temperature and the strain tested (i.e., R2 > 0.998, Figure 10A). 
An increase in the slope of the curves and, therefore, of the Young’s modulus as a function 
of the curing temperature, was found. Significantly different Young’s modulus values, 1.0 
MPa and 2.8 MPa were measured for curing temperatures of 50°C and 100°C, respectively, 
showing that higher curing temperatures resulted in stiff PDMS films (p < 0.001) (Figure 
.10B).  
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The results showed advancing contact angles varying from 105° to 111° and receding 
contact angles varied from 71° to 82°. The advancing contact angles for soft (1.0 MPa) and 
stiff (2.8 MPa) films were significantly different (p < 0.001). The receding angles differed 
significantly as well (p < 0.001). The equilibrium contact angles of PDMS films were 
similar and close to the hydrophobic range i.e., θ > 90° (Bracco et al. 2013 ). The surface 
roughness of the PDMS film was analysed by AFM for each condition. The results did not 
reveal any strong variations of the surface roughness with Ra approximately 50 nm on both 
1.0 and 2.8 MPa PDMS films (Figure 11B).  
 
3.5.2 Effect of PDMS Stiffness on Cell Morphology and Spreading   
To determine whether the substrate stiffness can influence the HAAECs’ morphology, the 
cells attached to FN-coated PDMS films in the serum free medium after incubation for 0.5, 
1, 2, 4, and 6 h were fixed and stained for F-actin and DNA (Figure 12A). Most of the 
HAAECs attached to the FN-coated PDMS films after 0.5 h remained rounded and 
contained few actin stress fibres. As time increased, the HAAECs tended to spread and 
better organize their actin cytoskeleton, which appeared more intensely stained. The actin 
stress fibre network appeared organized at 4 h.  
To better quantify the morphology of HAAECs as a function of time and PDMS stiffness, 
at least 77 cells where analysed for each condition to compute the roundness shape factor 
(with a perfect circle having a roundness factor of 1 and a line acquiring a roundness factor 
of 0) and cell surface area (Figure 12B and C). As expected, on both PDMS films, HAAECs 
were more circular after incubation for 0.5 h, with a roundness shape factor higher than 
0.79, compared to the longer time points. For instance, the deviation from the circular form 
was significant between cells attached on both PDMS films after 0.5 h compared to those 
at 4 h (p < 0.001). The data also implied some significant impact of the PDMS film stiffness 
on the roundness shape factor at 2 h (p < 0.05). The cells attached to 1.0 MPa FN-coated 
PDMS films were less rounded compared to 2.8 MPa FN-coated PDMS films.  
The HAAECs surface area increased as a function of time between 0.5 and 2 or 4h 
depending on the PDMS bulk stiffness (Figure 12C). On 1.0 MPa PDMS films, the cells 
spread over time and reached their maximum surface area at 2 h (ex. an approximately 2.2-
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Roundness: The roundness shape factor of the labelled HAAECs was measured. The results 
are presented as the mean ± standard error of the mean from three independent experiments 
and for each condition, at least, 77 cells were analysed. (C) Cell Surface Area: The cell 
surface area (mean ± standard error of the mean) from the same images were also measured 
(significant difference: * p < 0.05, ** p< 0.01, *** p < 0.001).  
 
3.5.3 Effect of PDMS Stiffness on Focal Adhesion  
Two independent time course experiments were performed to determine the capacity of 
HAAECs to attach to FN-coated PDMS films and form focal adhesion after 1 and 4 h in a 
serum free medium by immunostaining of vinculin (Figure 13A), a structural protein 
present in focal adhesion (Ivanova et al. 2017; Ilić et al. 2004). The actin cytoskeleton was 
also stained (Figure 13A). Early, on the soft PDMS film (1.0 MPa), the vinculin staining 
appeared as large dots located at the cell periphery, while on the stiff films, the staining 
appeared with lower intensity. The collected images suggested a slightly faster organization 
of vinculin molecules for HAAECs attached to the soft PDMS films. However, after 4 h, 
the cells had enough time to similarly organize the vinculin at focal adhesion points on all 
experimental conditions.   
To verify whether cells can more rapidly organize their focal adhesion on the FN-coated 
soft films (1.0 MPa), signalling proteins were studied by determining the activation state 
of the focal adhesion kinase (FAK) in HAAECs attached to PDMS films, from the same 
experiments as those for the vinculin (Figure 13B). FAK plays a crucial role in both focal 
adhesion and fibrillar adhesion formations (Ilić et al. 2004; Carraher and Schwarzbauer 
2013). The activation of FAK can be initiated by its auto-phosphorylation on tyrosine 
residues-397 (Y-397), due to integrin clustering (Mitra et al. 2005). FAK activation then 
allows the recruitment of other signalling proteins (such as Rho family of GTPases) 
influencing the formation of actin stress fibres (Mitra et al. 2005). Thus, immunolabeling 
of phosphorylated FAK (pFAK) at Y-397 was performed at 1 and 4 h (Figure 13B). The 
results suggest a stronger p-FAK (Y-397) organization at the periphery of HAAECs 
adhered to the soft PDMS film compared to the stiff ones, after 1 h. Nevertheless, at 4 h, 
the p-FAK (Y-397) staining was similar on both PDMS films, and p-FAK was detected on 
broader areas of the cell’s surface on its substrate side.  
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HAAECs attached to FN-coated PDMS films (1.0 MPa and 2.8 MPa) which displayed 
distinct centripetal tensin organization was determined. The results are presented as the 
mean ± standard deviation gathered from three independent experiments where at least 132 
cells were counted for each condition (significant difference: ** p < 0.01). (C) Fibronectin 
Fibrils: Immunofluorescence labeling of FN was performed on HAAECs attached to FN-
coated PDMS films (1.0 MPa and 2.8 MPa) after incubation for 6 h. Images are 
representative of two independent experiments. White arrows in fibronectin image on 1.0 
MPa PDMS film highlight the fibril formation. Scale bar: 100 µm. 
 
To further investigate the effect of PDMS films stiffness on fibrillar adhesion formation 
(Faucheux et al. 2006), the number of cells showing tensin organization aligned in their 
central areas, on the side attached to film surface, was determined on soft (1.0 MPa) and 
stiff (2.8 MPa) films, for cells in each condition. The percentage of HAAECs on the soft 
films with aligned tensin structures, characteristic of fibrillar adhesion, increased 
significantly (p < 0.01) by approximately 5-fold in comparison to the stiff films (Figure 
15B). 
Furthermore, the capacity of HAAECs to reorganize the FN matrix was confirmed by 
immunolabeling with the polyclonal total FN antibody (Figure 15C), performed on 
specimens from two independent experiments. The results showed that most of the 
HAAECs attached to soft films could form FN fibrils (as shown on the left side in Figure 
15C). In contrast, only few HAAECs attached to stiff films possessed short FN fibrils, and 
most of the cells had only some FN aggregates.   
 
3.5.6 Effect of PDMS Stiffness on HAAECs Migration  
Since fibrillar adhesion may direct the migration process of porcine aortic endothelial cells 
(Canver et al. 2016), human microvessel endothelial cells (Wijelath et al. 2002) and human 
umbilical vein endothelial cells (HUVEC) (Wijelath et al. 2006), we investigated the 
potential effect of stiffness on HAAECs migration (Figure 16).  
Consequently, a scratch migration assay was performed on the confluent HAAECs layer 
attached to the soft (1.0 MPa) or stiff (2.8 MPa) films in a medium containing 1% serum 
for 24 h, following 4 h of serum starvation (Figure 16A). The width of the scratch was 
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3.6 DISCUSSION  
EC dysfunction is known to play a major role in the development of atherosclerosis disease 
through cell environment changes (Rohwedder et al. 2012). Such changes are associated 
with an increase in FN deposition in the sub-endothelial basement membrane contributing 
to endothelial activation in early atherogenesis (Orr et al. 2005; Cseh et al. 2010; Moore 
and Fisher 2012; Rohwedder et al. 2012; Al-Yafeai Zaki et al. 2018)  as well as subsequent 
stiffening of the arterial wall (Ozolanta et al. 1998; Karimi et al. 2013). To study the 
potential effects of Young’s modulus on the FN/ECs interaction, we used an in vitro model 
by seeding ECs on FN-coated PDMS films with the Young’s modulus values varying from 
healthy arteries to atherosclerosis stage 3. PDMS was the polymer of choice because of its 
optical, surface, and mechanical properties. It has an adjustable stiffness and allows for the 
design of moulds with different geometries (Lee et al. 2004). We first verified that the 
curing temperatures applied on the PDMS polymer allow the fabrication of films with two 
distinct Young’s modulus values (i.e., 50 °C for E = 1.0 MPa and 100 °C for E = 2.8 MPa), 
which agrees well with the recent data published by Campeau et al. (2017). Tuning PDMS 
stiffness was achieved through temperature modification while maintaining the same 
Sylgard® base/cross-linker ratio (10/1) for all films. Campeau et al. (2017)  also studied the 
effect of aging on PDMS mechanical properties. They found that PDMS stiffness were 
unchanged within one week at room temperature. The method used to prepare PDMS films 
in the present study differs from Seo et al. (2013) through which they prepared PDMS films 
with Young`s modulus values between ~0.1 and 1.7 MPa by using a base/cross-linker ratio 
ranging from 10/0.25 to 10/4, and a curing temperature of 60 °C for 2 h. Seo et al. (2013) 
did not provide further information on the physicochemical properties of the PDMS 
affected by altering base/cross-linker ratio. In contrast, using a base/cross-linker ratio of 
10/1, Raczkowska et al. (2016) produced 60 µm-thick soft and stiff PDMS films with 
Young’s modulus values of 0.24 and 1.67 MPa, by adding benzophenone (a UV sensitive 
photosensitizer) and controlling the duration of UV irradiation (wavelength equal to 254 
nm). They found a contact angle of approximately 108° for both films and, more 
interestingly, the XPS analyses implied no significant changes regarding the atomic 
composition of the PDMS surface (Raczkowska and PrauznerBechcicki 2016). We also 
verified that both PDMS films had quite similar hydrophobicity (contact angles) and 
94 
 
roughness. Our data showed a close equilibrium contact angle i.e., approximately 90° 
(hydrophobic) and similar roughness (around 50 nm) for PDMS films with E = 1.0 MPa 
and 2.8 MPa. Juárez-Moreno et al. (2015) fabricated PDMS films with a Young`s modulus 
of 2 MPa with the same 10/1 base/cross-linker ratio and observed a contact angle of 102° 
and a roughness of Rms ~ 17 nm. Campeau et al. ( 2017) observed a contact angle of 
approximately 110° for 10/1 PDMS films with Young’s modulus values ranging from ~1.7 
to ~3.7 MPa. Some studies observed a slight decrease in the hydrophobicity of PDMS films 
as a result of the increase in cross-linker concentration (Seo et al. 2013; Kuo et al. 2009). 
For example, Seo et al. (2013) observed that the contact angle had a tendency to decrease 
from 120° to 100° while the base/cross-linker ratios raised from 10/0.25 to 10/4. In 
contrast, Brown et al. (2005) reported similar contact angles (100°) for PDMS films with 
base/cross-linker ratios ranging from 10/1 to 50/1.  
We sterilized the PDMS films with an ethanol wash and UV exposure (30 minutes) prior 
to FN coating and cell seeding. Campeau et al. (2017) observed no significant changes of 
the PDMS Young’s modulus due to UV exposure (up to 1 h) or ethanol wash. Using FN-
coated PDMS films with stiffness values mimicking healthy versus atherosclerosis arteries, 
we found that the HAAEC roundness shape factor was approximately 0.65 at 4 h, which 
was more elongated compared to the shorter time points i.e., 0.5, 1, and 2 h. Using FN-
coated (2 µg/mL) PDMS films with a Young’s modulus of 2 MPa, Goli-Malekabadi et al. 
( 2017) found that approximately 80% of HUVEC cultured in a high-glucose medium, 
containing 10% FBS, had a roundness factor higher than 0.6 at 4 h. After 8 h, approximately 
80% of HUVECs on the 2 MPa PDMS films displayed roundness factors above 0.5. In the 
present study, the HAAEC roundness shape factor was significantly decreased at 2h on 1.0 
MPa compared to 2.8 MPa FN-coated PDMS films. The HAAECs spreading as a function 
of time also revealed that the HAAECs attached to FN-coated PDMS films (1.0 MPa) 
reached their maximum surface area at 2h, while those on stiffer FN-coated PDMS films 
(2.8 MPa) were spread at 4h. Nevertheless, the cell spreading area at 4h was similar on 
both FN-coated PDMS films (1 MPa and 2.8 MPa). The HAAECs appeared also to shrink 
on both PDMS films at 6h may be due to a reorganisation of their cytoskeleton in serum 
free condition. Weng and Fu (2011)  using PDMS films with various stiffness from 0.1 kPa 
to 1.2 MPa found that spread area of HUVEC as well as FA organization/maturation 
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increased more rapidly in soft to medium stiffness range (less than 15 kPa) compared to 
medium to rigid stiffness range (15 kPa to 1.2 MPa). They also found that for a similar 
substrate elasticity, the cell spreading depended on the size and localization of extracellular 
matrix islands. 
Several studies showed that the cell spreading (endothelial cells, fibroblasts) was more 
important and faster on stiff surface (1-3MPa) compared to soft one (0.1-10 kPa) 
(Versaevel et al. 2017; Sun et al. 2012). For example, using FN rectangular micropatterns 
on PDMS with a surface area of 1200 µm2 and an aspect ratio of 1:10, Versaevel et al. 
(2017) recently found that the spreading time of HUVEC was significantly reduced on 
3MPa PDMS film compared to the soft films (5 and 9 kPa). However, the soft PDMS films 
used in these studies had a stiffness value around 5 to 10 kPa, while in the present work, 
the stiffness of the soft PDMS films is 1 MPa. It is therefore quite difficult to compare our 
results with those of these studies.  
Furthermore, some recent studies revealed that stress relaxation due to substrate 
viscoelasticity play also a crucial role in the cell spreading as well as cell-matrix interaction 
(Chaudhuri et al. 2015; Zheng et al. 2017). For example, Chaudhuri et al.(2015) found that 
soft materials allowing stress relaxation can favor a cell spreading similar to stiffer 
substrates. A difference between the substrate stress relaxation on our FN-coated PDMS 
films might explain our experimental results and await a future study to better characterize 
this phenomenon.  
FAK activation is crucial for focal adhesion formation (Kim et al. 2018). Moreover, using 
the mice model with a disrupted FAK gene, Ilić et al. (2004) showed that FAK activation 
is required in the development of fibrillar adhesion by ECs in mice. Using immunostaining 
of both vinculin and p-FAK (Y-397), we found a slightly faster organization of focal 
adhesion in HAAECs attached to FN-coated PDMS film (1.0 MPa) compared to the 2.8 
MPa films. These results are in accordance with the maximal spread area reached at 2h on 
1MPa PDMS films. This phenomenon was not linked to a difference in FN amount or FN 
RGD cell binding/PHSRN synergy domains accessibility, as shown by the ELISA assays. 
Using a FN concentration of 10 µg/mL and ELISA assays, Seo et al. (2013) also found that 
bulk stiffness (from ~ 0.1 to 1.7 MPa) did not influence the amount of adsorbed total FN 
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on PDMS films. They also suggested that the accessibility of the FN cell binding domain 
was not directly related to the bulk stiffness. However, the sensitivity of ELISA method 
might not be efficient enough for recognizing small variations of available cell binding FN 
motifs (Seo et al. 2013). 
We also studied the influence of PDMS stiffness on the formation of fibrillar adhesion since 
the FN matrix assembly plays a vital role in the pro-inflammatory response of EC 
(Yurdagul et al. 2014; Yun et al. 2016). Interestingly, the FN matrix was shown to 
contribute to vascular remodelling (Hielscher et al. 2016), whereas blocking FN 
polymerization by applying inhibitory peptides in mice carotid arteries prevented vascular 
wall thickening (Chiang et al. 2009). After 6 h of inflammatory stimulation by adding an 
oxidized low-density lipoprotein (oxLDL) (100 µg/mL), Yurdagul et al.(2014) found a 2-
fold increase in the number of human primary monocyte adhesion on human aortic 
endothelial cells (HAECs) attached to FN (10 µg/mL) compared to basement membrane 
extracts (including proteins such as laminin I, collagen IV, entactin, and heparin sulphate 
proteoglycan) of a murine source. Using α5 and tensin immunolabeling (Faucheux et al. 
2006), we found that HAAECs attached to FN-coated 1.0 MPa PDMS films better 
organized their fibrillar adhesion compared to those attached to 2.8 MPa films. The number 
of cells with aligned tensin organization showed an approximate 5-fold increase in the 
percentage of cells that formed fibrillar adhesion on the PDMS film with stiffness 
mimicking healthy arteries. These results were confirmed by the FN fibril formation in 
HAAECs attached to these films. Using protein-coated (laminin, vitronectin, and collagen 
IV) SiO2 glass (E = 65 GPa) (Li and Vlassak 2009) and PDMS films with Young’s modulus 
values of 5 kPa and 2 MPa, Casillo et al.(2017) recently inspected FN fibrillogenesis in 
HUVEC under serum-starved conditions. After 24 h, using a monoclonal antibody against 
human cellular FN, they observed longer and brighter fibrils on SiO2 glass compared to 
both PDMS films, whereas no strong variation of FN fibrils formation between soft (5 kPa) 
and stiff (2 MPa) PDMS films was reported. However, the experimental conditions (cells 
and protein coating) used by Casillo et al.(2017) were different from the present study.  
Hielscher et al.(2016) documented a 50% increase in green Fluorescent protein (GFP)-
transfected HUVEC migration on a FN-rich biological decellularized extracellular matrix 
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(ECM) after 7 and 12 h in a medium containing serum compared with substrates that 
included the FN inhibitor peptide pUR4B, which blocked FN fibrillogenesis. In the present 
study, the migration of HAAECs was similar on FN-coated PDMS films with stiffness 
values of 1.0 and 2.8 MPa after incubation for 24 h despite a significant reduction in 
fibrillar adhesion formation after 6 h on stiff films. The migration assay was performed at 
24h to observe significant difference in the width of the scratch gap, but such assay required 
1% serum, which may allow ECs to use FN from the serum. Gray et al.(2003) worked on 
two FN-coated (33 µg/mL) PDMS films with E = 12 kPa and 2.5 MPa and showed that 
BPAECs migrate from soft regions towards stiff areas, where the cell density in this area 
became approximately 40% higher, after 48 h. However, Gray et al. (33) used a soft PDMS 
with a stiffness around 10 kPa, while we compared materials with stiffness of 1 and 2.8 
MPa mimicking healthy and atherosclerotic arteries, respectively. 
In addition to ECs, other cell types that are engaged in atherosclerosis lesions, such as 
SMCs, are able to produce insoluble FN (Glukhova et al. 1989). In fact, the migration of 
SMCs from an arterial media to intima fortifies atherosclerotic plaque development by 
supporting formation of a fibrous cap (Moss and Ramji 2016) and contributes to the 
accumulation of FN (Glukhova et al. 1989). However, SMCs (from human internal thoracic 
artery) that engulfed the LDL could not organize any FN fibril assembly, leading to a lack 
of type I collagen fibrillogenesis, which in turn, undermines vessel wall stability (Frontini 
et al. 2009). Hence, further investigation using a co-culture of ECs and SMCs on ECM 
protein-coated (FN, collagen type I) PDMS films (Bouafsoun et al. 2006; Versaevel et al. 
2017) will help to better understand some key events (such as crosstalk between 
ECs/SMCs/ECM proteins as well as endothelial to mesenchymal transition) involved in 
the development of atherosclerosis lesions (Dejana et al. 2017; Zhang et al. 2015).  
 
3.7 CONCLUSION  
Using FN-coated PDMS films with distinct stiffness (Young’s modulus) values, we found 
that at 4 h, morphology and spreading of HAAECs did not significantly change due to 
Young’s modulus changes. However, the cells reached their maximal spreading areas and 
FA organization faster on 1MPa PDMS films compared to 2.8 MPa. After 6h, HAAECs 
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had a higher capacity to form fibrillar adhesion and FN fibrils on films with a Young’s 
modulus of 1.0 MPa, representing a healthy to early atherosclerotic human artery compared 
to films with E = 2.8 MPa, representing more developed stages of atherosclerosis. Our 
findings suggest a favourable effect of a lower Young’s modulus, representing arterial wall 
stiffness during early atherosclerosis, on FN fibrils formation by ECs.  
This study aims to improve the scientific community’s insight about atherosclerosis 
development, while, in addition, investigating cell responses to stiffness variations of 
biomaterials will be helpful to the field of biomedical engineering, particularly for implant 
design. 
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So far, we have introduced how FN-coated PDMS with two distinct stiffness values would 
affect HAAECs adhesion kinetics (spreading and roundness factor) as well as adhesion and 
FN fibrillar adhesion. Here, we further improved our in vitro model to replicate 
atherosclerosis conditions by investigating potential effects of Coll I and FN/Coll I coatings 
as well. This allowed us to elucidate under these experimental conditions, the influence of 
BMP-9 on EC dysfunction regarding the expression of vascular adhesion molecules 
(VCAM-1) involved in leukocyte recruitment as well as AJ integrity involved in leukocytes 
diapedesis. Such events were studied with and without atherosclerotic-related soluble 
inflammatory cytokine TNF-α.   
 
4.1 RÉSUMÉ  
L'athérosclérose, qui est initiée par un dysfonctionnement des cellules endothéliales (CE), 
est à l’origine de plusieurs maladies cardiovasculaires, principale cause de décès dans le 
monde. Lors de la progression de cette maladie, les CE sont exposées à des modifications 
de leur microenvironnement, entre autres, une augmentation de la fibronectine (FN) et du 
collagène de type I (Coll I) dans la membrane basale (BM) et la rigidification de la paroi 
artérielle. Le comportement des ECs peut aussi être régulé par d’autres facteurs solubles 
comme la BMP-9 qui peut affecter la réponse des CE à la cytokine inflammatoire TNF-α. 
Nous avons donc étudié l’influence de l’élasticité de films de polydiméthylsiloxane 
(PDMS) et du changement de composition de la BM (FN et/ou Coll I) sur la capacité des 
cellules endothéliales abdominales aortiques humaines (HAAEC) à répondre à la BMP-9 
± TNF-α. Les HAAEC répondaient plus rapidement à la BMP-9 en termes d’activation des 
Smad1/5/8 sur FN et FN plus Coll I par rapport au Coll I. Les Smad1/5 phosphorylées 
étaient transloquées dans le noyau après 4h de traitement par la BMP-9. De plus, une co-
stimulation par BMP-9 et TNF-α augmentait significativement les niveaux d'ARNm de 
VCAM-1, IL-1β et IL-6 après 24h en fonction du type de protéines adsorbées à la surface 
des films de PDMS. L’expression des gènes IL-1β et IL-6 induite par une co-stimulation 
BMP-9 et TNF-α était aussi accrue sur les films de PDMS ayant une élasticité mimant celle 
des artères en athérosclérose tardive. Enfin, après 48h, conformément aux résultats q-PCR, 
nous avons observé une expression plus importante de la protéine VCAM-1 suite au 
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traitement combiné TNF-α / BMP-9. De plus, les jonctions adhérentes via VE-cadhérine 
étaient partiellement rompues. Ces résultats montrent que tout changement associé à la 
composition de la BM et une diminution de l’elasticité du substrat, phénomènes présents 
dans l’athérosclérose, jouent un rôle clef dans la réponse des HAAECs à la BMP-9 en 
condition pro-inflammatoire. 
MOTS CLÉS: module de Young, VCAM, VE-cadhérine, Interleukine, TNF-α, 
athérosclérose 
 
4.2 ABSTRACT   
Atherosclerosis, which is initiated by endothelial cell (EC) dysfunction lining the inner 
lining of the arteries, is responsible for several cardiovascular diseases, the leading cause 
of death in the world. During the progression of this disease, EC are exposed to changes in 
their microenvironment, including an increase in fibronectin (FN) and collagen type I (Coll 
I) content in the basement membrane (BM) and wall stiffening. The behavior of ECs is 
also regulated by other soluble factors such as BMP-9 that affects the EC response to the 
inflammatory cytokine TNF-α. We therefore studied the influence of the stiffness of 
polydimethylsiloxane films (PDMS) and the change in BM composition (FN and / or Coll 
I) on the ability of human aortic abdominal endothelial cells (HAAEC) to respond to BMP 
-9 ± TNF-α. HAAECs responded more rapidly to BMP-9 in terms of activation of Smad1 
/ 5/8 on FN and FN plus Coll I compared to Coll I. After 4h of treatment with BMP-9, the 
phosphorylated Smad1 / 5 were translocated into the nucleus. In addition, co-treatment by 
BMP-9 and TNF-α significantly increased VCAM-1, IL-1β and IL-6 mRNA levels after 
24 h depending on the type of proteins adsorbed on the surface of the PDMS films. IL-1β 
and IL-6 gene expression induced by BMP-9 plus TNF-α was also increased on PDMS 
films having a stiffness mimicking that of arteries at a late stage of atherosclerosis. Finally, 
after 48h, according to the q-PCR results, we observed an increase in the expression of the 
VCAM-1 protein following combined TNF-α / BMP-9 treatment. In addition, adherent 
junctions via VE-cadherin were partially disorganized. These results showed that any 
changes associated with the composition of BM and an increase in substrate stiffness, 
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phenomena found in atherosclerosis, play a key role in the response of HAAECs to BMP-
9 in a pro-inflammatory environment. 
KEYWORDS: Young’s Modulus, VCAM, VE-cadherin, Interleukin, TNF-α, 
atherosclerosis 
 
4.3 INTRODUCTION  
Endothelial cells (ECs) that form a monolayer known as endothelium (Hansson 2005; 
Muller 2013) play an essential role in maintenance of vascular homeostasis through taking 
part in processes such as blood fluidity (Michiels 2003), inflammatory response (Moss and 
Ramji 2016), and wound healing (Kolluru et al. 2012). ECs function is linked to their 
environment, which includes basement membrane (BM), namely part of the extracellular 
matrix (ECM) adjacent to the endothelium (Hynes 2004; Legate et al. 2006; Alexander and 
Bendas 2011; Chen et al. 2015; Feng et al. 2017; Giordano et al. 2018), as well as soluble 
factors (circulating growth factors (GFs) (Bidart 2012)), and mechanical cues (such as 
arterial wall stiffness and wall shear stress, WSS (Chatzizisis et al. 2007; Shirwany and 
Zou 2010; Baeyens et al. 2016; Durham et al. 2018)). These factors properties differs under 
healthy (physiological) and unhealthy (pathological) conditions (Voss and Rauterberg 
1986; Moore and Fisher 2012; Durham et al. 2018).  
For instance, during development of atherosclerosis, a chronic inflammatory disease 
common in arteries (Ross et al. 1977; Stocker and Keaney 2004; Hansson 2005), the EC 
basement membrane becomes rich in fibronectin (FN) (Voss and Rauterberg 1986; Moore 
and Fisher 2012), which binds to ECs mostly through α5β1 and αvβ3 integrins (Krammer 
2002). α5β1/FN binding can stretch FN molecules and pave the way for fibrillar adhesion 
and formation of insoluble FN fibrils (Zamir et al. 2000). Yurdagul et al. (2016) 
demonstrated that α5β1/FN binding amplifies oxidized low-density lipoprotein (ox-LDL), 
a key component in atherosclerosis (Maiolino et al. 2013) through ECs injury via 
increasing expression of vascular cell adhesion protein-1 (VCAM-1). 
FN can also bind to collagen type I (Coll I) (Erat et al. 2013; Sevilla et al. 2013), another 
ECM protein which is more abundant in atherosclerosis (Voss and Rauterberg 1986). For 
example, Dzamba et al. (1993) reported that Coll I promoted FN fibril formation in 
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fibroblast cultures via α1(I) collagen chains/FN binding. Coll I is mostly known for 
providing structural stability but it can also induce actin stress fiber formation via binding 
to α1β1 and α2β1 integrins in ECs (Di Lullo et al. 2002; Iivanainen 2003; Whelan 2003).  
In addition to changes in the protein content of the BM, atherosclerosis is associated with 
arterial wall stiffening (Shirwany and Zou 2010; Durham et al. 2018). For instance, it has 
been shown that human coronary artery experiences a shift in Young’s modulus from 
around 1 MPa under healthy conditions up to around 3 MPa in advanced atherosclerosis 
(Ozolanta et al. 1998; Karimi et al. 2013). Substrate stiffness influence ECs behavior has 
been reported in many studies (Stroka et al. 2012; Goli-Malekabadi et al. 2017; LaValley 
et al. 2017; Eguiluz et al. 2017; Campeau et al. 2017; Zhao et al. 2018). In a previous study, 
we developed an in vitro model consisting of FN-coated PDMS films with two distinct 
Young’s modulus value of 1.0 and 2.8 MPa (Hassanisaber et al. 2019) representing healthy 
and atherosclerotic arteries, respectively (Ozolanta et al. 1998; Karimi et al. 2013). The 
model was employed to study HAAECs adhesion, spreading and capacity to develop focal 
and FN fibrillar adhesion (Hassanisaber et al. 2019). We reported up to around 5-fold 
higher tensin organization in fibrillar adhesion in human aortic abdominal endothelial cells 
(HAAECs) on FN-coated PDMS films with a Young’s modulus of 1.0 MPa compared to 
2.8 MPa, after 6h.  
In addition to interactions between ECs and the BM, soluble cytokines and GFs such as 
BMP-9 also influence ECs behavior (Griffioen and Molema 2000; Scharpfenecker 2007; 
David et al. 2009; Suzuki et al. 2010; Cunha et al. 2010; Tian et al. 2012; Larrivée et al. 
2012; Meeteren et al. 2012; Xu et al. 2012; Mitrofan et al. 2017). Several interplays 
between BMP-9 and critical factors in atherosclerosis such as FN and TNF-α have been 
already found (Tian et al. 2012; Mitrofan et al. 2017). For example, using mouse embryonic 
endothelial cells (MEECs), Tian et al. showed that FN coating can induce BMP-9-mediated 
Smad1/5/8 activation, followed by reduced angiogenesis (Tian et al. 2012). They showed 
such a FN related effect is associated with α5β1 integrin and endoglin (ENG) (Tian et al. 
2012). However, the effect of Coll/FN combined with substrate stiffening on the ability of 
ECs to respond to BMP-9 in a pro-inflammatory environment is still unknown. 
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Thus, in the current study, we used our in vitro model consisting of FN- and/or Coll I-
coated PDMS films (1 and 2.8 MPa) to shed more light on potential interplays between 
BMP-9 and changing factors in the ECs microenvironment during atherosclerosis 
including: BM protein composition (FN and Coll I), ECM stiffening (through PDMS 
stiffness), and inflammatory chemokine TNF-α. We first investigated how ECM proteins 
can affect the kinetics of Smad1/5 activation in HAAECs treated by BMP-9 (12 ng/mL, 
corresponding to a BMP-9 physiological dose found in plasma (David et al. 2008)) and the 
nuclear translocation of phosphorylated-Smad1/5. Then, the interplay between BMP-9 and 
pro-inflammatory TNF-α was studied at 24h in HAAECs attached to FN- and/or Coll I-
coated PDMS films (1 and 2.8 MPa) in terms of cell morphology and activation of genes 
encoding for proteins involved in inflammation (VCAM-1 and interleukin, IL-1, IL-6). 
Finally, after 48h, the adhesion molecules involved in leukocytes recruitment, by observing 
expression of VCAM-1 in attached HAAECs as well as the integrity of AJs implied in 
leukocyte diapedesis by determining VE-cadherin localization were studied.  
 
4.4 MATERIALS AND METHODS  
4.4.1 Polydimethylsiloxane (PDMS) Film Preparation  
As previously explained (Farcas et al. 2009; Rouleau 2010), the Sylgard® 184 silicone 
elastomer kit (Dow Corning, ON, Canada) was used to fabricate the PDMS films. Cross-
linker solution was added to the base solution (1:10 volumetric ratio) in a disposable beaker 
(400 mL polypropylene, Thermo Fisher Scientific, Massachusetts, USA, FB0129112) and 
the mixture was rapidly stirred using glass rods (around 5 minutes) until the mixture color 
changed from transparent into white, filled with small air bubbles.  
The mixture was then put under a vacuum chamber for 45 minutes (30 kPa). After 
degassing, the mix was put into either 66 mm-diameter glass petri dishes (5 mL each, to 
form culture surfaces for mRNA extraction tests) or 24 well plates (0.5 mL each, to form 
culture surfaces for paraformaldehyde, PFA, cell fixation). A forced convection oven was 
used to cure the films for 4 hours at either 50 °C or 100 °C, resulting in engineering 
Young’s modulus values of 1.0 MPa and 2.8 MPa, respectively (Hassanisaber et al. 2019).  
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4.4.2 FN and Coll I Coating on PDMS Films  
PDMS films were treated with 70% (v/v) sulfuric acid (Thermo Fisher Scientific, A300, 
diluted in distilled water) on their culture surface for 45 minutes. Acid was removed from 
the surface and films rinsed with distilled water for 10 seconds.  
Sterilization was performed with 70% ethanol (v/v) (Commercial Alcohols, Québec, 
Canada, P016-EAAN, diluted in distilled water) followed by rinsing in sterile MilliQ® 
purified water. After, films were placed under UV light in a safety cabinet for 30 minutes. 
At the final step, a PBS wash (PBS: 137 mM NaCl, Thermo Fisher Scientific S671, 2.7 
mM KCl, Thermo Fisher Scientific, P3911, 10 mM Na2HPO4, Thermo Fisher Scientific 
S0876, 1.91 mM, KH2PO4, Thermo Fisher Scientific, P5379, in 0.1 L distilled water) was 
performed on the culture surfaces and the protein solutions were introduced on the films (1 
mL for 24 well plates and 7 mL for 66 mm petri dishes). FN (human plasma FN, Sigma 
Aldrich, Missouri, USA, F0895) and Coll I from rat tail (Sigma Aldrich, Missouri, USA, 
C3867) were diluted in sterile PBS to produce FN (10 μg/mL, ~0.6 μg/mm2), Coll I (10 
μg/mL, ~0.6 μg/mm2) and FN/Coll I (10 μg/mL, ~0.6 μg/mm2 each) solutions. The samples 
were then incubated at 37 °C, overnight in a humidified incubator.  
 
4.4.3 Cell Culture and Cell Experiments 
Human abdominal aortic endothelial cells (HAAECs, PromoCell, Germany), at passage 4 
to 8, were used to perform the cell experiments. Porcine gelatin 0.1% (w/v) (Sigma Aldrich, 
G1890, diluted in PBS) was introduced into growth cell flasks (20 mL for T-175 culture 
flasks) overnight. ECs growth medium (PromoCell, C-22010) along with 5% fetal calf 
serum (CFS, PromoCell, C-37310), EC growth supplement/heparin (ECGS/H, PromoCell, 
C-37310), human epidermal growth factor (hEGF, PromoCell, C-30226), and 1% (v/v) 
penicillin streptomycin (PS, Wisent, Inc., 450-201-EL) were used to grow cells at 37 °C in 
a humid incubator, with 5% (v/v) CO2. Cell detachment was achieved by trypsin-EDTA 
0.25% (Gibco, Thermo Fisher Scientific, 25200-056) incubation (5 minutes, at 37 °C) 
followed by applying a 0.1% (w/v) neutralizing soybean trypsin inhibitor solution (in PBS, 
Gibco, 917075-029). 
106 
 
Once cells had detached from the flask, they were collected and centrifuged at 200 g for 8 
minutes. The supernatant fluid was removed and cells were resuspended in fresh culture 
medium to increase cell concentration. For both mRNA extraction and imaging 
experiments, ECs were serum starved for 4 hours (i.e. culture medium with 1% Penicillin-
Streptomycin). Cell density for all experiments was 10 000 cells/cm2.  
 
4.4.4 BMP-9 and TNF-α Stimulation  
In order to verify BMP-9 and TNF-α crosstalk on HAAECs function, four solutions were 
made with culture medium containing: control, recombinant human BMP-9 (12 ng/mL, 
3209BP/CF, R&D Systems, Minneapolis, MN, USA), TNF-α (10 ng/mL, 300-01A, 
Peprotech, Rocky Hill, NJ, USA), and BMP-9/TNF-α (12 ng/mL and 10 ng/mL 
respectively).  
 
4.4.5 Western Blot for Smad1/5/8 Activation Kinetics  
The WB procedure has been explained in previous works (Drevelle et al. 2013; Beauvais 
et al. 2016b). Shortly, to determine Smad1/5/8 activation in HAAECs (passage 4-6), cells 
were seeded on Petri dishes coated with FN (10μg/mL), Coll I (10μg/mL), FN/Coll I 
(10μg/mL each), and porcine gelatin (0.1% w/v). The cell lysates were collected after 
15min, 30min, 1h, 2h, and 4h for Western blot (WB) analysis. Phospho-Smad1/5/8 and 
Total-Smad were targeted with primary antibodies (phospho-Smad1/5, Ser463/465, Rabbit 
antibody, Cell Signaling, 9516, MA, USA) by overnight incubation at 4 °C, after several 
washes the Ag-Ac complexes were recognized by a peroxidase-conjugated anti-rabbit IgG 
secondary antibody (Sigma).  
 
4.4.6 Phospho-Smad1/5 Translocation into the Nucleus  
HAAECs (passage 4-6, 10 000 cells/cm2) were seeded on FN, Coll I, FN/Coll I-coated 
PDMS films with two distinct Young’s modulus values 1.0 and 2.8 MPa, in serum-starved 
conditions for 4h. BMP-9 was then added to half of the samples for 4h (on FN, Coll I, and 
FN/Coll I), after which cells were fixed with a paraformaldehyde 3% (m/v) solution (Sigma 
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Aldrich, P6148), for 15 minutes, at room temperature. After, the fixed samples were stored 
at 4 °C, and later used for immunofluorescence (IF) microscopy. The fixed cells were 
permeabilized by 0.5% (v/v) Triton X-100 (in PBS, Sigma Aldrich, T8787) during 5 min 
incubation at room temperature. A lipid-free skimmed milk solution (3% w/v in PBS) was 
then used to block nonspecific labeling for 45min at 37 °C. A primary rabbit antibody 
against P-Smad1/5 and the anti-rabbit IgG Alexa Fluor 488 secondary antibody (Thermo 
Fisher Scientific, A11070, Massachusetts, USA) were used to label pSmad1/5 while DAPI 
(Sigma Aldrich, 62248) was used to stain the nucleus.  
 
4.4.7 Cell Attachment and Morphology  
To determine EC attachment on different substrates as well as ECs morphology, HAAECs 
were seeded on the PDMS films in serum-free conditions for 4 hours followed by 24 hours 
of incubation in culture medium with 5% FCS, 1% PS, with or without BMP-9 and/or TNF- 
α. After fixation and permeabilization, the cells were labelled with 4-6-diamidino-2-
phenylindole (DAPI, Sigma Aldrich, 62248, 1 μg/mL) for cell nucleus (DNA) and using 
phalloidin-tetramethylrhodamine B isothiocyanate (Sigma Aldrich, P1951, dilution 1:200) 
for actin cytoskeleton. Samples were placed at 37 °C for 40 minutes, washed with PBS and 
mounted in 50% (v/v) Glycerol in PBS (Thermo Fisher Scientific, G33) solution on 29 mm 
glass-bottom Petri dishes (Cellvis, D29-20-0-N, California, USA). 
Microscopic imaging was achieved using an EVOS FL Auto microscope (Thermo Fisher 
Scientific).    
 
4.4.8 mRNA Extraction and q-PCR 
Culture medium was removed from samples and after two PBS washes (5 mL for each 
PDMS film molded in 66 mm Petri dishes), TRIzol™ Reagent (Invitrogen, 15596026, 
Carlsbad, CA, USA) was introduced on culture surface to extract total mRNA from 
HAAECs (300 µL for each PDMS film molded in 66 mm Petri dishes). The cell lysate was 
collected, and RNA dosage was achieved by using a microplate reader (BioTek® Synergy, 
Winooski, VT, USA). Aliquots containing 1 mg of RNA were treated with DNase while 
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oligo(dT) primers and Superscript II reverse transcriptase were used to obtain first strand 
complementary DNA (cDNA). Quantitative PCR (q-PCR) was performed on cDNA 
samples by using an iQ™5 Real-Time PCR detection system (Bio-Rad Laboratories, 
Hercules, CA, USA) employing iQ™ SYBR® Green SuperMix (1708880, Bio-Rad 
Laboratories). All primers were purchased from Qiagen (Hilden, Germany) including: 
Hs_GAPDH_2_SG, Hs_VCAM1_1_SG, Hs_ IL1B _1_SG, Hs_ IL6B _1_SG. GAPDH 
results were used for normalizing the data which was analyzed via a 2-(ΔΔCt) model, as 
previously explained (Drevelle et al. 2013).  
 
4.4.9 IF Imaging of VE-cadherin and VCAM-1  
To further investigate the localization of VE-cadherin (protein supporting EC-EC integrity) 
and the expression of VCAM-1 (pro-inflammatory adhesion protein), HAAECs were 
serum-starved for 4 hours followed by a 48 hour incubation in complete culture medium 
containing 5% FCS and 1% PS, with or without BMP-9 and/or TNF-α, at 37 °C under 5% 
(v/v) CO2. Samples were then fixed in 3% PFA, permeabilized, stained (nucleus/actin), as 
described above. Prior to immunolabeling of proteins, to prevent non-specific antibody 
adhesion, a blocking step was performed by introducing a 3% (w/v) skim milk solution (in 
PBS) on the samples at 37 °C for 45 minutes. The following primary and secondary 
antibodies were used to complete IF imaging: VCAM-1 primary mouse monoclonal IgG1 
antibody (13160, Santa Cruz Biotechnology, Inc., Texas, USA), VE-cadherin primary 
mouse monoclonal IgG1 antibody (9989, Santa Cruz Biotechnology Inc.), secondary anti-
mouse IgG FITC antibody produced in goat (5897, Sigma-Aldrich, MO, USA). The same 
methodology previously described (Lauzon et al. 2017) was used to complete analysis on 
the IF images.  
 
4.4.10 Statistical Analysis 
For q-PCR analysis, Microsoft® Excel was used to establish two-way ANOVA tables while 
the Tukey-Kramer test was employed to determine significance of data. Consequently, the 
degree of significance is presented with asterisks with respect to the studentized range q 
Tables (i.e. * p < 0.05, ** p < 0.01, *** p < 0.001).  
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4.5 RESULT and DISCUSSION  
4.5.1 Smad1/5/8 Activation and Their Translocation into the Nucleus  
At first, the effect of ECM proteins such as gelatin (denatured Coll IV) and FN/Coll I 
coated onto cell culture polystyrene on the kinetics of Smad1/5/8 activation (P-Smad1/5/8) 
in HAAECs treated by BMP-9 (12 ng/mL) was determined by Western blotting analyses 
(Figure 17). The total Smad was used as a control to verify that the expression of the protein 
was similar in all experimental conditions. The phosphorylation of Smad1/5/8 (P-
Smad1/5/8) was detected at 15 min in cells attached to FN (10μg/mL) or FN/Coll I- 
(10μg/mL each) coated polystyrene, while a P-Smad1/5/8 band appeared at 30 min in cells 
attached to Coll I (10μg/mL) or gelatin. The intensity of the P-Smad1/5/8 bands appeared 
also higher when the HAAECs were attached to FN (10μg/mL)-coated polystyrene. Using 
starved (6h) human microvascular endothelial-1 cells, HMEC-1, Tian et al. reported 
Smad1/5/8 activation due to BMP-9 treatment (2 ng/mL) on FN coating after 30 min (Tian 
et al. 2012). Their data verified higher Smad signaling as a result of an increase in FN 
concentration (from 0 to 40μg/mL) (Tian et al. 2012).  
Since the Smad1/5 were phosphorylated within 30 min in ECM proteins coated polystyrene 
and their translocation into the nucleus is required to regulate the expression of targeted 
genes, we investigated the P-Smad1/5 translocation into the nucleus in HAAECs attached 
to FN, Coll I, FN/Coll I-coated PDMS films (1.0 and 2.8 MPa), with or without BMP-9 
(12 ng/mL) for 4h (Figure 18). A strong labeling of P-Smad1/5/8 was detected in the 
nucleus of HAAECs attached to FN and/or Coll-coated PDMS films (1.0 and 2.8 MPa) 
treated with BMP-9 as shown by the co-localization with DAPI staining. In contrast, no 
specific P-Smad labeling was detected in untreated cells. A lot of P-Smad1/5/8 was also 
observed in the cytoplasm of HAAECs attached to FN or Coll I-coated PDMS films (1.0 
MPa) suggesting that the translocation was less important at 4h compared to FN/Coll I-
coated soft PDMS films (1.0 MPa). The P-Smad1/5/8 nuclear translocation appeared more 
important at 4h on 2.8 MPa PDMS films coated by Coll I in comparison to FN or FN/Coll 
I.  
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4.5.2 HAAECs Attachment and Morphology  
Since HAAECs attached to FN and/or Coll I-coated PDMS films (1.0 and 2.8 MPa) 
respond to BMP-9 in terms of Smad1/5 activation and their nuclear translocation at 4h, 
subsequent activation of targeted genes encoding proteins involved in leukocytes 
recruitment, inflammation as well as HAAECs permeability was determined at 24h. The 
activation of these genes induced by BMP-9 in HAAECs attached to ECM-coated PDMS 
films was also analyzed in a pro-inflammatory environment by adding TNF-α.   
First the influence of substrate stiffness, change in ECM composition as well as BMP-9 +/- 
TNF-α treatment was determined on HAAECs morphology (Figure 19). In untreated 
conditions (without BMP-9 or TNF-α), cell numbers, qualitatively, appeared higher on FN 
and FN/Coll I coatings compared to Coll I, with no effect of PDMS stiffness. Consistent 
with our observation, Campeau et al. reported a ~1-fold decrease at 48h in the number of 
HAAECs attached to Coll I-coated (10μg/mL) PDMS films (E ~ 2 MPa) compared to FN 
and FN/Coll I-coated (10μg/mL each) films (Campeau et al. 2017). Also, using FN-null 
mouse embryonic fibroblasts, Sevilla et al. showed that inhibition of FN/Coll I binding 
would reduce (~2-fold) cell numbers after 6 days (Sevilla et al. 2013). This might be also 
the case for HAAECs as we observed increased cell numbers on FN/Coll I coatings rather 
than with Coll I alone.   
On all coatings and whatever the substrate stiffness, the cell number seemed to be 
decreased in the presence of TNF-α or BMP-9 (except for FN-coated soft films 1MPa). 
However, BMP-9/TNF-α combined stimulation affected less on cell number.  
David et al. (2007) also reported a reduced human dermal microvascular endothelial cells 
(HMVEC) proliferation, after 48h as result of BMP-9 treatment (10 ng/ml) (David et al. 
2007). However, our data suggested that BMP-9 (12 ng/mL) treatment decreased in the 
cell number when applied on HAAECs attached to Coll I and/or FN coatings except on 
softer PDMS films (1.0 MPa).   
Regarding cell morphology, on Coll I coatings, cells appeared to have a smaller surface 
area and they organized fewer actin stress fibers. While, on FN and especially on FN/Coll 
I coatings, ECs spread better displaying stronger actin stress fiber organization. PDMS 
stiffness did not show any effect on cell morphology. 
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On Coll I coatings TNF-α did caused a weaker organization of actin stress fibers in cells 
compared to FN. In general, combined FN/Coll I coatings appeared to reduce TNF-α 
influence on ECs morphology compared to controls. Stiffness did not show an important 
role regarding TNF-α treatment results. Rotundo et al. demonstrated that TNF-α can disrupt 
subendothelial FN structure and reduce calf pulmonary artery endothelial cells (CPAE) 
RGD-mediated adhesion to FN (Rotundo et al. 2002). Our data suggest that such effects 
might be limited when Coll I is mixed with FN coatings. Regarding a TNF-α effect on cell 
morphology, Deli et al. and Marcos-Ramiro et al. have reported increased actin stress fibers 
formation due to TNF-α stimulation in ECs (Deli et al. 1995; Marcos-Ramiro et al. 2014). 
However, these studies did not address the effect of protein coating.  
For BMP-9 treatment, similarly to TNF-α, we observed less spreading on Coll I coatings 
and, to a lesser extent, on FN and FN/Coll I coatings. Cells appeared well spread with 
FN/Coll I coatings, particularly on softer PDMS films. When combined TNF-α/BMP-9 
treatment was applied, cells showed better spreading and well-organized actin stress fibers 
except for Coll I coatings on both soft and stiff PDMS films. There are no available data 
in the literature regarding BMP-9 effect on ECs spreading and actin stress fiber 
organization regarding ECM protein coatings and substrate bulk stiffness in the range 
relevant to the arterial wall.  
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4.5.3 Gene Activation Induced by BMP-9 in HAAECs Attached to ECM-Coated 
PDMS Films with Stiffness of 1 or 2.8 MPa 
HAAECs were seeded on FN, Coll I, and FN/Coll I-coated PDMS films with two distinct 
Young’s modulus values (i.e. 1.0 and 2.8 MPa) and, after 24h the activation of genes 
encoding VCAM-1, IL-1, and IL-6 was analyzed using q-PCR.  
 
4.5.3.1 VCAM-1  
The HAAECs attached to FN (Fibro) and/or Coll I coated PDMS films had similar VCAM-
1 gene expression regardless of PDMS stiffness (Figure 20A). There is also no significant 
effect of the type of protein coating or PDMS stiffness on HAAECs response to TNF-α. 
For example, adding TNF-α to HAAECs attached to FN/Coll I coated PDMS films (1.0 
MPa) significantly increased VCAM-1 mRNA levels around 150 fold compared to the 
control without TNF-α (p<0.05). TNF-α is known to increase leukocyte recruitment 
through enhancing expression of VCAM-1 in HUVECs seeded on gelatin coatings (Min et 
al. 2005; Funk et al. 2012). We also found that BMP-9 treatment did not induce any 
significant increase in VCAM-1 gene expression compared to controls regardless of protein 
coatings and PDMS stiffness. In the same way, Mitrofan et al. (2017) recently found that 
BMP-9 alone (5 ng/mL) had no effect on the expression of E-selectin, VCAM-1 and 
ICAM1 in human aortic endothelial cells (HAECs). In contrast, pretreatment of HAECs 
with BMP-9 (5 ng/mL, 16h) followed by TNF-α (0.05 ng/ml, 4h) induced both gene and 
surface expression of these adhesion molecules in HAECs (Mitrofan et al. 2017). Appleby 
et al. (2016) suggested that the effect of BMP-9 on the expression of VCAM-1 is 
concentration, and EC type dependent. Using flow cytometry analysis, they showed that 
BMP-9 (5 ng/mL, 16h) increased the expression of VCAM-1 in BOEC, but not in 
HPAECs. However, they did not discuss the effect of substrate protein coating.  
Interestingly, we found that the combined effect of TNF-α/BMP-9 on HAAECs depended 
on the type of coated proteins. The expression of the VCAM-1 gene was significantly higher 
in HAAECs attached to FN--coated PDMS films (1.0 and 2.8 MPa) in the presence of TNF-
α/BMP-9 compared to TNF-α alone (at least p<0.05, ) or BMP-9 alone (at least p<0.05). 
In the presence of TNF-α/BMP-9, mRNA VCAM-1 levels were also increased around 3.3 
117 
 
fold (p<0.01, 1.0 MPa) and 4.3 fold (p<0.001, 2.8 MPa) in HAAECs attached to FN-coated 
PDMS films compared to Coll I-coated PDMS films. Mitrofan et al. (2017) suggested that 
BMP-9 might prime ECs to increase their response to pro-inflammatory stimuli such as 
TNF-α. However, we found that the changes in BM due to atherosclerosis development 
may also play a crucial role in this phenomenon.  
 
4.5.3.2 IL-1β and IL-6   
Since TNF-α/BMP-9 strongly influenced VCAM-1 gene expression depending on the 
proteins coating, their combined effect on the expression of genes encoding for IL-1β 
(Figure 20B) involved in atherosclerosis (Libby 2017) and IL-6 that can induce endothelial 
cell activation and leukocytes recruitment (Romano et al. 1997; Hartman and Frishman 
2014) (Figure 20C) was also studied. Indeed, the important role of pro-inflammatory 
cytokines such as IL-1 and IL-6 in atherosclerosis progression is a well-known 
phenomenon (Ramji and Davies 2015). It has been also shown that inhibition of IL-1β and 
IL-6 signaling might be a promising therapeutic strategy against atherosclerosis (Ridker 
2016). To the best of our knowledge, there are no published data discussing BMP-9 effect 
on IL-1β or IL-6 gene expression in ECs regarding ECM protein coatings and substrate 
stiffness. 
We found that HAAECs attached to FN- and/or Coll 1-coated PDMS films had similar IL-
1β or IL-6 expression. BMP-9 alone had no significant effect on both IL-1β and IL-6 mRNA 
levels. In contrast, TNF-α alone increased significantly the levels of IL-1β mRNA in these 
cells compared to controls, while it had no effect on IL-6 mRNA. Furthermore, the effect 
of TNF-α on IL1β expression depended on both the type of protein coating and PDMS 
stiffness. For example, in the presence of TNF-α, IL1β gene expression was higher in 
HAAECs attached to Coll 1-coated PDMS films (1 or 2.8 MPa) compared to FN- or 
FN/Coll 1-coated PDMS films (at least p<0.01). In the presence of TNF-α, IL1β gene 
expression was also significantly increased in HAAECs cells attached to 2.8 MPa PDMS 
films coated by Coll 1 compared to Coll 1-coated PDMS 1.0 MPa films (p<0.001). While 
IL-1β expression in HAAECs on Coll 1-coated PDMS films (2.8 MPa) was lower with co-
treatment by TNF-α/BMP-9 compared to TNF-α alone (at least p<0.05), the expression of 
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IL-6 gene was enhanced in HAAECs on FN/Coll 1-coated PDMS films (2.8 MPa) by TNF-
α/BMP-9 compared to TNF-α alone. TNF-α and BMP-9 co-stimulation increased the 
mRNA levels of IL-6 in a protein coating and substrate stiffness-dependent manner. BMP-
9 plus TNF-α significantly increased the mRNA levels of IL-6 in HAAECs on 2.8 MPa 
PDMS films coated by FN/Coll 1 compared to FN or Coll 1 alone (p<0.05). These results 
highlight the complex phenomenon (BM composition, substrate stiffening) that may 
influence the response of ECs to BMP-9 in a pro-inflammatory and pro-atherogenic 
environment. 
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For the TNF-α treatment, we observed increased VCAM-1 expression with no significant 
influence of proteins coating or stiffness. Consistent with gene expression data (Figure 
20A), BMP-9 did not increased VCAM-1 protein expression compared to control, 
regardless of coatings and stiffness (Figure 21A, B). Also, in agreement with gene 
expression data (Figure 20A), we observed enhancing effect of TNF-α and BMP-9 for 
VCAM-1 protein expression on FN-coated soft/stiff films (Figure 21A, B). However, 
further experiments are required to confirm these preliminary observations. TNF-α is 
known for activating ECs and to upregulate VCAM-1 expression, through transcription 
factor NF-κB transcriptional activity, and to increase leukocyte recruitment (Funk et al. 
2012). Using HAECs, Mitrofan et al. (2017) reported on a synergy between BMP-9 (5 
ng/mL, 16h) and TNF-α (0.05 ng/mL, 4h) in enhancing VCAM-1 protein expression. Their 
data revealed increased monocyte recruitment (around 1.6-fold) for such VCAM-1 
upregulation in HAECs (Mitrofan et al. 2017).  
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4.5.4.2 VE-cadherin  
Our immunolabelling results suggesting an increase in VCAM-1, a molecule associated 
with leukocyte recruitment (Muro 2007; Funk et al. 2012; Appleby et al. 2016; Mitrofan et 
al. 2017) and extravasation (Michiels 2003; Angelini et al. 2006; Funk et al. 2012; Ley 
2013), in HAAECs attached to FN-coated films when treated with BMP-9 plus TNF-α. We 
also investigated VE-cadherin protein localization into cell-cell contact point (Figure 22A, 
B, and C). Likewise VCAM-1 expression experiments, HAAECs were seeded on Coll I, 
FN, and FN/Coll I-coated PDMS films with two distinct Young’s modulus values 1.0 MPa 
and 2.8 MPa for 48h with or without BMP-9 and/or TNF-α.  
The type of protein coating did not seem to have any influence on VE-cadherin 
organization. In fact, VE-cadherin was localized at the cell-cell contact on all coatings. 
Such localization was more evident on stiffer PDMS films (i.e. 2.8 MPa). TNF-α induced 
a disorganization of VE-cadherin at cell-cell contact regardless of protein coating and 
substrate stiffness. TNF-α is known for inhibiting endothelial integrity through 
phosphorylating VE-cadherin in EC-EC AJs (Lampugnani 2010; Esser et al. 1998; 
Michiels 2003; Angelini et al. 2006; Funk et al. 2012). Such phosphorylation increases 
endothelial permeability through disruption of VE-cadherin localization into AJs 
(Lampugnani et al. 1997; Lee and Gotlieb 2002; Vestweber 2008; Abu Taha and Schnittler 
2014; Lampugnani 2010; Lampugnani et al. 2018).  
In the present study, BMP-9 treatment reduced VE-cadherin continuity at the cell-cell 
contact regardless of protein coating and substrate stiffness, despite VCAM-1 protein 
expression which was not affected by BMP-9 treatment compared to control. Also, VE-
cadherin localization into cell-cell contact was partially preserved on FN/Coll I coatings, 
especially on stiffer films. Considering BMP-9 effect, a recent study by Akla et al. (2018) 
revealed that BMP-9 had inhibitory signaling effects on VEGF-induced VE-cadherin 
phosphorylation (mice), demonstrating protective properties to the endothelium. 
Furthermore, they also reported (Akla et al. 2018) increased VE-cadherin localization into 
HUVEC cell-cell junction areas as well as reduced endothelial permeability in HUVECs 
cultures following BMP-9 treatment. Although such observation is in contrast with our 
data, Akla et al. (2018) tested HUVEC cultures under hyperglycemic conditions and the 
126 
 
presence of vascular growth factor VEGF. Also, we observed a slight increase of BMP-9-
mediated VEGF gene expression (supplementary data 1) that might be linked to VE-
cadherin reducing localization to AJs in our case. 
Interestingly, combined TNF-α/BMP-9 treatments reduced VE-cadherin localization into 
cell-cell junctions regardless of protein coatings and this effect was enhanced on the stiffer 
films (Figure 22C). It might direct VE-cadherin phosphorylation by VEGF and, 
subsequent, inhibition from EC-EC contact that increases endothelial permeability and 
facilitates leukocyte passage (Dejana 2004; Daniel 2013; Conway et al. 2017).  
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4.6 CONCLUSION  
Using ECM protein-coated PDMS films with two distinct Young’s modulus values (i.e. 
1.0 and 2.8 MPa), we investigated HAAECs behavior with BMP-9 ±TNF-α. Our data 
suggest faster activation of Smad1/5/8 on FN and FN/Coll I coatings compared to Coll I. 
The type of coating also strongly increase VCAM-1, IL-1β and IL-6 gene expression 
induced by BMP-9 and TNF-α co-stimulation. IL-1β and IL-6 mRNA levels were also 
higher in HAAECs attached to PDMS films mimicking arterial wall stiffness at late stage 
of atherosclerosis, excluding calcification, and coated by Coll 1 and FN/Coll I respectively. 
TNF-α/BMP-9 also increased VCAM-1 protein expression and reduced the localization of 
VE-cadherin at cell-cell contact (48h). Such data suggest that BMP-9, depending on BM 
composition changes and/or wall stiffness would influence TNF effects on both 
inflammation and leukocyte recruitment, and extravasation. Indeed, excessive leukocyte 
migration into subendothelial regions is a key event in atherosclerosis development. 
Further experiments with leukocyte/ECs co-cultures would shed more light on how BMP-
9 may affect ECs’ role during atherosclerosis progression in function of changes in BM 
composition and substrate stiffness.      
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5 CHAPTER 5 Conclusion and Perspectives  
5.1 Conclusion Globale 
Au cours de ce projet de doctorat, nous avons pu produire des films de PDMS mimant 
l’élasticité de la paroi artérielle coronaire humaine dans des conditions saines et une 
athérosclérose précoce (module de Young 1,0 MPa), et athérosclérotique (2,8 MPa) en 
faisant varier la température de polymérisation. Normalement, l’élasticité des films de 
polydiméthylsiloxane (PDMS) est obtenue par ajustement lors de leur fabrication du 
rapport massique base: agent de polymérisation, ce qui peut affecter d’autres propriétés du 
PDMS. Nous avons tout d’abord vérifié la valeur du module de Young avec des tests de 
traction. La rugosité de surface et l'angle de contact des films de PDMS n’étaient pas 
affectés par cette méthodologie de préparation du PDMS. 
En utilisant ces films, nous avons donc pu développer un modèle in vitro pour étudier l’effet 
de l’élasticité liée à l’athérosclérose sur le comportement des cellules endothéliales 
abdominales aortiques humaines (HAAEC). 
Nous avons étudié la morphologie et la cinétique d'étalement des HAAEC ensemencées 
sur des films de PDMS recouverts de fibronectine (FN) jusqu'à 6h et avons observé une 
organisation plus rapide des adhérences focales (FA) après 1 heure, en accord avec un 
étalement significativement plus important après 2h. Cette capacité à organiser plus 
rapidement des points focaux pourrait aussi expliquer pourquoi ces cellules étaient 
également capables de former des sites d’adhésion fibrillaire plus nombreux après 6h. 
En effet, en ciblant plusieurs molécules (la sous-unité d’intégrine α5, la tensine et les 
fibrilles de FN), nous avons pour la première fois démontré une augmentation de l’adhésion 
fibrillaire dans les HAAECs adhérant au PDMS 1.0 MPa recouvert par la FN. Néanmoins, 
nous n’avons pas remarqué d’effet significatif de l’élasticité du substrat sur la migration 
cellulaire après 24h. Ces adhésions fibrillaires régissent néanmoins la capacité des cellules 
à réorganiser leur matrice de FN et par la même à influer sur l’organisation de l’ECM 
comme le collagène de type I (Coll I) avec lequel elles interagissent.  
Dans la seconde phase de cette étude doctorale, nous avons donc étendu le modèle par 
l’ajout de Coll I +/- FN. De plus, ce mélange Coll 1/FN correspond aussi à un des 
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changements de composition de la BM lors de l’athérosclérose. L'effet de la BMP-9 sur le 
comportement des HAAEC en condition pro-inflammatoire (TNF-α) a ainsi été étudié pour 
la première fois sur un PDMS ayant une élasticité représentant une athérosclérose précoce 
et avancée et recouvert par FN et/ou Coll 1.  
En outre, nous avons montré que le revêtement FN / Coll I est aussi efficace que la FN 
seule. Pour la première fois, nous avons vérifié la translocation induite par BMP-9 de     P-
Smad1/5/8 dans le noyau des HAAECs sur des films de PDMS revêtus de protéines ECM 
(4h). Après 24h, nous avons observé une réduction du nombre de cellules suite au 
traitement à la BMP-9 par rapport au contrôle, tandis que le traitement combiné TNF-α / 
BMP-9 empêchait cette diminution. 
Pour la première fois, nous avons analysé après 24 h les niveaux d'ARNm dans les CE 
attachées sur des films de PDMS recouverts de MEC avec une élasticité liée à 
l'athérosclérose en présence ou en absence de BMP-9 +/- TNF-α. Tandis que la BMP-9 
n’avait aucun effet significatif sur l’expression des gènes codant pour VCAM-1, IL-1β et 
IL-6, le TNF-α, quant à lui, induisait dans les HAAECs adhérant aux films de PDMS 
mimant les artères athérosclérotiques et recouverts de Coll I des niveaux d’ARNm IL-1β 
plus élevés. Comparé au TNF-α utilisé seul, la co-stimulation BMP-9 et TNF-α augmentait 
l’expression de gènes codant pour une molécule d’adhérence vasculaire (VCAM -1) ou 
pour IL-6, mais de manière dépendante des protéines matricielles et/ou de l’élasticité du 
matériau. Ainsi, tandis que sous l’action combinée de BMP-9 et TNF-α, la FN favorise 
l’expression génique de VCAM-1, le mélange Coll/FN, augmente celle de l’IL-6. De plus, 
l’expression des gènes codant pour IL-1β en présence de TNF-α et IL-6 sous l’action 
combinée de BMP-9 et TNF-α était significativement plus importante dans les HAAECs 
adhérant au PDMS mimant les artères athérosclérotiques (2.8 MPa) et recouvert 
respectivement de Coll-1 et FN/Coll I.  
L’augmentation de l’expression de VCAM-1 suite au traitement combiné BMP-9 et TNF-
α pourrait induire un recrutement accru des leucocytes par les CE dépendamment du type 
de protéines adsorbées. Pour vérifier cet effet potentiel, nous avons analysé l'expression de 
VCAM-1 au niveau de la protéine ainsi que la localisation de la VE-cadhérine dans le 
contact cellule-cellule en fonction de l’élasticité du substrat mimant la progression de 
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l'athérosclérose. Fait intéressant, en accord avec les données d'expression génique, la co-
stimulation TNF-α et BMP-9 augmentait l'expression protéique de VCAM-1 et perturbait 
la VE-cadhérine lors du contact cellule-cellule par rapport au témoin.  
Pour conclure, nous avons développé avec succès un modèle in vitro pour une étude du 
comportement des CE dans le contexte de l’athérosclérose, en particulier en ce qui 
concerne la rigidification artérielle, la composition en protéines de la MEC et le contact 
avec BMP-9 ± TNF-α. En outre, nous avons noté que la BMP-9 régulait la réponse des 
HAAECs au TNF-α en termes d’expression de VCAM-1, IL-1β  et IL-6 en fonction des 
protéines matricielles FN/Coll 1 et/ou de l’élasticité du substrat, ce qui pourrait expliquer 
une infiltration excessive possible de leucocytes dans les régions sous-endothéliales en 
fonction du stade d’athérosclérose. Des co-cultures leucocytes / CE sur des films de PDMS 
recouverts de FN /- Coll 1 de modules de Young 1 à 2,8MPa permettraient d’élucider le 
rôle de la BMP-9 au cours du développement de l’athérosclérose. 
 
5.2 Global Conclusion 
During this Ph.D. project, we were able to produce PDMS films mimicking the elasticity 
of the human coronary artery wall in health conditions (Young's modulus 1.0 MPa) and 
atherosclerotic conditions (2.8 MPa) by varying the polymerization temperature. Usually, 
the stiffness of polydimethylsiloxane (PDMS) films is obtained by using various base: 
curing agent mass ratios, which may affect other properties of the PDMS. We first checked 
the Young's modulus value of PDMS films by tensile tests. The surface roughness and 
contact angle of the PDMS films were unaffected by the way PDMS films were prepared. 
Using these films, we were able to develop an in vitro model to study the effect of 
atherosclerotic stiffness on human aortic abdominal endothelial cell behavior (HAAEC).  
In the first phase of this PhD project, we have studied the morphology and spreading 
kinetics of HAAECs seeded on FN-coated PDMS films up to 6 h and observed a faster 
organization of focal adhesions after 1 h in agreement with spreading significantly higher 
after 2 h. This ability to organize focal adhesion points more rapidly could also explain 
why these cells were also able to form more fibrillar adhesion sites after 6 h. Indeed, by 
targeting several molecules (the α5 integrin subunit, the tensin and FN fibrils), we have for 
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the first time showed an increase in fibrillar adhesions in HAAECs adhering to FN-coated 
PDMS 1 MPa films. Nevertheless, we did not notice any significant effect of substrate 
stiffness on cell migration after 24 h. However, these fibrillar adhesions govern the ability 
of cells to rearrange their FN matrix and thereby affect the organization of the ECM 
proteins like type I collagen (Coll I) with which they interact. 
In the second phase of this PhD project, we extended the in vitro model by adding Coll I 
+/- FN. The use of Coll I / FN better mimics one of the changes in BM composition during 
atherosclerosis. The effect of BMP-9 on the behavior of HAAECs under pro-inflammatory 
conditions (TNF-α) was thus studied for the first time on a PDMS substrate covered by FN 
and / or Coll I with substrate bulk stiffness representing early and advanced atherosclerosis 
conditions. 
We showed that FN coating / Coll I is as effective as FN alone on Smad activation. For the 
first time, we verified that BMP-9-induced the nuclear translocation of P-Smad1/5 after 4 
h in HAAECs attached to PDMS films coated with ECM proteins. After 24 h, we observed 
a reduction in the number of cells following treatment with BMP-9 compared to the control, 
while the combined TNF-α / BMP-9 treatment prevented this decrease. 
We analyzed after 24 h the mRNA levels in ECs attached to MEC-coated PDMS films in 
the atherosclerotic stiffness range in the presence or absence of BMP-9 +/- TNF-α. BMP-
9 alone had no effect on VCAM-1, IL-1β or IL-6 gene expression, while TNF-α induced, 
for example, higher levels of IL-1β mRNA in HAAECs adhering to Coll I-coated stiff 
PDMS films. BMP-9 and TNF-α co-stimulation increased the expression of genes coding 
for a vascular adhesion molecule (VCAM -1) or IL-6 compared with TNF-α alone, but in 
a manner dependent on the matrix proteins and/or the elasticity of the material. Thus, while 
under the combined action of BMP-9 and TNF-α, FN favored gene expression of VCAM-
1, the mixture Coll / FN favored that of IL-6. In addition, expression of the genes encoding 
for IL-1β in the presence of TNF-α and IL-6 in the presence of BMP-9 plus TNF-α was 
significantly greater in HAAECs adherent to the 2.8 MPa PDMS films coated, respectively, 
with Coll-1 and FN / Coll I. Such a result on the expression of VCAM-1 following the 
combined BMP-9/TNF-α treatment suggests a potential increase in leukocyte recruitment 
by EC depending on the type of proteins adsorbed. To verify such effect, we analyzed the 
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expression of VCAM-1 at the protein level as well as the localization of VE-cadherin in 
cell-to-cell contact in HAAECs attached to the PDMS films. Interestingly, consistent with 
gene expression data, TNF-α / BMP-9 co-stimulation increased VCAM-1 protein 
expression and disrupted VE-cadherin at cell-to-cell contact compared with the control.  
To conclude, we have successfully developed an in vitro model to study the EC’s behavior 
in the context of atherosclerosis, particularly with respect to arterial stiffening, protein 
composition of BM, and BMP-9 ± TNF-α. We noted that BMP-9 regulates the response of 
HAAECs to TNF-α as a function of FN / Coll I matrix proteins, as well as substrate stiffness 
which could explain possible excessive leukocyte infiltration into the subendothelial 
regions depending on the stage of atherosclerosis. Leukocyte / EC co-cultures on FN / 
Coll1-coated PDMS films of Young’s modulus values from 1 to 2.8 MPa would help to 
elucidate the role of BMP-9 during the development of atherosclerosis. 
 
5.3 Perspective  
To prioritize the potential future work, a time-base overview is presented through the 
following steps:  
In short-term: 
• Verify the leukocyte recruitment by HAAECs attached to FN-coated PDMS 
with or without BMP-9 and/or TNF-α.  
• Identify the mechanism of BMP-9 action on HAAECs attached to FN-
coated PDMS by targeting its receptors in ECs via testing: 
o Involvement of type I Thr/Ser receptors (ALK1/ALK2) or type II 
receptors (BMPRII) 
o Crosstalk between BMP-9 receptors and integrins (e.x., α5β1)    
In long-term: 
• Establish a VSMCs/HAAECs co-culture model to better investigate BMP-
9/ECs role in atherosclerosis.  
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• Apply WSS via dynamic model in tubular PDMS scaffolds to better 
understand how BMP-9 affect EC function during atherosclerosis 
development. For example, the effect of pretreatment with healthy range of 
WSS (e.x., 12 dyne/cm2) prior to BMP-9 and/or TNF-α stimulation can be 
investigated regarding EC gene/protein expression of adhesion molecule 
VCAM-1.  
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6 APPENDIX A 
 
Dimensions of the molds used for PDMS film fabrication in this project.  
 
  
Diameter Height Length Width
Rectangle NA 1.6 62 10 1
Cylinder 73.8 3 NA NA 10
Cylinder 31.8 3 NA NA 4
Cylinder 60 15 NA NA 5
Cylinder 15.6 3.4 NA NA 0.5
Shape
Total applied 
PDMS 
volume (mL)
Dimensions   (mm)
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